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Abstract 
 
Gas-filled microbubbles suspended in a liquid or suitable gel are useful as a pressure 
probe for MRI. These microbubbles create size-dependent magnetic perturbation in 
their immediate vicinity, which alters the measured MR signal. The flexibility of these 
biocompatible bubbles enables them to undergo a change in size due to a change in 
pressure, resulting in a measurable MR signal change. The novel work we present here 
focuses on demonstrating, by in-vitro and in-vivo investigations, that phospholipid 
microbubbles entrapped in alginate spheres can be used as a contrast agent to measure 
pressure variations in the human stomach.  
The development of the pressure-sensitive contrast agent by entrapping microbubbles 
into alginate gel spheres is first presented. The T2eff relaxation time of the alginate 
spheres has been assessed using an MSME sequence and is found to decrease by a factor 
of 2 in the presence of microbubbles. Furthermore, by applying increasing pressure on 
to the alginate spheres containing microbubbles, the T2eff is seen to increase as the 
pressure increases, with a sensitivity of 43 % change per bar. 
The pressure sensitivity of the contrast agent is further assessed, in-vitro, by performing 
rapid pressure cycle experiments with the use of the RARE sequence, which exhibited 
around 40 % signal change per bar, in both the 2.35T small animal Bruker and the 3T 
whole body Philips MRI scanners. Although this sensitivity is seen to decrease in the 
presence of a simulated gastric acid solution, the effect has been minimised by 
suspending the alginate spheres in a locust bean gum gel with a 2 % w/v concentration. 
The gel solution is also acting as an immobiliser tool preventing the spheres from rising 
due to the buoyancy of the microbubbles. 
The capability of the contrast agent in sensing the dynamic pressure change in the 
stomach is then tested through in-vivo investigation. The study has been carried out on 
healthy human volunteers by preparing contrast agent as a meal for direct ingestion and 
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further imaged with the 3T whole body scanner. Initial results with the RARE sequence 
showed the signal change was dominated by the breathing movement, an artefact which 
was then dramatically reduced by the use of the BTFE sequence. However, the 
heterogeneity of the meal being captured in different images of the dynamic 
measurement was found to be another contributing artefact and we attempted to 
minimise this by locking the image acquisition to a specific volume of the meal with the 
use of respiratory triggering. As a result, the signal intensity change exhibited in the meal 
within the antrum region is between 5 to 10 %. This is slightly higher than expected 
signal variation which should be around 1.6 to 4.3 %, when considering the typical 40 % 
per bar sensitivity. 
Nevertheless, a novel pressure-sensitive contrast agent has been produced and its 
capability in measuring pressure changes in simulated human gastric conditions has 
been demonstrated. Furthermore, the preliminary in-vivo study demonstrates that this 
contrast agent shows great potential in sensing the dynamic pressure change in the 
human stomach. As a medical diagnostic tool, this will be useful for the clinician as an 
alternative avenue from the current invasive methods in diagnosing the clinical 
conditions related to functional dyspepsia.   
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Preface 
 
This thesis is divided into eight chapters detailing the works that have been undertaken 
in developing and testing a microbubble-based MRI contrast agent for pressure 
measurement in the human stomach. The research has been funded by MARA (Council 
of Trust for the Bumiputera), a Malaysian government agency, and the work has been 
carried out at the Nottingham Trent University and the University of Nottingham.  
Chapter 1 provides an introduction that describes the practical motivation of the study 
and it further discusses the background information of the topics that are relevant to 
this work. Chapter 2 explains the detail of the components and the methods that have 
been used to design the microbubble-based contrast agents. 
Chapters 3 to 6 discuss the experimental work involving in-vitro investigations to 
demonstrate the suitability and capability of the contrast agent in measuring pressure 
changes, including within the environment simulating the human gastric conditions. 
Each chapter is further divided into subsections explaining the experimental methods 
and results of the studies with the relevant discussions.   
The remaining experimental chapter (Chapter 7) discusses the in-vivo investigations that 
were carried out on human volunteers demonstrating the functionality of the contrast 
agent, as a meal, in sensing the dynamic pressure change in the stomach. Finally, the 
summary of the works presented in this thesis is also provided in the final chapter of the 
document. 
The appendix includes sections showing the scientific posters related to the study that 
have been presented by the author in various conferences, locally and internationally. 
It is in the author’s professional opinion that there is at least one publishable manuscript 
that could potentially be produced from this study, where work towards achieving this 
has been initiated at the time of submitting this document. 
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1. INTRODUCTION 
Practical Motivation 
Contrast agents are used widely in various medical applications providing a specific 
alteration and enhancement in the image contrast, useful to the clinical diagnostic. A 
notable combination between MRI and contrast agents has shown great impact in 
clinical applications, especially in helping to further distinguish between the healthy and 
unhealthy tissues or organs. Our work in this project is intended to explore the feasibility 
of using gas-filled microbubbles within a tailored MRI contrast agent and its suitability, 
for in-vitro and in-vivo applications, in measuring pressure changes in the human 
stomach. 
It has been demonstrated in a previous MRI study (Alexander, McCreery et al. 1996) that 
microbubbles have great potential to be used within contrast agents in measuring 
pressure changes in the vascular system and other organs. Commonly, phospholipids 
molecules are used as a thin shell material encapsulating gas in the core creating 
micrometre-sized bubbles. The compressibility of these bubbles causes them to undergo 
size changes due to pressure, therefore altering the corresponding NMR signal. In 
ultrasound imaging, this type of bubble is commercially available in the form of an 
injectable fluid solution.  
In some clinical conditions such as functional dyspepsia, the symptoms of the patient 
are greatly related to the disruptions of normal function of the stomach (Wilmer, Van 
Cutsem et al. 1998), and are thought to result in abnormal variations in the meal 
pressure exerted by the stomach. It should therefore be of great value to develop a 
pressure-sensitive MRI contrast agent. The solution we have explored in this study 
consists in entrapping microbubbles in alginate gel spheres and we further 
demonstrated its sensitivity in measuring the pressure changes in in-vitro and in-vivo 
applications.  
In order to map pressure changes in different areas in the meal within the stomach, it 
would be challenging to use a fluid solution because the pressure would nearly 
equilibrate instantaneously throughout the meal’s volume. However, using a soft-solid 
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material, such as a large collection of small alginate spheres as an artificial meal is 
expected to overcome this issue allowing measurement of pressure changes to local 
compression. In this way, the microbubbles are immobilised in an elastic gel network 
whilst maintaining its compressibility and flexibility.    
Aims and Objectives 
This work is focusing on the development of microbubble-based contrast agents for 
ingestion, for humans, with applications in diagnostic Magnetic Resonance Imaging of 
the gastrointestinal system, by means of non-invasive meal pressure measurement.  
The aims of the works are 
x to design a microbubble-based contrast agent for ingestion and in-vivo MR 
investigation of the pressure spatial distribution in the human stomach’s meal. x to rapidly map the NMR relaxation time changes within the contrast agent as the 
pressure change.  
x to test and quantitate the performance of the contrast agent on in-vitro 
applications, including within the condition simulating the human stomach. 
x to demonstrate a spatial pressure gradient on the microbubble-containing meal 
using MRI.  x to test, through in-vivo applications, the capability of the contrast agent in 
sensing pressure changes in the stomach of healthy human volunteers.  
 
The Principles of MRI
In this section, we will discuss the basic theory related to Magnetic Resonance Imaging 
(MRI), to be able to have a fundamental understanding before we further discuss its 
application in our study. 
Magnetic Features of the Nucleus 
MRI works using the intrinsic magnetisation of some nuclei and also requires these to 
be placed in an external magnetic field. Nuclear spin is an intrinsic property of each 
atomic nucleus. It can be zero or non-zero for a given nucleus based on the combination 
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of protons and neutrons that constitute it. Nuclei with a non-zero spin exhibit magnetic 
moment and angular moment characteristics. There are some biologically-relevant 
elements, in particular, hydrogen (1H), carbon (13C), oxygen (17O) and sodium (23Na) 
which are able to produce signals known as nuclear magnetic resonance (NMR). As the 
human body is composed of approximately 62 % of hydrogen atoms, the nucleus of this 
atom, the proton, is the principal element for generating NMR signals. The magnetic 
characteristics of the nucleus are described by the nuclear magnetic moment. It is a 
vectorial field quantity that can be represented by a collection of vectors indicating the 
magnitude and direction of the magnetic field distribution surrounding the nucleus. 
Basically, the spinning proton, or nuclear spin, generates its own small magnetic field. 
A great abundance of spins aligned together will result in a measurable magnetic 
moment, called the macroscopic nuclear magnetisation. Naturally, the spins in a 
biological tissue for example, are distributed with random orientations due to the 
thermal energy being orders of magnitude larger than the magnetic energy interaction 
with the earth’s magnetic field. As a result, the macroscopic magnetisation is 
approximately zero. However, if these spins are placed in a strong static external 
magnetic field, B0, they will tend to align with it in two possible orientations, either 
parallel or antiparallel to it. The orientation of each spin depends on how much energy 
it has, the anti-parallel requires higher energy than parallel spins. The energy difference 
between parallel and antiparallel states is directly proportional to the strength of B0. A 
slightly greater number of spins exist in a parallel direction resulting in a measurable net 
magnetisation, M0, in the direction of B0. This process is called nuclear spin polarisation. 
The ratio of the number of spins parallel (low energy) with spins antiparallel (high 
energy) is given by the Boltzmann distribution: 
 
௛ܰ௜௚௛௟ܰ௢௪ =  ݁ିఊ԰஻బ௞்  
Equation 1.1 
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where ௛ܰ௜௚௛ is the number of spins in the high energy, ௟ܰ௢௪ is the number of spins in 
the low energy, ߛ  is the gyromagnetic ratio of the nuclear species of interest, (԰ =݄/ʹ˒ ) is Plank’s constant, ܤ଴  is the strength of the external field, ݇ is Boltzmann’s 
constant and ܶ is the temperature. 
During the polarisation, the spin also experiences a torque which makes it precess 
around the direction of ܤ଴. The precession occurs at an angular frequency, known as the 
>ĂƌŵŽƌĨƌĞƋƵĞŶĐǇ͕ʘ0, that is proportional to ܤ଴, as described by the Larmor equation, ߱଴ =  ߛܤ଴ 
Equation 1.2 
 
Nuclear Magnetic Resonance
To be able to measure M0, a brief radiofrequency (RF) excitation field, which is 
orthogonal to the direction of B0, is applied. This results in the tilting of M0, at an angle 
relative to the direction of B0, on to the plane which conventionally known as the 
transverse plane (x-y) (Figure 1.1). IŶŽƌĚĞƌƚŽŚĂǀĞĂŶĞīĞĐƚ, the frequency of the RF 
pulse, transmitted by a coil, is tuned to match the Larmor frequency. Furthermore, as 
the RF pulse is applied, all the spins are in phase coherence, which means that they point 
into the same direction.  
As a result, a voltage is induced which is proportional to the angle of the M0 relative to 
the direction of the B0. This voltage constitutes the NMR signal itself and can be 
monitored by using a receiver coil. In the absence of the external RF field, the net 
magnetisation will always attempt to return to the equilibrium state by precessing (at 
ƚŚĞ>ĂƌŵŽƌĨƌĞƋƵĞŶĐǇͿĂďŽƵƚƚŚĞĚŝƌĞĐƚŝŽŶŽĨƚŚĞƐƚĂƚŝĐŵĂŐŶĞƚŝĐĮĞůĚ͘Therefore, when 
the RF pulse is turned off, M0 is left to precess about the longitudinal axis and the 
amplitude of the magnetisation in the transverse plane decays exponentially to zero 
within a typical time called T2 or transverse relaxation time.  
11 
 
 
 
Figure 1.1 – (a) The net magnetisation (bolded arrow), M0, is parallel to the direction of 
B0 on a z-axis called by convention the longitudinal axis. (b) After application of the RF 
pulse, M0 resides in the transverse (x-y) plane. The dotted circle represents the 
trajectory of the magnetisation vector experiencing precession about the polarising field. 
 
NMR Relaxation Time 
Relaxation times describe how long the magnetisation takes to get back to equilibrium 
after an RF pulse. There are two types of relaxations involved, which are spin-spin and 
spin-lattice relaxation, also respectively known as T2 and T1 relaxations.  
Spin-Spin Relaxation 
Spin-spin relaxation is also called the T2 relaxation. Whenever the spins come close to 
each other, an interaction takes place which affects their individual magnetic moment 
and relative phase angle, irreversibly. With time, phase scrambling increases, until it 
reaches the point where the spins are fully out of phase, resulting in a zero vector sum 
of nuclear magnetisation. Normally, the time taken for the magnetisation to reach zero 
is of the order of milliseconds (or longer), with an exponential time-course, as in: ܯ௫௬ (ݐ) = ܯ଴݁ି ௧ ୘మΤ  , 
Equation 1.3 
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where ܯ௫௬ (ݐ) is the transverse component of magnetisation at time, ݐ, and ܯ଴ is the 
transverse magnetisation at ݐ= 0. The relaxation time T2 is therefore also the time taken 
by the transverse component of magnetisation to decay to approximately 37 % of its 
original amplitude after the excitation RF pulse. 
Inhomogeneities in the polarising field will also further contribute to the spin phase 
scrambling. However, this effect is fully reversible in the absence of molecular diffusion, 
and partially reversible in the presence of molecular diffusion. After a single excitation 
pulse, the exponential decay time constant due to both spin-spin interaction and 
external field inhomogeneities is known as T2*, which is shorter than T2 relaxation.
Spin-Lattice Relaxation 
In parallel, after the RF pulse is switched off, the magnitude of longitudinal 
magnetisation begins to recover to equilibrium in an exponential time course, 
simultaneously with transverse magnetisation decay. However, the time taken for the 
longitudinal magnetisation to recover is usually longer (or equal) than for the transverse 
magnetisation. The term spin-lattice relaxation is describing the spins interacting with 
the lattice, e.g. the surrounding tissue. The time course of the magnetisation is as 
follows:  ܯ௭ (ݐ) = ܯ௭(0)݁ି ௧ ୘భΤ + ܯ଴(1 െ ݁ି ௧ ୘భΤ ), 
Equation 1.4 
 
where ܯ௭ (ݐ)  is the longitudinal magnetisation at the time, ݐ , and M0 is the peak 
amplitude of the longitudinal magnetisation, in an equilibrium condition. When ݐ = T1, ܯ௭ is approximately 0.63M0, meaning that the T1 relaxation time is the time taken by 
the longitudinal magnetisation to recover to 63 % of its peak amplitude. 
Magnetic Field Gradients  
In addition to the polarising field and RF coils, an MRI machine is normally equipped with 
a third coil assembly which enables the encoding of the NMR signal so as to reconstruct 
two or three-dimensional images. This coil is commonly known as the gradient coil. It is 
usually mounted in the core of the scanner generating a longitudinal magnetic field with 
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spatial variations in strength, enabling the information on the position where the NMR 
signal is emitted to be worked out from the frequency of the signal. 
For example, one of the coil types that can be used for this purpose is the Maxwell pair, 
which uses a single pair of coils as shown in Figure 1.2 to generate a field gradient (Gz) 
in the z-axis, along the direction of the polarising ĨŝĞůĚ͘dŚĞĮĞůĚŐĞŶĞƌĂƚĞĚďǇƚŚŝƐĐŽŝů
has a linear spatial dependence towards the middle of it. At the centre of the gradient 
coils, and also the centre of the polarising coil, there is no additional magnetic field 
generated. The field resulting from the addition of the polarising field and that of the 
field gradient respectively increases or decreases linearly along the coordinate of the z-
axis for positive and negative values of z.   
 
Figure 1.2 – A single pair of coils with counter-rotating currents (blue circles) known as 
the Maxwell pair is used to produce a field gradient (Gz), represented with the diagonal 
blue line, along the direction of the polarising field (z-axis), in the MRI scanner 
(McRobbie, Moore et al. 2006).  
 
When both of the polarising and gradient fields are combined, the resulting externally 
applied field is now also spatially dependent, which consequently affects the 
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magnetisation precession frequency. This means that protons in the centre of the coil 
precess at the same frequency as those affected by the polarising field only, and 
increases or decreases respectively with distance from the centre. This spatially 
dependent Larmor frequency is represented by the equation below: ߱(ݖ) = ߛ(ܤ଴  + ܩ௭ݖ) 
Equation 1.5 
 
The gradient field can be applied in different axis, Gx, Gy or Gz or combinations of these, 
which can be used for this purpose, allowing us to produce transverse, sagittal, coronal 
or oblique slices. 
Spatial Encoding 
The NMR signal is a rapidly changing electric voltage in the receiver coil, oscillating at 
high frequencies. This is converted to a digital signal which is stored temporarily in the 
ĐŽŵƉƵƚĞƌďĞĨŽƌĞďĞŝŶŐƌĞĐŽŶƐƚƌƵĐƚĞĚŝŶƚŽƚŚĞĮŶĂůŝŵĂŐĞ͘ It has been described in the 
previous section, by combining the polarising field and the RF excitation with a gradient, 
the MR interactions and information collections are focused to a two-dimensional plane, 
which also known as slice selection. In order to obtain a further localised information 
within this plane, the NMR signal is encoded in terms of the spatial frequencies of the 
object using phase encoding and frequency encoding gradients. 
Phase Encoding 
The phase-encoding is the process of locating an MR signal by altering the phase of spins 
in one dimension with a pulsed magnetic field gradient along that dimension prior to 
the acquisition of the signal. This allows the information to localise the signal to a 
particular row of the data matrix.  
If the system starts with all the magnetic moments aligned, we can cause a spatially 
dependent de-phasing by applying this gradient. Then, wŚĞŶǁĞƐǁŝƚĐŚŽī the gradient, 
all the nuclei will revert to their originaůĨƌĞƋƵĞŶĐǇŽƌƐƉĞĞĚ͕ďƵƚǁŝůůŬĞĞƉƚŚĞŝƌĚŝīĞƌĞŶƚ
phase angles. This way, they are said to be phase encoded. The relative phase 
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ĚŝīĞƌĞŶĐĞƐďĞƚǁĞĞŶ ƐŝŐŶĂůƐŝŶĚŝīĞƌĞŶƚůŽĐĂƚŝŽŶƐƌĞŵĂŝŶƵŶƚŝůĞŝƚŚĞƌĂŶŽƚŚĞƌŐƌĂĚŝĞŶƚŝƐ
applied or the phase become scrambled due to T2*. 
Frequency Encoding 
Frequency encoding uses the same gradients as in phase encoding but this time the 
magnetic resonance signal is collected during the application of the gradient. Using 
frequency encoding removes the need to wait for the repetition time between steps in 
the second dimension. In spin warp imaging, after the excitation RF pulse, a phase 
encoding step is performed at a given intensity before measuring the magnetic 
resonance signal during the application of a frequency encoding gradient. This is then 
ƌĞƉĞĂƚĞĚǁŝƚŚĚŝīĞƌĞŶƚƉŚĂƐĞĞŶĐŽĚŝŶŐŐƌĂĚŝĞŶƚŝŶƚĞŶƐŝƚŝĞƐ͘ 
If we applied frequency-encoding gradients in two directions at the same time we would 
have no way of knowing whether a particular frequency in the signal originated from 
one or the other (or both) of the applied gradients. By combining phase encoding and 
frequency encoding in two orthogonal directions we can collect all the spatial 
frequencies that we need to make the image unambiguous. The collected signal from 
both of these techniques is stored in k-space. 
k-Space 
k-Space is the raw data matrix, which is used to store the digitised MR signals during 
data acquisition. The signal information collected from the frequency and phase is 
encoded as rows and columns. During the collection of the information, the k-space is 
filled line by line. Once the matrix is full, the data in k-space is reconstructed using a 
mathematical operation called Fourier transform (a mathematical operation that relates 
the phase and encoding data) to produce the final image. Although the transformed 
data matrix size corresponds to the image matrix size, the pixels do not correspond 
directly with each other. For example, the information in the top right pixel in k-space 
does not contain the raw information for the top right pixel in the final image. Instead, 
in k-space, the central regions contain signal-to-noise and contrast information for the 
image, and data around the edges contain all the information about the image 
resolution. 
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Generating Echoes 
There are two main types of echoes in MRI, the Spin Echo (SE) and the Gradient Echo 
(GE). Both techniques begin with an RF pulse excitation to flip the magnetisation into 
the transverse plane.  
The spin echo phenomenon has been first discovered and explained by Hahn (Hahn 
1950). A schematic representation of the spin echo generation is shown in Figure 1.3. In 
the SE technique, the RF pulse flips the longitudinal magnetisation to the transverse 
plane, leaving the spins to dephase naturally, as explained in section 1.3.2. Subsequently, 
an RF pulse with 180° flip angle, also called refocusing pulse, is applied to rephase the 
spins and to create an echo (Carr, Purcell 1954). Following the application of the 
refocusing 180° pulse, the phase angle of spins is inverted (Figure 1.3 (d) and (e)), 
resulting, after a specific time duration, in the partial cancellation of the dephasing 
effect caused by the polarising field inhomogeneities. After a delay of time equal to the 
time between 90° and 180° pulses (TE/2), the spins phase coherence is partially re-
established, producing a spin echo. The time taken from the 90° RF pulse to the 
production of the spin echo is known as the echo time (TE).  
The refocusing can be repeated several times to allow determination of the spin-spin 
relaxation exponential time constant. Because of molecular self-ĚŝīƵƐŝŽŶ, the spins will 
ŶŽƚ ƌĞŵĂŝŶ ŝŶ ƚŚĞ ƐĂŵĞŵĂŐŶĞƚŝĐ ĮĞůĚ ĚƵƌŝŶŐ ƚŚŝƐ ƉƌŽĐĞƐƐ͕ ĂŶĚ ŝŶ consequence the 
magnetisation will not return to its original value, instead returning to some percentage 
of it. The drop in peak magnetisation of each echo is another measure of the properties 
of the system and takes place exponentially with time constant known as the effective 
T2 (T2eff). ǇĐŚŽŽƐŝŶŐĂƐƵŝƚĂďůĞǀĂůƵĞĨŽƌƚŚĞĞĐŚŽƚŝŵĞ͕ƚŚĞĞīĞĐƚŽĨƚŚĞĚŝīƵƐŝǀĞŵŽƚŝŽŶ
can be minimised or enhanced. 
The main difference between SE and GE techniques is the absence of the refocusing RF 
pulse in GE. Gradient echo sequences use field gradients to dephase or refocus the 
magnetic moments. In the most basic GE sequence, after the application of the 
excitation RF pulse, a magnetic field gradient is applied which causes the spins to 
dephase rapidly. A field gradient with opposite polarity is further applied, after a period 
of time, TE/2, which change the direction of the induced precession. This causes the 
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spins to rephase and creating gradient echo. This means the spins are refocused by 
reversing the direction of the spins rather than flipping them over to the other side of 
the plane (the x-y plane) as occurs with the SE sequence. However, the effects of the 
polarising field inhomogeneities are not cancelled out in GE, which means the signal 
decays faster. The GE technique requires a relatively short time, hence, this method is 
widely used in fast MR imaging sequences. 
 
 
Figure 1.3 – Diagram showing the formation of a spin echo (SE). a) After the 90° RF pulse 
excitation, a subsequent 180° RF pulse is applied to refocus the spin and thus, the SE 
signal is formed after a delay of time, TE. b) Magnetisation after tipping into transverse 
plane, c) Dephasing magnetisation, d) Dephased magnetisation, e) System after 
application of refocusing pulse along x, f) Magnetisation near beginning of echo 
envelope, g) Magnetisation at the echo time after the initial pulse. Red arrow is all 
magnetic moments in phase; yellow, green and blue arrows are, respectively, fast, 
medium and slowly dephasing magnetic moments. Diagram reproduced from Morris, 
2009. 
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Basic MRI Pulse Sequences 
A pulse sequence is a set of RF and gradients pulses which are usually repeated in a 
series, each separated by the repetition time, TR. Generally, a pulse sequence is created 
based on a spin echo or gradient echo. There is a great number of pulse sequences being 
used for MR image acquisition. In this study, three particular pulse sequences we used; 
Multi-Slice and Multi Echo (MSME), Rapid Acquisition with Relaxation Enhancement 
(RARE) and Balanced Turbo Field Echo (BTFE).  
MSME Sequence
The MSME sequence works based on the SE technique (Carr, Purcell 1954). In this 
sequence, the excitation 90° RF pulse is applied to flip the longitudinal magnetisation
into the transverse plane and then, followed by multiple refocusing 180° RF pulses to 
create an echo train. The amplitudes of the echoes are decreasing over time, in an 
exponential decay with decay constant called the effective transverse relaxation, T2eff. A 
train of echoes contribute to a single line in a raw data matrix, the k-space.  
After a delay of time, TR, the same step is repeated, meaning another echo train is 
collected. This process is continuously repeated until the k-space is fully scanned. The 
imaging time is longer when compared to other sequences e.g. RARE, because each k-
space line requires an excitation pulse. The advantage is a large amount of information 
is collected due to the multiple echoes. The MSME is effectively used as a method for 
measuring the T2eff value.  
RARE Sequence 
The RARE sequence is a fast imaging method with T2-weighting image quality (Hennig, 
Nauerth et al. 1986). The RARE sequence, which also known as Turbo Spin Echo (TSE), is 
a modification of the multi-echo sequence, thus involves RF excitation and echo train 
generation as seen before. Each echo in the echo train is individually phase encoded in 
an incremental order. In this sequence, each echo corresponds to a different line in the 
k-space. This means that a single echo train can be used to produce a full 2D image, if 
the T2 value is long enough. One of the parameters to be determined for this sequence 
is the effective echo time, TEeff, which is defined as the time between the application of 
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the excitation RF pulse and the echo acquired at the centre of k-space. In our application, 
the typical TEeff explored is ranging between 300 to 600 ms. 
BTFE Sequence 
The Balanced Turbo Field Echo (BTFE) (Oppelt, Graumann et al. 1986), also commonly 
known as TrueFISP (True Fast Imaging with Steady-state Precession), is a gradient echo 
technique. This sequence is based on a gradient echo steady state magnetisation 
method, in which the magnetisation is kept constant with each repetition. This requires 
the same sequence of RF excitation pulse repeated with a very short TR, which is shorter 
than the T2 value, until the magnitude of the magnetisation is constant from one 
repetition to the other. Once this equilibrium is reached, two types of signals are 
produced: the first signal is free induction decay (FID), which is formed after excitation 
with the most recent RF pulse. The second component is spin echo, which is formed 
when the residual echo from the previous RF excitation is refocused by the current RF 
pulse. 
Due to the ultrashort acquisition time, the image quality of the BTFE images is not 
affected by motion, which make this sequence suitable for cardiac and abdomen 
imaging where breathing and organ involuntary movement could cause the image 
artefacts.  
Additionally, it has been previously shown that it is possible to produce a T2eff-weighted 
MR image using single-shot BTFE with a spin echo (SE) preparation pulse, which is also 
known as the T2-preparation time, applied immediately before the BTFE pulse (Hoad, 
Cox et al. 2010). This method is particularly useful in our application as we need this 
time delay to leave some time for the T2* contrast to take place in the contrast agent.  
Magnetic Susceptibility Effect 
The application of an external magnetic field is able to induce a magnetisation in a 
material. The strength and polarity of the resulting magnetisation depend on the 
material under investigation, based on their electrons arrangement in the atomic and 
molecular structure. This is described macroscopically as the magnetic susceptibility 
effect.  
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The following equation defines the magnetic susceptibility of a material:  
 ࡹ = ߯ࡴ  
Equation 1.6 
 
where M is the magnetisation of the material, ɖ is the magnetic susceptibility and H  is 
an externally applied magnetic field. 
The magnetic susceptibility is classified into at least three categories: diamagnetic, 
paramagnetic and ferromagnetic. Diamagnetic materials induce an internal 
magnetisation effect, also known as negative susceptibility, which opposes to the 
external field direction, lowering the overall magnetisation within the material. 
Examples of diamagnetic materials are water and most organic compounds. In contrast, 
paramagnetic materials will slightly increase the resulting magnetic field, hence, it is 
defined as having a positive susceptibility. Gadolinium-based contrast agents, widely 
used in medical applications, exploit this effect. Similarly, ferromagnetic materials will 
also increase the local magnetic field, but to such an extent that it severely disturbs the 
magnetic field homogeneity, and consequently deteriorates the signal acquisition. 
The Effect of Internal Magnetic Field Gradients 
 ŐƌĂĚƵĂů ĐŚĂŶŐĞ ŽĨ ĮĞůĚ ƐƚƌĞŶŐƚŚ͕ Žƌ ŵĂŐŶĞƚŝĐ ĨŝĞůĚ ƐƉĂƚŝĂů ŐƌĂĚŝĞŶƚ͕ ŝƐ ŐĞŶĞƌĂƚĞĚ
between two adjacent materials with different inherent magnetic susceptibilities. The 
susceptibility contrast created by these two materials causes a local field gradient 
commonly known as an internal magnetic field gradient. In some cases, this effect is 
regarded as a disadvantage because it can cause image artefacts for example in the brain, 
ǁŚĞƌĞƚŚĞƐŝŶƵƐƐƉĂĐĞƐĮůůĞĚǁŝƚŚĂŝƌĂƌĞŝŶƚŚĞŝŵŵĞĚŝĂƚĞvicinity of bone and soft tissue 
generating strong internal gradients. However, this effect can be used to an advantage, 
such as in our work, where we exploited the magnetic susceptibility difference between 
gas and liquid in a gas-filled microbubble.
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Magnetic Field Perturbation Around Compressible Sphere 
 
 
Figure 1.4 – Schematic representation of the gas-filled microbubble with radius ܴ 
showing the local magnetic perturbation at the coordinates (ݎ, ߠ) in an external field ܤ଴ 
as explained in Equation 1.7. 
 
The effect of a gas-filled microbubble residing in a liquid and further placed in a static 
magnetic field has been explored in previous work. A magnetic susceptibility step 
change takes place at the microbubble periphery due to the gas-liquid interface at the 
microbubble shell. This is defined by the following (spherical coordinate system) 
equation (Dharmakumar, Plewes et al. 2002) οܤ(ݎ,ߠ)ܤ଴ = 13ο߯ ൬ܴݎ൰ଷ (3 ܿ݋ݏଶߠ െ 1), 
Equation 1.7 
 
where οܤ is the local magnetic perturbation at the coordinates (ݎ, ߠ), ݎ is the radial 
distance from the centre of the microbubble at angle ߠ from the direction of the static 
polarising magnetic field, ܤ଴ , and ο߯  is the magnitude of magnetic susceptibility 
difference between the bubble gas with the surrounding medium, and ܴ is the radius of 
the microbubble (Figure 1.4).  
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Figure 1.5 – Schematic plot showing the magnetic field perturbation of two different 
sizes of bubbles (central disc), (a) 2 µm and (b) 3 µm, with the proton undergoing the 
same diffusion random path (white lines). Their measured FID is shown respectively in 
(c) and (d) (Morris 2009). 
 
As the proton-carrying molecules in the suspending fluid diffuse around a microbubble, 
they sample different magnetic field strengths as a result of the perturbations, with the 
molecules closer to the vicinity of the microbubble experiencing faster dephasing 
compared to those farther away. In addition to this, the compressibility of these bubbles 
enables them to undergo a radius change when an external pressure is applied, which 
consequently changes the spatial distribution of the local magnetic field perturbation 
and thus the T2* NMR relaxation time (Alexander, McCreery et al. 1996). This effect is 
demonstrated in Figure 1.5. The greater the field perturbations sampled by the proton, 
the greater the extent to which the signal will decay due to dephasing, which yields 
image contrast to fluid pressure. There is a number of works that have been published, 
theoretical and experimental, regarding the application of this system, and these are 
exhaustively discussed in section 1.5. 
23 
 
Microbubble-based Contrast Agents 
As we have seen, gas-filled microbubbles create a magnetic susceptibility effect due to 
the air to liquid interface. Various works have demonstrated that microbubbles with this 
unique susceptibility effect offer the design of promising contrast agents for a direct 
pressure measurement in fluid. The potential application of the microbubble in MRI was 
initially described by Unger et al., suggesting this can be used as a contrast agent to 
improve visualisation of blood circulation in the brain (Unger, Ugurbil et al. 1994). Soon 
after, the application of these bubbles in an MRI pressure measurement was 
experimentally explored and proposed as a non-invasive technique to evaluate a 
cardiovascular function (Alexander, McCreery et al. 1996). 
 
Microbubble-based Contrast Agent Design 
Components 
Microbubbles are typically formulated from biocompatible materials, such as 
phospholipids and biopolymers, as a shell and a gas filling in the core (Chow, Chan et al. 
2010). Concomitantly, the main components of our contrast agent consist of the shell 
material of the microbubbles, the gas filling and the medium in which they are 
suspended. The properties of each of these components are discussed in this section.  
1.4.1.1.1 Shell Materials  
The shell material is used to encapsulate the gas in forming the microbubble. The 
selection of its material is important to obtain a stable microbubble preparation. In 
medical imaging applications, the microbubble shell consists of biocompatible materials 
to enable this type of contrast agent suitable to be used in the human body. There are 
two types of microbubble shell currently available, the stiff type which is typically made 
from polymers (Glynos, Koutsos et al. 2009) and the flexible shell normally composed of 
phospholipids (Santos, Morris et al. 2012). In our works, we used phospholipid as the 
bubble shell material of our contrast agent, due to its compressibility, in response to an 
external pressure. The characteristics of both shell types will be explained in this section.  
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1.4.1.1.1.1 Phospholipids 
For MRI pressure measurement, phospholipids such as Dipalmitoyl Phosphatidylcholine 
(DPPC) and Distearoyl Phosphatidylcholine (DSPC) are preferable for a flexible shell to 
maximise the compressibility effect (Kaur, Morris et al. 2009).  
A phospholipid is an amphiphilic molecule, with a hydrophilic head group and a 
hydrophobic tail, which works as an air-water interface layer between the gas bubble 
and its surrounding medium. As suggested in Figure 1.6, the hydrophilic polar head 
orients itself spontaneously facing outwards to the aqueous region, whilst the 
hydrophobic tail consisting of hydrocarbon chains tends to face inwards to the air or gas 
phase (Tanford 1980).  
 
Figure 1.6 – The hydrophilic polar head orients itself spontaneously facing outwards to 
the aqueous region, while the hydrophobic tail tends to face inwards to the air or gas 
phase. 
 
In addition, it has been shown by adding cholesterol to the components of phospholipid 
formulations that the stability of microbubbles can be significantly increased without 
affecting its size (Kaur, Morris et al. 2009). This component acts as an additional 
hydrophilic coating to the microbubble shell and prevents them from coalescing, which 
increases their longevity in the surrounding medium. 
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1.4.1.1.1.2 Polymer 
Another type of gas-filled microbubble that is currently used is the polymeric 
microbubble (Bloch, Wan et al. 2004), but not in the pressure measurement context. Its 
shell component is made from polymer materials such as polymer polylactide. 
Compared to the phospholipid microbubble, the shell properties of polymeric 
microbubble are generally stiffer (Glynos, Koutsos et al. 2009). Nevertheless, this type 
of microbubbles is extensively used as an ultrasound contrast agent, particularly in 
monitoring blood flow through the circulatory system, and has shown a great success as 
a drug delivery carrier in biomedical applications (Hernot, Klibanov 2008).  
1.4.1.1.2 Gas Filling 
The properties of the gas filling in the core of microbubbles have an influential effect on 
its stability. In the early design of microbubbles, the air was used as a gas filling. They 
were made commercially available for ultrasound imaging applications, requiring an 
injection into blood vessels (Keller, Glasheen et al. 1989). The challenge when using this 
contrast agent is that the microbubbles disappear from the bloodstream within seconds 
after administration because of the high solubility of air in the blood (Schutt, Klein et al. 
2003). Schutt et al. explained the reason for this is that the gas pressure within the 
bubbles is the sum of the equilibrium pressure (Henry's law); the Laplace pressure, and 
the blood pressure, which together exceed the gas pressure in the blood. 
Hence, inert gases with high molecular weight and low solubilities such as 
perfluorocarbons and sulphur hexafluoride have been used in more recent microbubble 
contrast agents (Sboros 2008). This increases their stability and has effectively 
prolonged their lifespan in the medium compared to the air (Kogan, Gessner et al. 2010). 
For this particular reason, in our study, perfluorocarbon gas, octafluoropropane, was 
used in all of our preparations to make stabilised microbubbles and the methods of 
production will be fully discussed in chapter 2 of this thesis. A list of commercially 
available microbubbles and their gas filling is shown in Table 1.1.  
Suspending Medium 
The suspending medium is the viscous solution surrounding the microbubbles and 
constituting a full part of the contrast agent. It serves as an immobilising tool, and also 
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enables the MR measurements to be taken. Normally, the microbubbles are produced 
in an aqueous solution which gives these bubbles a natural buoyancy. It is essential that 
the suspending medium fulfils certain requirements, not just to prevent the bubbles 
from rising but also to keep them functional. It should furthermore contain free water 
molecules which are able to diffuse around the microbubble with a self-diffusion 
coefficient as close to that of bulk water as possible. In addition, the suspending medium 
must be made from materials which are harmless to the human body allowing us to use 
the contrast agents for medical purposes.  
Within the past MRI investigations, the earliest work was using methylcellulose as a 
microbubble suspending medium, as reported in 1996 (Alexander, McCreery et al. 1996), 
where the bubbles were seen to rise within the preparation. Over the past years, several 
other types of suspending media have been used relating to microbubble-based contrast 
agents and mostly containing polysaccharide molecules, for example, gellan gum and 
xanthan gum (Morris, Bencsik et al. 2008). The long chain properties of polysaccharide 
molecules (Figure 1.7), enables them to form a polymer network to entangle the 
microbubbles, making this molecule one of the most common materials used as a 
suspending medium for microbubbles. Morris has demonstrated the gellan gel at 2 % 
(w/v) concentration was able to immobilise the bubble with minimal reduction in the 
diffusion coefficient. Furthermore, another useful property of many polysaccharides is 
that their viscosity can be further increased by cross-linking their structure with a salt. 
 
Figure 1.7 – The Chemical structure of the gellan gum (Cassanelli, Norton et al. 2017). 
 
For the purpose of our study, we used gellan gel (2 % w/v) to immobilise the bubbles in 
the initial part of our experiments, and then we further moved on to using alginate as it 
is able to entrap microbubbles and form a soft solid gel while maintaining flexibility to 
compression. This owes to their special ability to form a sphere mainly in the presence 
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of calcium ions (Draget, SkjakBraek et al. 1997). When these ions are added, the 
molecular chains in the alginate solution bound to each other in a process known as 
cross-linking (Figure 1.8). In general, alginate is a natural polysaccharide commonly 
extracted from brown algae, which is part of the cell wall and intracellular material 
(Rinaudo 2014). It has been widely used in the food industry (Lee, Rogers 2012) as a food 
additive, stabiliser and thickening agent. In addition, this substance is available at food 
grade standard which allows us to use this semi-solid sphere with microbubbles 
entrapped as a meal and contrast agent for pressure measurements in the stomach 
using MRI.  
 
Figure 1.8 – Diagram showing the structures of molecules in the alginate (far left) and 
the chains of these molecules bound to each other in the presence of calcium ion (right). 
Source: (Lee, Rogers 2012). 
 
Production Methods 
Advancement in the production techniques of gas-filled microbubbles has primarily 
enhanced the stability, concentration and monodispersity of these bubbles, which are 
the key points in most of their applications.  Over the years, there have been various 
techniques developed to create these microbubbles. In this section, we discussed three 
main methods of gas-filled microbubbles production: shear mixing, flow focusing and 
sonication. 
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Shear Mixing 
Shear mixing is one of the conventional techniques in manufacturing microbubbles. It 
uses mechanical agitation to produce sufficient force to introduce gas from the ambient 
environment into the aqueous lipid mixture, resulting in the formation of stabilised 
microbubbles. Commonly, a vial is filled with lipid suspension with a gas head space and 
then shaken rapidly to yield the microbubbles. The rate of this alternating motion is 
important in determining the amount and size of the microbubbles formed, with higher 
rate making a smaller size bubble. There are several variants of the equipment in making 
microbubble using this method, a popular mechanical shaker (VIALMIX®) used in clinical 
applications to create a leading ultrasound contrast agent has a shaking frequency of 
approximately 4500 oscillations per minute (Sboros, Moran et al. 2001). In our work, we 
used this technique to fabricate our microbubbles because the equipment is 
comparatively inexpensive and produces microbubbles rapidly and in large enough 
density and overall quantity. The method of production will be further explained in 
chapter 2 (section 2.2.2) of this document. Figure 1.9 shows the microscopic image of 
microbubbles produced using this technique. 
The size of the microbubbles is controllable up to a point by varying the speed of the 
shearing motion, with faster shearing giving smaller bubbles. At too slow speed, neither 
cavitation nor vortexing occurs whilst at too high speed, the membrane is just disrupted 
with no formation of bubbles. 
 
Figure 1.9 – Microscopic image reproduced from Bencsik et al. (2012), showing the gas-
filled microbubbles with the mean size of 2.3 µm (standard deviation 1.7 µm) produced 
by using the same mechanical shaker (CapMixTM) we used for our microbubbles 
preparation. 
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Flow Focusing 
The flow focusing technique offers an alternative route for microbubble production with 
high reproducibility and improved control over the size distribution. The microbubbles 
are generated by utilising the flow focusing technique, using a microfluidic device, to 
force a central stream of gas and two opposing inlets of aqueous lipid solution through 
a narrow orifice, forming microbubbles with a well-defined constant size (Figure 1.10). 
Previously, Talu et al. (2007) has demonstrated the size distribution of microbubbles 
produced from flow focusing technique is more monodisperse with ĚŝĂŵĞƚĞƌϯ͘ϳʅŵ
(standard deviation 0.2 ʅŵ) compared to the commercially available microbubbles 
Definity®, which are made from shear mixing, ǁŝƚŚĚŝĂŵĞƚĞƌϮ͘ϳʅŵ;standard deviation 
Ϯ͘Ϭʅŵ) (Figure 1.11). In microfluidic flow focusing systems, the selection of parameters 
such as liquid pressure and gas flow rate are primarily determining the microbubble size 
(Talu, Hettiarachchi et al. 2007). 
Regardless of how advanced this technique is in the ability to produce highly 
monodisperse microbubbles, it suffers from disadvantages as it is usually time 
consuming and suffers from low microbubble concentrations, for example it takes 
approximately 10 min to produce 1 ml of microbubbles solution using this technique 
(Peyman, Abou-Saleh et al. 2012), whilst it only takes 45 s to achieve twice of the amount 
using shear mixing method (Bencsik, Al-Rwaili et al. 2013). This drawback is the major 
reason we have not used this technique in making our microbubbles preparation.  
 
Figure 1.10 – Illustration reproduced from Hettiarachchi et al. (2007) showing a typical 
design of a flow focusing system. (a) The device consists of liquid inlet and gas inlet. (b) 
By controlling the liquid (phospholipid solution) and gas flow rate, the microbubbles are 
produced out from the small orifice into the collection reservoir. 
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Figure 1.11 – Comparison of the size distribution between microbubbles produced from 
shear mixing (Definity®) and flow focusing techniques. The microbubbles manufactured 
by flow focusing technique (Talu, Hettiarachchi et al. 2007) is highly monodisperse with 
diameter 3.7 ʅŵ;standard ĚĞǀŝĂƚŝŽŶϬ͘Ϯʅŵ) compared to the commercially available 
contrast agent Definity®, diameter Ϯ͘ϳ ʅŵ ;ƐƚĂŶĚĂƌĚ ĚĞǀŝĂƚŝŽŶ Ϯ͘Ϭ ʅŵͿ͘ Reproduced 
from Talu et al. (2007). 
 
Sonication 
Another technique that was previously used in generating gas-filled microbubbles is 
sonication. This method is very similar to the shear mixing technique, with the main 
difference being that it involves the application of a sonication probe (with ultrasonic 
frequency around 20 kHz), instead of the mechanical agitation, to the suspending fluid 
(commonly lipids solution) resulting in the microbubbles formation (Otto 2007). It has 
been demonstrated that the bubbles size distribution produced from sonication is found 
to be twice bigger than the bubbles from mechanical agitation (Daeichin, van Rooij et al. 
2017). One of the first generation of commercially available microbubbles (Albunex®) 
had been produced using this technique, with the bubble size around 4 µm (Keller, 
Glasheen et al. 1989). 
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Commercial Products 
There are multiple variants of microbubble contrast agents that are commercially 
available. They are used widely in ultrasound imaging (Klibanov 2009), hence, most of 
these products have been tailored for their utilisation in this particular field. 
Nevertheless, their application is not only limited to this, their potential has attracted 
interest from various fields particularly in MRI, diffraction-enhanced imaging (DEI) and 
positron emission tomography (PET), and has been exploited over the years (Kogan, 
Gessner et al. 2010).  
Among the first generations of microbubble contrast agents that became commercially 
available was Echovist® which was first approved in France and Italy, then followed by 
Germany, in 1991 (UBM Medica Network 2017). This contrast agent marketed by 
Schering (Berlin, Germany) in Europe for the ultrasound imaging examination of the 
heart and venous system (Baert 2008). It contains galactose, which is a type of sugar, 
and air as gas filling but unfortunately is not stable enough to survive in the blood system 
after injection for any time duration greater than 5 minutes. Soon, its formulation was 
improved and then replaced by Levovist® in 1995. In the meanwhile, Albunex® received 
its clearance from the FDA in the U.S.A. in 1994 for use in echocardiography. Its 
ingredients consist of human albumin as shell material and air as gas filling (Keller, 
Glasheen et al. 1989). However, due to its instability and rapid dissolution in the blood, 
it is also no longer available in the market and has been replaced by its enhanced version, 
Optison® (GE Healthcare, New Jersey, U.S.A.) (Podell, Burrascano et al. 1999). 
The second generations of commercial microbubble contrast agents are usually filled 
with a perfluorocarbon gas. As we have discussed in the section 1.4.1.1.2, this plays an 
important role in enhancing the stability of microbubbles due to its low solubility. 
Optison® is one of the first commercial products using a perfluorocarbon gas, 
octafluoropropane, as a microbubble core filling. It obtained its first approval in 1998 in 
the U.S.A. and later in most European countries.  
In 2001, Definity® was approved in the U.S.A. for clinical use, as well as in Canada. It also 
uses octafluoropropane as a gas filling with phospholipid as its shell property (Lantheus 
Medical Imaging 2017). In the same year, SonoVue® (Bracco Imaging, Milan, Italy), which 
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consists of phospholipid as a shell material encapsulating sulphur hexafluoride in the 
core, has also received its approval for clinical use in Europe. Table 1.1 shows some other 
commercially available products of microbubbles with different shell properties, gas 
filling and their size distributions.  
Name Shell material Gas filling Size (µm) 
Echovist® Galactose Air N/A 
Albunex® Albumin Air 4.3 
Optison™ Albumin Octafluoropropane N/A 
Quantison™ Albumin Air 4.5 
Pesda™ Albumin Decafluorobutane 4.7 
Definity® Phospholipid Octafluoropropane 1.1-3.3 
Imagent® Phospholipid Perfluorohexane 6 
Sonovue® Phospholipid Sulfur hexafluoride 2 
Levovist® Phospholipid Air 2-4 
BiSphere™ Polylactide/Albumin Nitrogen 3 
Imagify™ Polylactide Perfluoropropane N/A 
Sonazoid™ Lipid Perfluorobutane 2.2 
Sonavist Cyanoacrylate Air N/A 
 
Table 1.1 – Commercial products of microbubbles with different shell properties, gas 
filling and size distributions (Sboros 2008, Stride, Saffari 2003). Some of these products 
(bold) are no longer available in the market. 
 
Previous Works Relevant to the Field 
This section covers the important points of previous works that are relevant to the field 
of our study. The first part explains the developmental work regarding microbubbles and 
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their current applications, and the second part discusses the importance of pressure 
measurement for the human gastrointestinal system and the currently available 
methods.  
Gas-filled Microbubble 
Application in Ultrasound 
In a medical application, ultrasound imaging works  by using of a transducer to send 
ultrasound waves, ranging from 2 to 10 MHz (Bushberg, Seibert 2011), which propagate 
through the tissues and become partially reflected, or scattered, from acoustic 
heterogeneities, usually interfaces between different tissue types. This heterogeneity 
occurs due to the differences in acoustic impedance of each type of the tissue. Then, the 
reflected waves are detected at the outer surface of the body under investigation, 
usually by the same transducer that sent them in, and recorded and processed. 
Gas-filled microbubbles have been used as an effective contrast agent in medical 
ultrasound imaging to enhance the image contrast, which helps to further differentiate 
between tissue types, both normal and pathological (Ophir, Parker 1989). Their 
application has been extensively explored as an intravascular contrast agent in 
ultrasonography (Keller, Segal et al. 1989). The appearance of these microbubbles in the 
blood circulation system creates an acoustic impedance difference between the bubbles 
and the surrounding tissue, offering a unique avenue in manipulating the signal and 
image contrast. This is made possible due to the unique ability of these bubbles to 
intimately interact with the ultrasound beam; they either oscillate, coalesce or fragment 
(Figure 1.12), which then emit variable spectral and energy of the reflected waves. 
Furthermore, the magnitude of the scattered wave is extensively enhanced by up to ten 
fold more than that of red blood cells due to the ability of the microbubble to oscillate 
in response to the ultrasound wave (Ophir, Parker 1989), enabling the detection of a 
single microbubble.  
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Figure 1.12 – Optical frame images corresponding to the oscillation (a - d) and 
fragmentation (f) of microbubble in response to the ultrasound wave. The bubble has 
an initial diameter of 3 µm, shown in (a). The streak image in (h) shows the diameter of 
the bubble as a function of time, and dashed lines represent the times at which the two-
dimensional frame images in (a) – (g) were acquired relative to the streak image. 
(Chomas, Dayton et al. 2000). 
 
This phenomenon can be explained by Equation 1.8 below (Schutt, Klein et al. 2003), 
describing the intensity of ultrasound scattered by small spherical particles, which is 
smaller than the wavelength of the ultrasound beam. It is seen to be proportional to the 
square of the difference in compressibility and the difference in density of the scatterer 
and the medium.  
 ܫ ܫ଴ൗ ~ 1 9ܸ݊ൗ [݇ସݎ଺(ߛ௖ + ߛௗ ܿ݋ݏ ߠ)ଶ ݀ଶΤ ]                              
Equation 1.8  
 
Where I is the scattered intensity, I0 is incident intensity, n is the number density of the 
scattering particles, V is the scattering volume, k is the wave number, r is the radius of 
the particle, Ȗc is the compressibility term, Ȗd is the density term, ș is the scattering angle 
and d is the distance from the scatterer. 
Following the intravenous injection of microbubbles, this technique enables the 
visualisation of the real-time images of blood flowing through the heart chambers, 
vessels, and capillaries. 
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MR Experimental Work
1.5.1.2.1 MR Pressure Probing 
The first experimental work exploring the potential of microbubbles as MRI contrast 
agent was published by Alexander and colleagues (Alexander, McCreery et al. 1996). In 
this study, the authors used phospholipid for the microbubbles shell and investigated a 
variety of gases as a core filling for their effect on the MR signal, including nitrogen, 
argon, air, oxygen, xenon, neon, perfluoropentane, perfluorobutane, and sulphur 
hexafluoride. The average sizes of the microbubbles produced were between 4 and 9 
µm. Additionally, a 2 % methylcellulose solution was used as a suspending medium to 
immobilise the microbubbles during the MRI measurements. Spin-echo and gradient 
echo pulse sequences were used to measure signal intensity coming from the 
microbubbles.  
It was demonstrated that the nature of the gas in the microbubbles has an influence on 
the susceptibility effect, which consequently further affects the transverse relaxation 
time of the preparations, with a higher gas concentration exhibiting lower relaxation 
times. They discovered that the microbubbles with oxygen, perfluorocarbon and air 
filling demonstrated the greatest effect on the T2eff with the increase in gas 
concentration. Then, the authors applied pressure between 0 and 300 mmHg to the 
microbubbles in a contained fluid system and demonstrated that microbubbles with an 
air filling exhibited an increase in relaxation rate, 1/T2eff, with an increase in pressure, 
compared to the neon-filled microbubbles.  
In addition, they also investigated the (T2*-weighted) signal intensity change on the air-
filled microbubbles by cycling the pressure between 0 and 300 mmHg. They showed the 
MR signal intensities consistently increased with increasing pressure on gas-filled 
microbubbles. However, they discovered that the signal intensity had only partially 
returned to its original when the applied pressure was released. They suggested that 
this could be due the rise of the microbubbles within the phantom and microbubbles 
deterioration over the course of the MR measurements.  
This endeavour has disclosed a substantial potential for microbubbles and opened up 
the route for their use as contrast agents in MR imaging, which further lead to various 
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experimental and numerical works undertaken by many researchers exploring its 
susceptibility effect. 
In 2012, Bencsik and colleagues published work demonstrating phospholipid 
microbubbles exhibiting MR sensitivity up to 23 % signal change per bar (Bencsik, Al-
Rwaili et al. 2013). It was demonstrated that this high sensitivity was solely due to the 
bubble radius change as the applied pressure was changed. In this occasion, the 
microbubbles with a mean radius of 1.2 ± 0.8 µm were produced from a mechanical 
agitation method. Phospholipids were used as shell material and octafluorocarbon 
(C3F8) gas was used in the core. In addition, a 2 % (w/v) gellan gel was used as a 
suspending medium to further immobilise the bubbles. In this paper, the authors 
presented their experimental data and corroborated them with numerical simulation to 
further validate the results.   
1.5.1.2.2 MR Tracking 
There are several other MRI investigations demonstrating the susceptibility effect of 
gas-filled microbubbles (Wong, Huang et al. 2004, Cheung, Chow et al. 2009), but not in 
the context of fluid pressure mapping. Cheung and colleagues carried out an in-vivo 
investigation demonstrating the susceptibility effect of microbubbles in the brain blood 
vessels (Cheung, Chow et al. 2009). In their work, the microbubble suspensions were 
injected into rats intravenously following which they demonstrated a linear correlation 
between T2* with the microbubble volume fractions, using MRI at 7T. They suggested 
that microbubbles have the potential use as a real-time MRI guidance in various 
applications such as vascular drug delivery for diagnostic and therapeutic purposes. 
However, inadequate sensitivity is the main limitation for the clinical application 
because the microbubble induced susceptibility effect is relatively weak compared with 
other MR susceptibility contrast agent. This means that this contrast agent requires a 
dosage of microbubbles too high to allow a useful effect in clinical applications. 
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MR Numerical Simulation Studies 
1.5.1.3.1 Sensitivity  
The NMR relaxation change due to bubble size change at atmospheric pressure has been 
modelled by Dharmakumar in terms of external magnetic field strength, bubble 
concentration and susceptibility difference between encapsulated gas and surrounding 
fluid, both for gradient echo and spin echo sequences (Dharmakumar, Plewes et al. 2005, 
Dharmakumar, Plewes et al. 2002). As a result from their numerical simulations, 
Dharmakumar and co-workers have shown the extent to which the sensitivity of the 
microbubbles related to pressure change was affected by these variables. However, the 
effects of these variables have not been experimentally fully explored yet.
In this simulation work, the authors modelled the microbubble by placing a single sphere 
in the centre of the ‘universe’ which was made of a cubic space of length L discretised 
into series of smaller cubes of length ξ2Dοt, where D is the proton diffusion coefficient 
and οt = 10 µs is the duration of time spent by a water proton at a given point. The ratio 
of the sphere volume to the universe volume simulates the bubble gas volume fraction. 
Then, 104 protons were randomly disseminated around the sphere with a uniform 
distribution within this universe. Each proton was able to move in different directions at 
ĞǀĞƌǇƚŝŵĞŝŶƚĞƌǀĂůŽĨѐƚ͕ďƵƚŶŽƚĂůlowed to enter the sphere. From this estimation, they 
determined the NMR free induction decay (FID) rate (1/T2* or R2*) and the CPMG signal 
decay rate (1/T2eff or R2eff) due to the presence of the microbubbles. The procedure was 
repeated with different pressure conditions, investigating the dependence of these 
parameters.  
Following the results, it was found that the relation between relaxation rates and the 
pressure sensitivity to the bubble size are different for the FID and CPMG signals (Figure 
1.13). The sensitivity of R2* increased with the increase in bubble radius up to a critical 
value, which is identified as Rcrit on the plot. Beyond this point, the sensitivity remained 
constant. However, the sensitivity of R2eff rose with an increase in bubble size and 
peaked at Rcrit and then decreased thereafter. The simulation result is in agreement with 
the theory.   
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Figure 1.13 – Plot of the relation of the bubble size with the pressure sensitivity of both 
R2* and R2eff. The black square and the open circle, respectively, indicate R2* and R2eff 
simulations, while the dotted line and the solid line, respectively, represent R2* and R2eff 
theory (Dharmakumar, Plewes et al. 2002). 
 
 
 
Figure 1.14 – Plot of the relation of field strength and susceptibility difference with FID 
and CPMG spin-spin relaxation rate constants (Dharmakumar, Plewes et al. 2002). The 
symbols are the same as in Figure 1.13.  
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However, the dependence of the external field strength, B0, and susceptibility difference, ο߯, on R2* and R2eff was different between the theory and the simulation result, which 
was respectively seen in linear and quadratic relations (Figure 1.14). Soon after, Bencsik 
et al. (2013) improved this result, also through a numerical simulation, where he 
successfully demonstrated the simulation result synced with the theory, in quadratic 
correlation (Bencsik, Al-Rwaili et al. 2013). This was achieved by optimising the ѐt value, 
specifically changing this parameter on different bubble size. 
1.5.1.3.2 Enhancing susceptibility Effect 
The microbubble inadequate sensitivity to a small pressure change is severely limiting 
its potential for in-vivo applications. By increasing the magnetic susceptibility of the 
microbubbles, it should be possible to open up a range of imaging techniques to allow 
the monitoring of blood pressure in the body with a much lower density of microbubbles. 
Dharmakumar and co-workers have published another paper exploring the possibility to 
increase the efficiency of the microbubbles by exploiting the susceptibility effect using 
numerical simulations (Dharmakumar, Plewes et al. 2005). 
In this work, the authors suggested enhancing the susceptibility by incorporating 
magnetic nanoparticles of high dipole moment, such as iron, magnetite and hematite, 
on the lipid shell of the microbubbles, thereby extensively increasing the susceptibility 
difference between the bubble gas and the medium. In theory, as the bubble changes 
in size, for a given change in pressure, the differential changes in the dipole moment is 
larger relative to the uncoated microbubbles, imposing ŐƌĞĂƚĞƌĮĞůĚǀĂƌŝĂƚŝŽŶƐƐĂŵƉled 
by the spins. They investigated this effect through numerical estimations, by comparing 
the R2 changes on the air-filled microbubbles coated with magnetite with the ones 
without coating. It was found that even with a much lower volume fraction, the pressure 
sensitivity of microbubbles with magnetite coating is significantly higher compared to 
the microbubbles without coating (Figure 1.15).  
Soon after, it was demonstrated that the susceptibility effect of gas-filled polymeric 
microbubbles can substantially increase by entrapping iron oxide nanoparticles into the 
microbubble shell, a method suggested to be applicable to lipid-shell microbubbles too 
(Chow, Chan et al. 2010). Thus, it was shown that microbubbles with a unique 
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susceptibility effect offer a promising and viable contrast agent for a direct pressure 
measurement in tissue and fluid. 
 
 
Figure 1.15 – Plot comparing the effect of pressure changes on R2eff of microbubbles 
with (open circle) and without (solid circle) magnetite coating, with the air volume 
fractions 0.0344 % and 0.1527 %, respectively (Dharmakumar, Plewes et al. 2005).  
 
Pressure Measurements in the Human Gastrointestinal System 
Practical Motivation 
Great efforts have been taken to understand the behaviour of clinical conditions related 
to functional gastrointestinal disorders (Wilmer, Van Cutsem et al. 1998) and MRI has 
been known as a non-invasive method to study these diseases (Marciani 2011, Parker, 
Tucker et al. 2016). They are generally associated with the disturbance on the normal 
activities of muscle movement, known as the motility of the gastrointestines, or of the 
sensitivity of the nerves of these organs.  
One of the conditions which is known as functional dyspepsia, is associated with 
hypersensitivity to gastric distention (Tack, Caenepeel et al. 2001). Commonly, there are 
multiple symptoms present in the patient with this syndrome, including a pain in the 
epigastric area (located in the upper central region of the abdomen), bloating, nausea, 
belching and vomiting. In the past, it has been shown that there are abnormal patterns 
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of the gastric motility (Wilmer, Van Cutsem et al. 1998), especially at the distal part of 
the stomach, the antrum. The pattern of the digestive muscle contractions of the 
stomach wall has been observed by inserting a catheter with a probe into the stomach. 
This customary probe is fully equipped with multiple pressure sensors enabling the 
detection of pressure waves propagated from the muscle tensions. Using this technique, 
it was found in a previous study that the pressure exerted in the antrum during digestive 
period is ranging between 30 and 82 mmHg (Bortolotti, Annese et al. 2000).  
However, even with the help of advanced computer analysis, this technique still lacks 
the ability to identify a specific motility pattern, allowing the differentiation of the 
healthy individuals with the patients with functional dyspepsia. Additionally, this 
existing method of diagnosis can cause discomfort to the patient due to its invasive 
procedure. The catheter can also occasionally be moved from the intended area, which 
can impede the accuracy of the measurement (Wilmer, Van Cutsem et al. 1998). We 
further discuss this procedure in the following subsection 1.5.2.2.  
In a more recent study, the symptoms of the patients suffering from this disease have 
also been shown to be intensified after having a meal (Farre, Vanheel et al. 2013). Having 
this in mind, in order to help the clinicians to further understand the disease, it would 
be tremendously useful to have a tool for diagnosis which is able to simulate a meal and 
simultaneously measure the dynamic meal pressure variation supplied by the stomach, 
by using a much less intrusive technique. No such method is currently available, hence, 
the exploration of such an edible contrast agent combined with MR imaging is the point 
of this study. Fundamentally, developing the right diagnostic tool, particularly being able 
to measure the dynamic pressure changes within the meal in the stomach, can produce 
a great impact on the clinical understanding of this disease which can lead to better 
decision making and ultimately to the treatment option. 
Current available methods 
In the study of the function of the gastrointestinal tract, currently available methods, 
manometry (Herbella, Aprile et al. 2014) and barostat (Farre, Vanheel et al. 2013), have 
shown promise in assessing the pressure exerted by the human stomach. Both 
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techniques involve the insertion of a catheter or tube into the stomach through the 
oesophagus, from the nose or mouth.  
The manometry technique works by introducing pressure-sensitive sensors and locating 
them in various areas in the stomach. Then, this probe is connected to a recording 
apparatus and computer to quantify the pressure changes in the stomach. There are 
two types of procedures performed using this method: ambulatory or stationary. The 
first one (Bortolotti, Annese et al. 2000) requires a prolonged measurement, which 
usually takes about 24 hours of observation. During this period, the participants are 
supplied with portable devices for the measurement and encouraged to carry on with 
their normal daily routine. On the other hand, stationary manometry (Stanghellini, 
Ghidini et al. 1992) is usually performed in a short term, up to 5 hours. For this procedure, 
after the insertion of the probe, the participants are being monitored in a controlled 
area and normally being asked to lie on a hospital bed for the period of observation. 
The barostat study involves the introduction of a tube with a deflated balloon at the tip 
through the mouth and into the stomach (Farre, Vanheel et al. 2013). A fluoroscopy 
scanning is usually performed during the insertion of the tube to assist the positioning 
of the balloon in the stomach. This tube is then further connected to the barostat device 
enabling a volume of air to be driven to inflate or deflate the balloon. The volume and 
pressure measurements are taken as the balloon inflates and deflates in the stomach.  
Both of these conventional techniques are invasive, which can perturb the true 
physiology of the stomach (de Zwart, Haans et al. 2007) and are less comfortable to the 
patient, compared with the one we have explored in our study.  
Previous Studies of Alginate Spheres 
Alginates are polysaccharide compounds, extracted from brown seaweeds (Rioux, 
Turgeon et al. 2007), where their main role is to provide a structural matrix to support 
a cell. In food industry, alginates are commonly reacted with calcium ions to create a 
more elastic and stable gel (Duez, Mestdagh et al. 2000), which is widely used as a 
thickening and stabilising agent (Draget, SkjakBraek et al. 1997).  
There have been studies investigating the behaviour of alginate spheres in 
gastrointestinal conditions (Hoad, Rayment et al. 2009, Rayment, Wright et al. 2009), 
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but not in the context of MRI pressure probing, and no involvement of microbubbles. In 
the initial in-vitro investigations undertaken by Reyman and co-workers (Rayment, 
Wright et al. 2009), they suggested that the alginate spheres have a great potential to 
be utilised as a non-invasive monitoring technique for gastrointestinal studies, as an 
alternative method to the existing invasive approaches. Soon after, the same group of 
investigators published the second part of their work, in-vivo investigations, 
demonstrating the characteristics of these spheres in the human gastrointestinal system 
using MR imaging (Hoad, Rayment et al. 2009).  
In these studies, they have shown that there is a significant decrease in the T2eff values 
of the alginate spheres when they were placed in the acidic (pH 2) human gastric 
solution. They suggested that this phenomenon should be attributed to the distinctive 
character of the alginate, in that it forms a tighter gel network in a lower pH environment, 
which further caused them to shrink resulting in the expulsion of the ‘free’ water 
molecules from the sphere.  
Hence, by taking this valuable information, we initially anticipated that these alginate 
spheres could be used as a carrier to our microbubbles in measuring the pressure 
exerted by the human stomach. Therefore, we loaded them with gas-filled microbubbles 
and explored their functionality in-vitro and in-vivo, and this constitutes the main body 
of the present study.  
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2 DESIGN OF THE MICROBUBBLE-BASED CONTRAST AGENTS 
Introduction 
This chapter covers the methods that have been used to generate microbubble-based 
contrast agents for the purpose of our study. Concerning the contrast agent 
preparations, we can divide this into two stages, which are in-vitro and in-vivo 
experiments. Most of the contrast agent preparations for in-vitro works were carried 
out in a standard chemistry laboratory. In order to produce a contrast agent that is 
suitable for human consumption, the methods that have been used for the in-vitro study 
were reproduced in a food-safe laboratory with food-grade ingredients.  
Components of the Contrast Agents 
The microbubbles were prepared following the method described in a previous study 
(Bencsik, Al-Rwaili et al. 2013). Generally, the components of microbubble contrast 
agents consist of a gas, a thin lipid shell and a suspending medium. 
Materials 
The following is a list of the materials that have been used to produce the microbubble 
contrast agents for our study. 
a) The phospholipids used as the microbubble shell materials were DPPC (1,2-
dihexadecanoyl-sn-glycero-phosphocoline) and DSPE-PEG2000-PE (1,2-
distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol) 
– 2000]) (Figure 2.1). A long-chain lipid from the DPPC provides a stable bubble 
shell which has low surface tension and reduced gas permeability (Lozano, Longo 
2009). The additional PEG components on the phospholipids (DSPE-PEG2000-PE) 
formulations can significantly increase the stability of microbubbles by acting as 
an additional coating to the microbubble shell and prevents them from 
coalescing (Needham, Kim 2000). Both of these substances were purchased from 
the Avanti Polar Lipid, Alabama, USA (Avanti Polar Lipids 2017).  
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Figure 2.1 – The chemical structures of the phospholipids used as microbubbles shell 
materials; a) DPPC and b) DSPE-PEG2000-PE (Avanti Polar Lipids, 2017). 
 
 
b) A perfluorocarbon gas, octafluoropropane (C3F8), was used as the core-filling gas 
of our microbubbles. This particular gas is innocuous (non-toxic gas) and it has a 
lower solubility in water compared to other gases, e.g. nitrogen and air (Podell, 
Burrascano et al. 1999), which increases the stability of the bubbles in the 
medium. Besides, the resulting microbubbles from using C3F8 gas exhibit a high 
monodispersity in term of size distribution. 
c) Gellan gum in a powder form obtained from CP Kelco, UK. 
d) Sodium alginate powder purchased from Special Ingredients, UK. 
e) Calcium lactate powder purchased from Special Ingredients, UK. 
f) Locust bean gum powder purchased from Special Ingredients, UK. 
 
Gas-filled Microbubbles Preparations 
The microbubbles were prepared following the method described in a previous study 
(Bencsik, Al-Rwaili et al. 2013). The preparation involved two distinct consecutive parts 
in creating the bubbles. The first part of the preparation involved the formulation of a 
phospholipids solution in a standard chemistry laboratory:  
a) Firstly, 500 mg of DPPC powder was dissolved into 200 ml of chloroform.  
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b) Separately, 25 mg of DSPE-PEG2000 was dissolved in a mixture of chloroform (9 
ml) and methanol (1 ml).  
c) Both solutions were mixed in a round bottom flask to a v/v ratio of 1.6/1.36 and 
then evaporated at 60°C to eliminate the chloroform solvent.  
d) The resulting thin film layer of lipids at the bottom of the flask was hydrated with 
a premixed solution of water (99 ml), glycerol (1 ml) and NaCl (396 mg) and 
further sonicated for 1 hour.  
e) Finally, the phospholipid solution was transferred into a vial and ready to be used 
for microbubbles production in the second part of the preparation.  
The second part of the process involved the introduction of the gas into the 
phospholipids solution to create the microbubbles: 
a) A volume of 1 ml of the phospholipids solution was transferred into a 2ml vial 
with a rubber septum cap. Two needles with different lengths were inserted into 
the vial through the cap as shown in Figure 2.2. Using the longer needle, 10 ml 
of C3F8 gas was bubbled through the solution via a gas-tight syringe within 30s. 
The second needle provided an exhaust for the gas to escape. 
 
Figure 2.2 – Two needles were inserted into a 2-ml vial to bubble through the 
phospholipids solution with perfluorocarbon, C3F8, gas. 
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b) Both needles were then removed simultaneously as soon as the syringe was 
empty.  
c) The vial was then shaken (4300 oscillations per minute) for 45s using a capsule 
mixing device (CapMixTM; 3M, Bracknell, UK) (Figure 2.3). 
d) Fairly monodisperse gas-filled microbubbles were made by mechanical agitation 
with a mean size distribution 2.4 ± 1.7 µm (Bencsik, Al-Rwaili et al. 2013) (Figure 
1.9Figure 1.9 – Microscopic image reproduced from Bencsik et al. (2012), 
showing the gas-filled microbubbles with the mean size of 2.3 µm (standard 
deviation 1.7 µm) produced by using the same mechanical shaker (CapMixTM) we 
used for our microbubbles preparation.). 
 
Figure 2.3 – Left: A capsule mixing device (CapMixTM) with a 2 ml vial containing the 
phospholipids solution and the C3F8 gas, placed on the lever and ready to be shaken. 
Right: A shaken phospholipids solution vial, with microbubbles giving it a milky 
appearance, in a 2 ml vial. 
 
Microbubble Suspending Medium 
A polysaccharide gel was used as a suspending medium for the microbubbles 
preparation to further immobilise them. It prevented buoyant advection and assisted 
the distribution of microbubbles homogenously throughout the medium whilst allowing 
a very high self-diffusion of water molecules. Morris et al. demonstrated the diffusion 
coefficient of water molecules in a polysaccharide gel (gellan gum) is within 93 % similar 
to that of bulk water, in a temperature between 298 and 338 K (Morris, Bencsik et al. 
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2008). We used two types of the polysaccharide gel in our study, they are gellan and 
alginate gels.  
 
Gellan Gel Preparation 
For our study, 2 % (w/v) concentration of gellan gel was used as a suspending medium 
for the microbubbles. The preparations of the gel are described as follows: 
a) An appropriate quantity of gellan powder was weighed (typically 5 g to produce 
a final quantity of 250 ml of gel with 2 % w/v concentration). 
b) 250 ml of distilled water was placed in a flask and a few drops of antibacterial 
solution were added to prevent the solution from quickly deteriorating due to 
bacterial contamination. 
c) The Gellan powder was added slowly into the distilled water at room 
temperature and stirred constantly. (Adding all the powder at the same time 
would cause powder coagulation, in our case 1 g of gel powder was added every 
half hour). 
d) The powder was given time to fully dissolve, usually requiring continuous stirring 
for about 2-3 hours. 
e) The gel was left at room temperature and stirred occasionally for eight hours to 
release any trapped gas (air). 
f) Finally, the gel was further thoroughly degassed, using a high vacuum pump to 
prevent inclusion of gas bubbles within the gel, which could lead to spurious 
measurements in the later experiments. 
This fully prepared gellan gel, as a suspension medium, should be stored for no more 
than five weeks before use otherwise it becomes susceptible to deterioration due to 
contamination by microorganisms e.g. bacteria. 
Alginate Gel Preparation 
The alginate gel with 2 % (w/v) concentration was prepared following the procedure as 
previously described in section 2.2.3.1. Typically, 5 g of sodium alginate powder was 
58 
 
dissolved in 250 ml of distilled water. In the case for in-vivo study, the freshly prepared 
gel was used to make the contrast agent meal for each volunteer. 
 
Entrapping Microbubbles in Alginate Spheres for MRI Pressure Measurements 
in the Human Stomach 
In our initial attempt to entrap the microbubbles within the alginate spheres, we firstly 
tried a relatively low concentration (1 % w/v) of sodium alginate preparation, but this 
solution was found to not be viscous enough to immobilise the microbubbles as they 
were seen to rise within the spheres (Figure 2.4). Therefore, a higher concentration of 
sodium alginate gel (2 % w/v), which appeared viscous enough to immobilise the 
microbubbles, was used to make the microbubble-loaded alginate spheres for our study. 
In the following sub-section, the procedure to entrap the microbubbles into the alginate 
spheres is further explained. To the best of our knowledge, this method has never been 
explored before. 
 
 
 
 
 
 
 
Figure 2.4 – Image showing the alginate 
spheres with entrapped microbubbles in a 
2-ml test tube. These alginate spheres were 
prepared using sodium alginate gel at 1 % 
w/v concentration and the microbubbles 
appeared to rise within the spheres (milky 
appearance in the spheres), indicating that 
this concentration was not viscous enough 
in immobilising the microbubbles, hence, 
we used a 2 % concentration in the other 
preparations instead. 
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Sphere Formation 
Alginates are commonly reacted with calcium ions to create a more elastic and stable 
gel (Duez, Mestdagh et al. 2000). Soft-solid spheres were formed spontaneously when 
sodium alginate gel was dripped into a calcium lactate solution due to cross-linking 
between polymer chains of the alginate molecules. We further exploited this material 
to our advantage by using it as a medium to entrap the microbubbles. Following is the 
description of the preparation of the alginate spheres with microbubbles: 
a) The previously prepared gas-filled microbubbles (Section 2.2.2) were gently 
introduced into the sodium alginate solution (2 % w/v) in a 50 ml test tube. The 
solution was mixed gently, by horizontally rotating the test tube slowly until the 
initially clear alginate gel appeared milky, to ensure that the microbubbles were 
distributed evenly throughout the sodium alginate gel. 
b) The mixture was then transferred into a syringe and added dropwise into a 
calcium lactate aqueous solution (0.5 % w/v), then left in the solution for a time 
duration which is known as curing time. In order to reduce the variations in 
curing times between the individual spheres, three different containers of 
calcium lactate solution were used, so that the error due to curing time was 
minimised (no more than one minute) whilst the average curing time we ended 
up was 10 minutes. The investigation on the selection of the 10 minutes as an 
optimum curing time is further detailed in the next chapter (section 3.2.1). 
c) The resulting alginate spheres with entrapped microbubbles were then sieved 
from the calcium lactate solution (Figure 2.5).   
d) The spheres were further dabbed with a paper towel to dry and eliminate any 
excessive calcium solution before being placed into distilled water for storage. 
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Figure 2.5 – The alginate spheres with entrapped microbubbles were sieved out from 
the calcium lactate aqueous solution after being left to cure for 10 mins. 
 
Sphere Size 
The consistency of dripping the mixture of sodium alginate and microbubbles into the 
calcium lactate solution will affect the size distribution and the shape of the spheres. 
When it comes to in-vivo studies, which require the human volunteer to swallow the 
contrast agent as a meal, it is important to keep the spheres in optimum size so that we 
can have homogeneous spheres to ease the quantitation of the meal’s pressure from 
the region of interest (ROI) where numerous pixels are averaged. During preparations, 
this optimum size is achieved by keeping the distance between sodium alginate and 
calcium lactate solution constant while dripping (about 1 m apart), as well as the volume 
of the sodium alginate being dripped overtime. In order to measure their size, 20 
spheres were selected randomly immediately after preparation and their diameters 
were measured using a calliper. Then, the mean and the standard deviation of the 
diameter of these spheres were calculated and was found as 4.98 ± 0.30 mm. Figure 2.6 
shows three randomly selected alginate spheres with microbubbles and their 
corresponding sizes.  
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Figure 2.6 – The image is showing three randomly selected alginate spheres with 
entrapped microbubbles accompanied with their measured size in millimetres. The 
mean diameter of these spheres is 5.03 ± 0.11 mm. 
 
Suspending Medium for Microbubble-loaded Alginate Spheres 
Simulated Gastric Acid Solution 
In order to simulate human gastric conditions for in-vitro studies, an acid solution 
mimicking the acid secretion from the stomach was used to investigate the effect on the 
microbubble contrast agent. This solution has been prepared following the formulation 
previously used in investigating the alginate spheres functionality (Hoad, Rayment et al. 
2009). The details of the formulation of this solution are explained in the subsections 
below. 
Materials 
The following is the list of the ingredients (obtained from Sigma-Aldrich, UK) that were 
used to formulate the simulated gastric acid solution. The preparation of this solution is 
further described in the next subsection (2.4.1.2). 
a) Sodium chloride 
b) Potassium chloride 
c) Calcium chloride 
d) Hydrochloric acid  
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Preparations 
a) The ingredients were weighed as follows: 2.86 g of sodium chloride, 0.865 g of 
potassium chloride, and 0.4 g of calcium chloride.  
b) These were mixed and diluted into 1 L of distilled water.  
c) Then, while constantly stirring using a magnetic stirrer, hydrochloric acid was 
added gradually into the solution. A pH monitoring meter was used to observe 
the pH of the solution reduced to 2.0. 
d) The resulting solution was then used for the contrast agent experiments 
simulating a human gastric acid solution. 
Locust Bean Gum
Naturally, the alginate spheres with incorporated microbubbles float in water, which is 
a disadvantage to our study. Therefore, it is important to have a suspending medium 
which enables these spheres to be immobilised while keeping their functionality. For 
this purpose, we used a 2 % (w/v) solution of locust bean gum to set the spheres in place 
and preventing them from floating. Essentially, it is only the alginate spheres with 
microbubbles within the contrast agent meal that provide the MR sensitivity to pressure, 
therefore, these spheres need to be homogeneously distributed in the stomach to 
enable the mapping of the spatially varying pressure changes.  
The locust bean gum is a polysaccharide (Figure 2.7) vegetable gum, which is commonly 
extracted from the seeds of the carob tree, and it is widely used in the food industry as 
a thickening agent. The preparation of this gum is fully described below. 
 
Figure 2.7 – The chemical structure of the locust bean gum (Ventura, Paninho et al. 2015). 
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Preparations 
a) An appropriate amount of locust bean gum powder was weighed (typically 5 g in 
order to reach a final volume of 250 ml of solution with 2 % w/v concentration). 
b) 250 ml of distilled water was placed in a beaker and heated up to 60°C. 
c) The locust bean gum powder was further added slowly into the distilled water 
while being stirred. 
d) The powder was given time to dissolve by constantly stirring the mixture using 
a magnetic stirrer for about 1 hour. 
e) The resulting solution was then used as a suspending medium for the alginate 
spheres with microbubbles. 
Conclusions 
The microbubble-based contrast agents that have been described in this chapter are 
further used for the studies in the other following chapters. The studies involve in-vitro 
experiments and in-vivo applications of the contrast agent in investigating the pressure 
exerted by the human stomach. The next chapter discusses the effect of the curing time 
on the T2eff of the alginate spheres, which leads us to the selection of the optimum curing 
time for our preparation. The effect of the presence of microbubbles in the alginate 
spheres on the T2eff value is also explored.    
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3 MRI MEASUREMENTS OF THE CONTRAST AGENTS AT ATMOSPHERIC 
PRESSURE 
Introduction 
Viscous sodium alginate gel can be produced by dissolving a specific amount of sodium 
alginate powder in water. However, a stronger gel can be produced in the presence of 
salts, such as calcium ions, in the solution. When these ions are added to the alginate 
gel solution, the molecular chains become bound to each other in a process known as 
cross-linking, forming a rigid matrix at concentrations as low as 1 % w/v (Lee, Rogers 
2012). In manufacturing a pressure-sensitive contrast agent for gastrointestinal study, 
we use this strong gel to entrap the microbubbles and create a soft-solid sphere. The 
time duration of residence of the mixture of sodium alginate gel and microbubbles in 
the calcium lactate solution, also known as the curing time, will affect the resulting signal 
intensity on MR images. This chapter covers the MRI measurements investigating the 
effect of the curing time in term of relaxation time decay.  
Following that, the MRI measurements demonstrating the effect of the presence of 
microbubbles are undertaken by comparing the T2eff of the alginate spheres with and 
without microbubbles. The experimental set-up and the equipment required to perform 
the MRI experiments are also discussed. 
In the early development of our contrast agents, the MR experiments were initially 
carried out on a 2.35T BIOSPEC Bruker scanner, which can only accommodate small 
specimen for in-vitro testing of our contrast agent. In later stages of our study, in-vitro 
experiments were also carried out using a 3T Philips whole body MR scanner, to optimise 
the MRI sequences for the in-vivo experiments on the human volunteers. The results of 
the in-vitro experiments from both scanners are presented in this chapter as well as in 
later chapters. 
MR Relaxation Assessment at 2.35T Using A Small Animal Scanner 
The image acquisitions performed for this section were carried out using a 2.35T Biospec 
Bruker MR scanner (Figure 3.1) within the Physics Department of the Nottingham Trent 
University. 
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Figure 3.1 – The small animal MR scanner BIOSPEC 2.35T Bruker at the Nottingham Trent 
University. The scanner is equipped with a proton-imaging RF coil (inner diameter 72 
mm) and an imaging software Paravision 4.0. 
 
Assessing the Effect of Curing Time 
For the first part of the experiment, we aimed to investigate the effect of the curing time 
on the resulting MR images. To demonstrate this effect, we acquired MR images using a 
Multi-Slice Multi Echo, MSME sequence, assessing the T2eff of the microbubble-
entrapped alginate spheres with different curing time. 
Sample Preparations
The alginate spheres with microbubbles were prepared following the procedure fully 
described in section 2.3. In this experiment, the microbubbles were loaded into 2 % w/v 
sodium alginate gel and then divided into five batches; each of them was loaded into 
different syringes. Then, the sodium alginate gel was dripped into a 0.5 % w/v calcium 
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lactate aqueous solution in five different containers and left to cure respectively for 5, 
10, 20, 30 and 60 minutes. Following curing, each batch of the spheres was sieved out 
of the calcium solution and placed in distilled water in a 2-ml plastic test tube for MRI 
assessments. 
MR Measurements 
The five test tubes containing microbubble-loaded alginate spheres with differing curing 
times were assessed in terms of T2eff. They were placed in a homemade acrylic holder at 
the centre of the scanner prior to acquiring the MR images. 
The multi-slice T2eff-weighted images were acquired using an MSME sequence with a 
short echo time available, TE = 10 ms and a long repetition time, TR = 14000 ms, to 
ensure that all the magnetisation has returned to rest. The slice thickness was set to a 
0.4 mm, and 8 averages were taken for this measurement which lasted for 6 hours. 
Data Processing 
Home written Matlab® code was used to analyse the resulting images, by fitting a 
monoexponential decay curve to every pixel acquired at different echo times, producing 
the pixel effective relaxation time, T2eff, within the alginate spheres with the 
microbubbles. The thermal noise was also measured by quantitating the pixel intensity 
outside the sample. Then, it was subtracted from the signal intensity prior to the 
exponential function fitting.  
Results  
The results of this experiment are demonstrated in Figure 3.2 and Figure 3.3. The curing 
process is clearly affecting the MR images, resulting in a decrease of the pixel intensity 
in the alginate spheres with increasing curing time. This indicates that the longer the 
curing time of the alginate spheres, the lower the T2eff value (Figure 3.3). In addition, the 
change in the T2eff is seen to be much rapid in a lower curing time and then it slows down 
as the curing time progresses from 30 to 60 min. This is perhaps caused by the decline 
in the concentration of ‘free’ calcium ions within the solution after a period of time of 
the crosslinking process. The results show that the 10-min curing time provides spheres  
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Figure 3.2 – Multi-slice T2eff images (obtained with the MSME sequence) showing the 
effect of different curing times on the alginate spheres with microbubbles. The signal 
intensity in the spheres decreases as the curing time increases. Unfortunately, imaging 
artefacts causing a signal deterioration in some parts of the 5 min curing time images 
can be seen. 
 
 
Figure 3.3 – Plot showing the mean of the T2eff of alginate spheres with microbubbles, 
taken from one of the image slice in Figure 3.2 (slice position at 0.0 mm), differing in 
curing times. The T2eff value decreases as the curing time increases. The change in the 
T2eff is seen to be much rapid in the lower curing time and then this effect slows down 
as the time progresses from 30 to 60 min. 
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that are stable with a comparatively homogeneous signal intensity across the spheres, 
with less appearance for spatially varying T2eff.  
Although the 5-min curing time spheres appear homogenous on the MR image, 
unfortunately, they easily disintegrate in water which makes them less favourable for 
our preparations because the stability and the flexibility of the spheres are crucial to 
enable the contrast agent to withstand the pressure variations involved during ingestion. 
For curing time greater than 10 minutes, the pixel intensity of the entire sphere 
decreases, and radially decreasing T2eff can be gradually seen. This effect can be ascribed 
to the declivity of the gelation process of the spheres which takes place from the surface 
to the centre. When the sodium alginate is dipped into calcium solution, the calcium 
ions cross-linking starts at the surface of the sphere pulling the polymer chain of alginate 
closer together and creating a less permeable surface, which consequently slows down 
the calcium ions diffusion and crosslinking process as it goes further to the centre of the 
sphere (Chan, Lee et al. 2006). Hence, we decided to move forward with subsequent 
experiments in the current study with the 10 min-long curing preparations, which has a 
less spatially resolved effect yet adequate structural strengths in keeping the 
microbubbles inside the spheres. 
Another finding we have obtained from this experiment is that the pixel intensity coming 
from the surrounding water is higher, at least twice, to that coming from the alginate 
spheres indicating that the T2eff of these gel spheres is significantly lower than the bulk 
water. For polysaccharide solutions, such as alginate gel, the NMR signal is regulated by 
the exchange between water and polysaccharide chain protons (Degrassi, Toffanin et al. 
1998). This results in a considerable decrease in the transverse relaxation time of the 
gel, due to the reduction of the mobility of the proton in polysaccharide chain compared 
to bulk water (Ablett, Lillford et al. 1976).  
In the future, there are several experiments that we could venture into to further 
explore the preparation of the contrast agent. Firstly, the curing effect can be further 
investigated in forming a stable alginate sphere by manipulating the concentration of 
the calcium lactate solution. Secondly, exploring a different method of manufacturing 
the alginate spheres could result in the creation of homogeneous spheres, in particular, 
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internal gelation mechanism has been previously demonstrated as an alternative 
method with such a potential (Chan, Lee et al. 2006).  
 
 MRI Assessment of Alginate Spheres with and without Microbubbles 
Sample Holder Design 
A two-compartment cell was manufactured from transparent acrylic tubing. The design 
of this homemade sample holder is shown in Figure 3.4. Firstly, a tube with 3 mm wall 
thickness, 15 mm length and 37 mm diameter, was cut along a longitudinal section to 
create identical halves which are labelled C1 and C2 on the diagram. Then, a rectangular 
piece of acrylic was cut by using a laser cutter, with dimensions of 15x30 mm2 and 
thickness of 3 mm, labelled as B on the diagram. Another piece of acrylic was cut to form 
two disks with 37 mm diameters, labelled as A and D, and then, two circular apertures 
with diameters of 9 mm were cut on disk D.  
Afterwards, all parts were glued together as shown in Figure 3.4 by using an acrylic 
adhesive. Before it was further used for the experiment, the integrity of the sample 
holder was tested by filling it with water and pressurising it up to 2 bars to check for any 
leakage. The photo of the finished product is shown in Figure 3.5, containing two 
preparations of the alginate spheres. 
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Figure 3.4 – Diagram showing the design of a sample holder, manufactured from 
transparent acrylic tubing, which was cut by a laser cutter into five pieces, A, B, C1, C2 
and D. Then, all the pieces were glued together forming a two-compartment cell with 
one hole providing an inlet for each compartment. 
 
Sample Preparations 
In assessing the effect of the presence of microbubbles within the alginate sphere on 
the T2eff value, two preparations of alginate spheres were made following the method 
described in Chapter 2 (section 2.3). The two preparations were made identical except 
for the presence of microbubbles; one preparation was without microbubbles and the 
other one was with microbubbles entrapped. The spheres were transferred into the 
previously described two-compartment sample holder (Figure 3.5), to facilitate 
simultaneous assessment of both preparations, and then further placed in the 2.35T 
Bruker MR scanner for image acquisition.
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Figure 3.5 – Twin-compartment sample holder 
containing both preparations of alginate spheres, with 
(left hand side) and without (right hand side) 
microbubbles, in water suspension. The milky 
appearance of the left hand side specimen indicates the 
presence of the microbubbles in the alginate spheres. 
The sample holder is also equipped with Swagelok 
connectors and tubing, enabling pressure to be applied 
to the system to be changed, which is particularly useful 
for the pressurised experiment and this will be further 
discussed in Chapter 5. 
 
 
MR Measurements 
The MSME sequence at TE = 10 ms and a relatively shorter repetition time, TR = 2500 
ms, to further reduce the acquisition time, was used to acquire the multi-slice MR 
images with 2 mm slice thickness to demonstrate the T2eff value of both preparations. 
This also allows further optimisation of the next MRI sequence, used for the rapid image 
acquisition for pressure cycling experiments in Chapter 5 and provides evidence on the 
spatial distribution of the bubbles within the spheres. 
Results  
The results of this experiment are shown in Figure 3.6 and Figure 3.7. The T2eff image in 
Figure 3.6 shows two clearly differentiated compartments containing alginate spheres 
with different T2eff pixel intensities, demonstrating that the T2eff value is reduced by a 
typical factor of 2 in the presence of microbubbles within the spheres (compartment on 
the left-hand side). By plotting the T2eff pixel intensities distributions for both sphere 
preparations (Figure 3.7), their significant differences are further highlighted and 
quantitated.  The T2eff values are ranging between 200 and 300 ms for the spheres 
without microbubbles and between 100 and 200 ms for the spheres with microbubbles. 
This result agrees with the principle of the gas-filled microbubble acting as a magnetic 
field perturber, creating a magnetic field gradient at the gas-liquid interface, which 
consequently affects the MR signal (Alexander, McCreery et al. 1996). The average T2eff 
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value (180 ms) from this experiment is then used to optimise the imaging parameter of 
the RARE sequence in measuring the rapid pressure changes in the later chapter. 
An interesting additional outcome of this experiment is the demonstration of a spatial 
gradient of T2eff value seen between the centre and the periphery of alginate spheres 
with microbubbles. The microbubbles’ density and the curing process may both 
contribute to the mechanisms causing this radial spatial gradient. This effect will be 
further explored, also in Chapter 5, by measuring the sensitivity of the two areas to 
pressure changes. 
 
Figure 3.6 – Three consecutive slices of the T2eff images showing alginate spheres with 
(left compartments) and without microbubbles (right compartments). The T2eff is lower, 
typically by a factor of 2, in alginate sphere with microbubbles. 
 
 
Figure 3.7 – The plot showing the T2eff distribution of the MR image of slice 1 in Figure 
3.6, demonstrating the clear difference between both preparations, alginate spheres 
with and without microbubbles. The T2eff distribution of the alginate spheres with 
microbubbles is significantly lower than the spheres without microbubbles. 
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MR Relaxation Assessment at 3T using a Whole-Body Scanner  
The image acquisitions in this section were performed using a 3T Philips Achieva whole 
body MR scanner (Philips, Best, Netherland) in the Sir Peter Mansfield Imaging Centre 
at the University of Nottingham. The experiments were carried out to optimise the MRI 
sequences for the preparation for in-vivo experiments and further validating the results 
obtained in our previous experiments using a 2.35T small animal scanner. 
Methods  
Sample Preparation 
The contrast agent comprising alginate spheres with microbubbles was prepared 
following the method which previously described in section 2.3, with 10 minutes curing 
time. The spheres were suspended in a distilled water at room temperature. An hour 
before the MRI experiment, the spheres were loaded into a single-compartment sample 
holder (Figure 3.9) and then placed in a water bath at 37 °C, simulating the human body 
inner temperature. Later, the sample was wrapped in foam before being placed in the 
centre of the MR scanner.  
 
 
Figure 3.8 – The 3.0 Tesla Philips Achieva whole body MR scanner at the Sir Peter 
Mansfield Imaging Centre, University of Nottingham.  
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Figure 3.9 – A homemade single-compartment sample holder containing the alginate 
spheres with microbubbles, in water suspension. 
 
MRI Sequence 
The MR acquisition was carried out using a Balanced Turbo Field Echo sequence, BTFE, 
to measure the T2eff of the alginate spheres with microbubbles on the 3T whole body 
scanner. Eight sets of a single slice at 3 mm thickness were acquired by varying the echo 
time of the T2 preparation pulses, T2-prep time, before running a standard BTFE readout. 
The values of the T2-prep echo times were 20, 50, 80, 120, 180, 300, 500 and 800 ms.
After the MRI acquisition, the BTFE data were fitted by Dr Caroline Hoad from the 
University of Nottingham for the T2eff using a model to generate the decay curve 
spanning the evolution of the magnetisation after each radiofrequency pulse used in the 
sequence (Hoad, Cox et al. 2010). The difference between the modelled and acquired 
data was further minimised using a Powell fitting algorithm (Press, Teukolsky et al. 1992). 
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Results  
 
Figure 3.10 – MR image 
(acquired with the BTFE 
sequence) showing the 
T2eff value of the alginate 
spheres with 
microbubbles on the 3T 
Philips Achieva MRI 
scanner. 
 
 
 
 
The BTFE MR image in Figure 3.10 shows the T2eff-weighted of the sample containing 
alginate spheres with microbubbles. As a result, the T2eff differences can be seen 
between the centre and periphery, a similar effect to the one we have discovered in the 
previous experiment when using the 2.35T small animal MRI scanner. The T2eff value of 
the centre of the spheres is ranging between 150 and 240 ms and the periphery between 
55 and 100 ms. The average value (T2eff = 135 ms) is then used to optimise the next MRI 
sequence in measuring the sensitivity of the alginate spheres with microbubbles under 
pressure cycling in chapter 5. 
From this result, we can see that the overall T2eff value of the alginate spheres with 
microbubbles is approximately 33 % lower, as expected, than observed on the 2.35T 
scanner in section 3.2.2, which agrees with the theory in Equation 1.7 described in 
section 1.3.7.2 and in the numerical simulations demonstrated by previous researchers 
(Dharmakumar, Plewes et al. 2002, Bencsik, Al-Rwaili et al. 2013). This described that, in 
a higher external magnetic field, the magnetic susceptibility difference between the 
bubble and its surrounding is increased, which then cause the increase of the magnetic 
field perturbation on the microbubble surrounding. Consequently, the water molecule 
experiencing greater dephasing, hence the decrease in the T2eff. 
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Conclusions 
In this work, monodisperse gas-filled microbubbles were loaded into alginate spheres 
forming an MRI susceptibility contrast agent with a great potential for measuring 
pressure changes in the human stomach. The MRI measurements were performed on 
the contrast agent by assessing the T2eff and compared to that of the alginate spheres 
without microbubble. We have successfully demonstrated and quantified that the T2eff 
relaxation time substantial decreases in the presence of gas-filled microbubbles in the 
alginate sphere, at two different field strengths.  
Beforehand, the effect of curing time was also quantitatively assessed in terms of T2eff. 
As a consequent of curing, changes in the T2eff is seen over time and this may result from 
structural changes in the spheres’ characteristics, more specifically creating a more rigid 
matrix, which then influenced the interaction between the ‘free’ and ‘bound’ water 
molecules. In addition to that, the spatially variation of the T2eff is clearly revealed, 
showing gradual curing from the periphery towards the centre of the spheres. The T2eff 
of the periphery of the sphere is much lower to that of the core, typically by a factor of 
2.1, suggesting that there are more bubbles trapped in the periphery. This phenomenon 
will be further explored in chapter 5 revealing the sensitivity difference to the pressure 
changes of the two areas in alginate spheres.  
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CHAPTER 4 
T2EFF MAPPING OF MICROBUBBLE-LOADED 
ALGINATE SPHERES WITH PRESSURE 
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4 T2EFF MAPPING OF MICROBUBBLE-LOADED ALGINATE SPHERES WITH 
PRESSURE 
Introduction 
In this chapter, we measure the MR signal intensity changes when varying pressure is 
being applied to the alginate spheres with microbubbles. The MRI measurement is 
carried out by acquiring a series of MSME images whilst the pressure is simultaneously 
increased and independently measured. The experimental set-up and the equipment 
required performing the MRI experiment are also explained. 
When the pressure is applied, it is known that the microbubbles component in the 
contrast agent undergoes a change in size due to its flexibility and compressibility, which 
consequently alter the NMR signal, hence the change on its relaxation time 
(Dharmakumar, Plewes et al. 2002). In this chapter, we quantitatively explore this effect 
with a specific focus on the newly designed contrast agent, the alginate spheres with 
microbubbles. 
Methods  
Pressure Generation 
In order to apply a pressure to the microbubbles contrast agent, a pump is needed to 
drive a volume of excess fluid into a closed system where the contrast agent reside. In 
our experiments, a Gilson® pump Model 303 (Gilson Inc., Wisconsin, U.S.A.) (Figure 4.1) 
was used to deliver this task because it provided an adjustable and a constant flow rate 
allowing a good control of the resulting pressure.  
 
Figure 4.1 – The Gilson® pump Model 303 used to drive a volume of fluid into a closed 
system in order to apply a pressure to the microbubble-based contrast agent. 
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Sample holder design 
A single-compartment cell was manufactured from transparent acrylic tubing. The 
design of this homemade sample holder is shown in Figure 4.2. The part of the cell 
labelled as B on the diagram was built from a round tube, with 3 mm wall thickness, 15 
mm length and 37 mm diameter. Next, a piece of acrylic was cut by using a laser cutter 
to form two disks, each with a diameter of 37 mm and 6 mm thickness, labelled as A and 
C. Then, 9 mm circular apertures were formed on both pieces, one at the centre for disk 
A and one off-centred for disk C. Afterwards, all parts were glued together as shown in 
Figure 4.2 using an acrylic adhesive. Before it was used for the experiment, the integrity 
of the sample holder was tested by filling it with water and pressurising it up to 4 bars 
to check for any leakage. 
 
 
Figure 4.2 – Diagram showing the design of a sample holder, manufactured from 
transparent acrylic tubing. The second circular aperture, which is on disk C, was created 
to assist the filling process of the contrast agent into the sample holder, and it placed 
off-centred to ease the removal of any trapped air pocket by simply tipping the container 
to the side. 
 
Contrast Agent preparations 
Alginate spheres with microbubbles were prepared following the preparation as 
previously described in Chapter 2 (section 2.3). These spheres were suspended in 
distilled water before being transferred into the described sample holder with 
approximately 5 ml capacity (Figure 4.3) and then connected to a pump and a pressure 
gauge. While loading the contrast agent into the sample holder, an active measure was 
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taken to avoid any air pocket being trapped in the system, which can affect the 
effectiveness of the measurement if they were left in the sample. 
 
 
Figure 4.3 – Picture showing the sample holder containing microbubble-entrapped 
alginate spheres suspended in distilled water. The sample holder is equipped with inlet 
and outlet, which can be connected to the Swagelok tubing, enabling the fluid being 
driven into the system in order to apply pressure to the contrast agent.  
 
Experimental set-up 
The experiment was set up as shown in Figure 4.4. The sample holder containing alginate 
spheres with microbubbles was connected to the pump and then placed in the Bruker 
Biospec 2.35T MR scanner. The pump was further set to flow at a very low rate, 2 ml/hr, 
to supply a slowly increasing pressure to the system. Immediately after the pump was 
switched on, MR images were acquired simultaneously using the MSME sequence at TE 
= 10 ms and TR = 3000 ms (for a significant time saving), acquiring a dynamic 
measurement of the effective transverse relaxation time, T2eff, of the contrast agent. The 
experiment lasted for 2.5 hours allowing 15 separate sets of three-slice T2eff images to 
be taken every 9 minutes as the pressure in the system was very slowly increased, from 
0 bar to 1 bar.  
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Figure 4.4 – Illustration showing the equipment set-up for the experiment allowing the 
measurement of the T2eff increase to pressure increase. A sample holder containing 
alginate spheres with microbubbles was connected to a pump and pressure gauge by 
Swagelok tubing 
 
Results  
The resulting MSME images were processed using a home built Matlab® code, as 
previously described in section 3.2.1.3. Figure 4.5 shows two sets of the multi-slice T2eff 
images of the sample with different intensities demonstrating the T2eff change within 
the alginate spheres with microbubbles. These two sets of the three-slice images were 
taken at two different pressure values, 0.15 and 0.89 bar respectively. An increase of 
the signal intensity is clearly seen all over the spheres on a higher pressure value.  
In order to calculate the sensitivity of the spheres to pressure changes, for each 
repetition of the MSME sequence, we estimated the mean T2eff of the contrast agent by 
selecting the pixels corresponding to alginate spheres with microbubbles for each 
measured pressure. From the graph, the sensitivity of this contrast agent to the pressure
change appears to be as high as 43 % T2eff change per bar. A linear correlation is 
demonstrated with a clear increase of T2eff with increasing measured pressure seen all 
over the spheres as shown in Figure 4.6. This is directly linked to the change of the 
microbubble radius size in the alginate sphere which is in agreement with the numerical 
simulation undertaken by Dharmakumar et al., stating that the change in the bubble size 
due to change in pressure caused changes in the effective spin-spin relaxation rate 
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1/T2eff (or R2eff). The presence of the microbubbles perturbed the external magnetic field 
and a change in the bubble size results in a differing spatial extent of this field 
perturbation. The protons at the bubble surrounding experience a dephasing because 
they sample ĚŝĨĨĞƌĞŶƚŵĂŐŶĞƚŝĐ ĨŝĞůĚ ƐƚƌĞŶŐƚŚƐǁŚŝůĞ ĚŝĨĨƵƐŝŶŐ͘ dŚĞ ŐƌĞĂƚĞƌ ƚŚĞ ĮĞůĚ
perturbations sampled by the proton, the greater the extent to which the MR signal 
decays due to dephasing, which yields image contrast to the pressure. Therefore, as the 
bubble size decreases due to the pressure increase, the proton samples lesser field 
perturbations that cause it to experience less dephasing, hence the increase in the MR 
signal. 
 
 
Figure 4.5 – Two sets of the three-slice MSME images taken at different pressures 
showing the T2eff values within the alginate spheres with microbubbles. The image is an 
axial slice taken from the centre of the sample, which also reveals a spatial gradient of 
the T2eff between the centre and the periphery of the spheres.  
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Figure 4.6 – Graph showing a linear correlation between effective transverse relaxation 
time, T2eff, of microbubble-loaded alginate spheres with the pressure change. The T2eff 
value increases linearly as the pressure applied increases. The solid line denotes a trend 
line providing the best fitting of the data (blue circles). The spheres exhibit a sensitivity 
of 43 % T2eff change per bar. 
 
On the images, a spatial gradient is also revealed between the centre and the periphery 
of the spheres.  In order to demonstrate these spatial variations and the extent of the 
T2eff change to the pressure change in both regions, we divided each T2eff image by the 
first one measured (Figure 4.7). Then, this effect is further demonstrated in Figure 4.8 
by plotting the T2eff values in both regions as the pressure increases. It is seen that the 
T2eff value in the centre of the alginate sphere is constantly higher compared to the 
periphery. Both of these regions contribute to the increase in the T2eff value of the whole 
alginate spheres when the pressure is increased, with the periphery exhibits a higher 
sensitivity, which is up to 58 % T2eff change per bar whilst the centre exhibits 24 % change 
per bar (Figure 4.8). The sensitivity to pressure changes of these two regions within the 
spheres is further explored in the next chapter.  
In addition, there is no measurable change of spin density (Figure 4.9), as expected, with 
pressure, which constitutes further evidence that the change in MR signal is mostly 
caused by the size changes of gas-filled microbubbles as the pressure changes.  
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Figure 4.7 – Three of the T2eff division images, the same slice but at different pressures, 
revealing the spatial variations between the centre and the periphery of alginate sphere 
and demonstrating the sensitivity difference between the two regions to the pressure 
change. These images are produced by dividing each T2eff image with the first image 
acquired, at a pressure value 0.1 bar. 
 
 
 
Figure 4.8 – Graph showing the T2eff changes in the centre and the periphery of alginate 
sphere to the pressure change. In both regions of the sphere, the T2eff value increases 
linearly as the pressure applied increases. The linear lines (the dotted line for the centre 
and solid line for the periphery) best fitted the data and the gradients and y-intercepts 
for both lines are presented in the form of y=mx+c equations. The sensitivity of the two 
regions derived from the linear lines is 24 % T2eff and 58 % change per bar in the centre 
and periphery, respectively. 
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Figure 4.9 – The images showing the proton density of the sample taken at two different 
pressures, demonstrating there is no measurable change as the pressure change. 
Conclusions 
A pressure-sensitive contrast agent was produced from alginate spheres with entrapped 
microbubbles and its functionality was tested with MRI. In this experiment, the pressure 
was applied to the system and gradually increased while the MR images were 
simultaneously taken. The T2eff mapping results show an excellent linear correlation with 
the externally applied pressure, the T2eff within the contrast agent increased as the 
pressure increased. This result is consistent with the initial finding demonstrated by 
Alexander et al., although they were using less stabilised microbubbles (air-filled) with 
polydisperse size preparations, where the relaxation rate (1/T2eff) was seen inversely 
proportional to the pressure change (Alexander, McCreery et al. 1996). Also, the 
theoretical study demonstrated by Dharmakumar et al. (2002) is in agreement with this 
outcome. As the pressure increases, the size of the bubble decreases, the magnetic field 
perturbation is being altered, therefore the MR signal too.  
Additionally, we have also found that the sensitivity to pressure changes is different 
between the centre and the periphery of the alginate spheres, where the periphery 
exhibits a higher sensitivity, which is up to 58 % T2eff change per bar whilst the centre 
exhibits 24 % change per bar. We believe that the predominant reason for this is due 
the difference of the microbubbles distribution between these two regions. As a 
conclusion, the results we obtained in this chapter demonstrate that this contrast agent 
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can be used as a non-invasive technique for measuring pressure within a human body, 
particularly for gastrointestinal study. In the next chapter, with an aid of a rapid MRI 
sequence, we explore the ability of this contrast agent in measuring rapid pressure 
changes. 
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5 MRI SENSITIVITY OF MICROBUBBLE-LOADED ALGINATE SPHERES TO 
PRESSURE VARIATION 
Introduction  
In the previous chapter, we have demonstrated using an MSME sequence that the 
alginate sphere with microbubbles can provide the MRI scan to sense changes in 
pressure. Here, we explore the ability and the MR sensitivity of this novel contrast agent 
to measure a rapid pressure change in-vitro. In order to achieve this, the fast MR imaging 
sequence called Rapid Acquisition with Relaxation Enhancement (or RARE) was adopted 
allowing the acquisition of images while the pressure within the system was being 
rapidly changed. In parallel, the stability of the contrast agent was also assessed, by 
repeatedly cycling the applied pressure several times (whilst acquiring the RARE images).  
In order to use this contrast agent for measuring pressure changes in the human 
stomach, it must endure the human stomach conditions whilst maintaining its 
functionality. Hence, this study includes the measurement of the sensitivity of the 
alginate spheres with microbubbles in different environments mimicking the human 
stomach acid and temperature. On top of that, the sensitivity of this contrast agent is 
also observed using a 3-T whole body scanner intended to be used for the in-vivo 
experiments involving human volunteers. Both data acquired by the 2.35T Biospec 
Bruker and the 3T Philips Achieva scanners are presented in this chapter. 
 
In-Vitro Studies at 2.35 Tesla Using a Small Animal Scanner 
The image acquisitions performed for this section were carried out using a Biospec 2.35T 
Bruker small animal MR scanner (Figure 3.1) at the Physics Department of the 
Nottingham Trent University. 
NMR Signal Changes to Rapid Pressure Cycling in Water 
Sample Preparations 
Two preparations of alginate spheres were produced following the method described in 
Chapter 2. The two preparations were made identical except for the presence of 
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microbubbles; one preparation was without microbubbles and the other with 
microbubbles entrapped. The spheres were loaded into a twin-compartment sample 
holder (the same as used in section 3.2.2) to facilitate the simultaneous assessment of 
both preparations. 
Experimental Set-up 
The Swagelok tubing was connected to the two-compartment sample holder, containing 
the two preparations of alginate spheres with and without microbubbles, and to a pump 
and a pressure gauge (Figure 5.1). The inlets of the two individual compartments were 
interconnected at the same distance of 50 cm allowing identical pressure changes to be 
simultaneously applied to both preparations. Optimised RARE images were acquired 
with pressure cycling between 0 and 1 bar, at echo time TE = 10 ms every 7 seconds, and 
effective echo time, TEeff = 400 ms. It has been previously demonstrated that to achieve 
a maximum MR sensitivity, the effective echo time is optimised when TEeff = 2T2eff 
(Morris, Bencsik et al. 2008). Hence, the value of the TEeff of our RARE sequences was 
adjusted accordingly, from the previous experiment described in section 3.2.4.2. 
 
 
Figure 5.1 – Illustration showing the equipment set-up for the experiment measuring 
the MR sensitivity of the alginate spheres with and without microbubbles to pressure 
changes. A twin-compartment sample holder containing both alginate spheres 
preparations was connected to a pump and pressure gauge with Swagelok tubing. 
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Results 
On the RARE images, the signal intensity coming from the alginate spheres with 
microbubbles at 0 bar is lower to that coming from the alginate spheres without 
microbubbles by a factor of approximately 2.5, indicating, as expected, that the T2* is 
decreased in the presence of the microbubbles (Figure 5.2). In monitoring the MR 
sensitivity to pressure, the lower MR intensity pixels were selected, thereby eliminating 
the water solvent from the analysis to ensure that the signal intensity is solely coming 
from the spheres. The signal intensity of the first MR image is relatively high due to the 
T1 recovery effect, hence, we took the mean signal intensity of the second and the third 
images, where the magnetisation had reached its steady state while there was no 
measurable pressure applied, to calculate the sensitivity of the contrast agents to the 
pressure change. Essentially, we analysed the percentage of the relative signal intensity 
change compared with the alginate spheres ‘at rest’.  
Using this strategy, the MR signal intensity in the spheres with entrapped microbubbles 
exhibits changes of approximately 40 % signal change per bar. On the contrary, the signal 
intensity remains constant (to within 1 % due to noise and scanner electronic drift) 
throughout the experiment in the spheres without microbubbles, demonstrating that 
the signal change is indeed due to the presence of the microbubbles. In the preparation 
with microbubbles, there is a 10 % signal drift most probably due to bubble destruction, 
however, the sensitivity remains as high as 25 % change per bar, towards the end of this 
17-min long experiment after 12 pressure cycles (Figure 5.3). 
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Figure 5.2 – Two RARE images showing both compartments containing alginate spheres 
with (left) and without (right) microbubbles acquired at different pressure values; 0 bar 
in image a) and 1 bar in image b). At 0 bar, the signal intensities coming from the alginate 
spheres with microbubbles are much lower compared to the counterpart alginate 
spheres without microbubbles. At 1 bar, the signal intensities of the alginate spheres 
with microbubbles increase whilst the ones without microbubbles remain the same.  
 
 
 
Figure 5.3 – Graph showing the sensitivity of both alginate spheres with and without 
microbubbles. The MR signal intensity changes coming from alginate spheres with 
bubbles initially typically shows 40 % signal change per bar, whilst the signal intensity 
remains constant in alginate without bubbles. The percentage of the MR signal intensity 
change is relative to the second and the third images, where the magnetisation had 
reached its steady state while the measured pressure was still zero. The red curve shows 
the measured pressure. 
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MRI Sensitivity with Different Bubbles Densities, and Effect of an Acid 
Simulating Gastric Conditions 
It has been demonstrated by previous workers through a numerical simulation that the 
pressure sensitivity of the microbubbles can be further enhanced by increasing its 
density (Bencsik, Al-Rwaili et al. 2013). Although we have demonstrated in the previous 
experiment that the alginate spheres with microbubbles exhibited a maximum pressure 
sensitivity up to 40 % signal change per bar, it would be desirable if this sensitivity can 
be further enhanced to maximise its ability in assessing small pressure changes within 
the human stomach, a pressure range between 30 – 82 mmHg or 39 – 109 mbar 
(Bortolotti, Annese et al. 2000). Here, we explore this effect on two different 
microbubbles densities entrapped in alginate spheres, expecting to see an increase in 
the sensitivity for a higher bubbles density. At the same time, the effect of an acid 
solution, that is similar to the gastric secretions existing in the stomach, is also observed 
on these preparations.  
Sample Preparations 
In this experiment, two preparations of alginate spheres with different bubble densities 
were used; one preparation containing approximately twice more bubbles than the 
other did in terms of gas volume fraction, to demonstrate the resulting increase in the 
MR sensitivity to pressure changes. In order to achieve this, two vials containing 1 ml of 
phospholipid solution each were shaken using the usual capsule mixing device to yield 
the same amount of microbubbles in both vials. Then, both microbubbles preparations 
were placed into separate containers with different amounts of sodium alginate gel, one 
with 10 ml and the other is twice more volume (20 ml), before the two preparations 
were respectively dropped into separate calcium lactate solutions resulting in the 
creation of alginate spheres with different bubble densities (4.5 % and 8.3 %). Then, the 
two different alginate sphere preparations were loaded into a separate cell of the two-
compartment sample holder (same as discussed in section 3.2.2).  
Separately, an acid solution mimicking the human gastric conditions was prepared 
following the steps described in section 2.4.1. Then, 20 ml volume of this solution 
withdrawn into a syringe. 
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Experimental Set-up 
The main challenge for setting-up this experiment is that, in the acid solution, the 
alginate spheres are seen to exhibit a decrease in the T2*, which has also been 
mentioned in the previous study (Hoad, Rayment et al. 2009). In our initial attempt, we 
prepared the sample by suspending the alginate spheres in the acid solution before 
placing it into the scanner, but then the effect of the acid has already taken place before 
the scanning was started. By the time the first MR image was acquired, about 5 minutes 
after the spheres’ first contact with the acid, a substantial decrease in the MRI signal 
intensity had already taken place. 
In order to overcome this issue, we came up with a solution, by incorporating some 
additional assembly to the previous set-up described in section 5.2.1.2.; a syringe, an 
isolation valve and an outlet valve were also connected to the system, allowing the 
flushing with the simulated gastric acid solution (held in the syringe) (Figure 5.4). This 
would enable us to run the MR image acquisition, first, when the spheres reside in water 
suspension, and then, while flushing and immediately after the flushing of the acid 
solution into the system, replacing the water.  
The optimised RARE images with TEeff = 400 ms were acquired with pressure cycling 
between 0 and 1 bar, at TE = 10 ms every 7 seconds, initially, in the presence of water. 
Subsequently, the pressure cycling was stopped, then, the outlet valve and the isolation 
valve were released, and the water surrounding the alginate spheres was flushed out 
and replaced with the solution simulating gastric acid before the pressure cycling was 
resumed. A 20-ml volume of the acid solution, which was double from the volume 
capacity of the sample holder, was used to ensure a complete flushing of the water from 
the system was achieved. 
In addition, necessary precautionary measures have also been considered regarding 
health and safety issues in handling the acid solution while running the experiment. 
Specified personal protective equipment (PPE), consisted of gloves, safety goggles and 
laboratory coat, was used at all time while handling this solution. 
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Figure 5.4 – Illustration showing the equipment set-up for the experiment measuring 
the MR sensitivity of the contrast agent in a simulated gastric solution. The syringe is 
connected to the assembly, through isolation valve, enabling the flushing of the 
simulated gastric acid solution into the system.  
 
Results 
In comparing two different bubbles densities, in the initial pressure cycle with the 
presence of water, the sensitivity of alginate spheres with twice higher bubbles density 
is approximately 45 % change per bar, and 35 % in the lower density preparation (Figure 
5.5). This difference is less than expected, a 200 % increase has been demonstrated in 
previous work (Bencsik, Al-Rwaili et al. 2013) for an increase of twice of the bubble 
density. This is probably because at high enough density, the field gradients of individual 
bubbles will start overlapping, and the increase in MR sensitivity is not linear with bubble 
density anymore. At the same time, the signal drift, approximately 50 % over 10 pressure 
cycles, is observed more prominently in the higher bubble density, where it is only 11 % 
in the lower bubble density, suggesting that the bubble destruction due to pressure is 
higher as the experiment progresses, in the higher bubble density preparation. For 
further validation in the future, images of the contrast agents before and after of the 
pressure cycling can be acquired to be able to quantitate the signal change that caused 
by the bubbles destruction. Overall, although there is a slight increase of MR sensitivity 
with bubble density, the result suggests that there is no great benefit in exploring even 
higher values of bubble density. 
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Figure 5.5 – Comparison of the sensitivity to pressure changes between low and high 
microbubbles densities in water suspension and in simulated gastric solution. 
Approximately 29 % sensitivity increase can be seen in the alginate spheres with twice 
more bubbles. There is a 50 % decrease in the sensitivity of the contrast agents when 
the solution mimicking gastric acid replaced the water suspending the spheres. The MRI 
relative change is calculated by comparing the signal intensity with the start of the 
pressure cycling within the water, and the acid. This means the relative signal change in 
water (corresponds to the time measurement up to 13 min) is computed relative to the 
zero pressure in the water and the relative signal change in acid (corresponds to the 
time measurement 14 min onwards) is relative to the zero pressure in the acid. The start 
and the end of the flushing of the acid solution into the system are indicated by vertical 
dotted lines. The red curve shows the measured pressure. 
 
Following the introduction of simulated gastric acid, there is a decrease in the overall 
signal intensity of the samples. In a previous study carried out by Reyman and co-
workers, it was shown that in lower pH condition, the transverse relaxation time in 
alginate spheres considerably decreased, and it was further suggested that this was due 
to the shrinking and the formation of a denser acid gel network (Rayment, Wright et al. 
2009). This phenomenon suggests that the ‘free’ water molecules within the spheres are 
being expelled due to the shrinking of the alginate gel, hence the significant decrease 
on the observed signal intensity. This can be further demonstrated by observing the 
proton density changes within the spheres following the exposure to the acid solution, 
however, we have not explored this in our experiment. 
At the same time, we anticipated that the shrinking of the alginate gel affects the 
flexibility of the microbubbles within the gel, which explains the 60 % decrease of the 
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sensitivity of the contrast agent in the acid solution. Nevertheless, we have 
demonstrated that following the alginate spheres being dipped in the acid, the contrast 
agents and especially the one with a lower microbubbles density are still very much 
functional for a time duration of at least 20 minutes.
MRI sensitivity at Body Temperature, 37 °C 
Sample Preparations 
The contrast agent comprising of the alginate spheres with microbubbles was prepared 
following the steps explained in Chapter 2. Then, the contrast agent was placed in a one-
compartment sample holder in water suspension at room temperature.  
Experimental Set-up 
The set-up is similar to the previous experiment in section 5.2.2, which has an outlet 
valve and syringe connected (Figure 5.4), enabling the flushing of warm water into the 
system. However, in this experiment, one-compartment sample holder was used to 
contain the alginate spheres with microbubbles. Optimised RARE images were acquired 
simultaneously with pressure cycling between 0 and 1 bar, at TE = 10 ms every 7 seconds. 
Firstly, the pressure was cycled for approximately 12 min, with a cycle taking place every 
3 minutes. Then, the pressure cycling was stopped. The fluid surrounding the alginate 
spheres was then flushed out and replaced with water at 37 °C, before resuming the 
pressure cycling. 
The initial water surrounding the alginate spheres at room temperature was flushed out 
and replaced with 20 mL of water at 37 °C, which was twice than the volume of the 
sample holder, to ensure the fluid was completely replaced with warm water. However, 
we could not be certain that the spheres were actually at 37 °C, as we could not directly 
measure the temperature in the sample while running the experiment. We expected 
that there is a drop in the temperature of the water at 37 °C when it was flushed through 
a long thin tube to get into the main chamber of the sample. Perhaps for future 
reference, the temperature of the water coming out of the system should be monitored 
and keep the flushing through the sample with warm water until the outlet temperature 
reached 37 °C. 
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Results 
 
 
Figure 5.6 – Graph showing the MR sensitivity of the alginate spheres with microbubbles 
to pressure changes in distilled water at room (18°C) and body temperature, 37 °C. The 
sensitivity of the contrast agent in a warm surrounding water remains the same as in 
room temperature. The time of measurement up to 14.5 min corresponds to the relative 
signal change from alginate spheres in water at 18°C and from 15 min onwards at 37°C. 
The MRI relative change is calculated by comparing the signal intensity with each of the 
start of the pressure cycling. This means the relative signal change at temperature 18 °C 
is computed relative to the mean signal intensity at zero pressure (acquired at the 
beginning of experiment), and the relative signal change in water at 37 °C is relative to 
the mean signal intensity at zero pressure in water at 37 °C (acquired at the time 15.6 & 
15.7 min). The start and the end of the flushing of the water in water at 37 °C into the 
system are indicated by vertical dotted lines. The red curve shows the measured 
pressure. 
 
In the first pressure cycle at room temperature, the sensitivity exhibited is 
approximately 35 % signal change per bar, and then gradually decreased to 28 % change 
per bar after four pressure cycles. When warm water at 37 °C was introduced, the 
sensitivity further dropped to 26 % signal change per bar and then remains the same for 
at least another 15 min of observation (Figure 5.6). In accordance to the ideal gas law, 
the increase of the temperature will increase the volume of the microbubbles, causing 
the increase on its size which consequently changes the pressure sensitivity. The 
correlation between the bubble size and the pressure sensitivity has been estimated by 
Dharmakumar et al. through numerical simulations, showing the sensitivity increased 
with the expanse of the bubble, until it reached the size limit (2 µm radius), also known 
as critical bubble radius, which the sensitivity is then decreased beyond this point 
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(Dharmakumar, Plewes et al. 2002). This theoretical study has been further validated by 
Bencsik et al. which showed the maximum sensitivity to pressure changes can be 
achieved, indeed, by having the microbubbles at an optimum size (Bencsik, Al-Rwaili et 
al. 2013), although there is no experimental study available, to date, to offer sufficient 
data in order to conclude upon the applicability of these theoretical works. 
Furthermore, this result is significant evidence that the phospholipid microbubbles are 
robust enough in keeping the contrast agent stable and functional at body temperature. 
It is known that each type of phospholipid has a unique transition temperature, a 
temperature that induces a change in phase of the phospholipid. For example, DPPC, 
which is the main component of our microbubble shell has a transition temperature at 
about 41 °C (Avanti Polar Lipids 2017), which means only microbubbles experiencing 
higher temperatures than this will break as the phospholipids disperse (Zuo, Chen et al. 
2016). This temperature is proportional to the length of the hydrophobic chain of the 
lipids, and it has been demonstrated that the increase in the length of this chain 
contributes to the increase in the stability of the microbubbles (Borden, Longo 2002).  
Additionally, there is a slight increase, approximately 10 %, in the signal intensity of the 
water solvent after the flushing, which further demonstrates the temperature increase 
within the sample. The temperature dependency of the transverse relaxation time of 
water has been previously observed, which showed an increase in the relaxation time 
with increasing temperature (Vesanen, Zevenhoven et al. 2013).  
  
In-Vitro Studies at 3 Tesla using Whole Body Scanner  
The MRI experiments in this section were carried out on the 3T whole body scanner 
Philips Achieva in the Sir Peter Mansfield Imaging Centre at the University of Nottingham. 
Several in-vitro experiments were performed simulating the stomach conditions and 
aiming to optimise the MRI sequences as a step towards the in-vivo experiments. 
Besides, the experiments discussed here can also be used to further validate the results 
that have been achieved in our previous experiments using a 2.35T small animal scanner.  
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Assessing the Sensitivity of Contrast Agent in Water Suspension at 37 °C 
In this experiment, the MR sensitivity to pressure of the alginate spheres with 
microbubbles in water suspension was investigated by varying the effective echo time 
TEeff, and comparing them with the signal coming from the alginate spheres without 
microbubbles using the RARE sequence. Afterwards, the sensitivity coming from the 
centre and the periphery of the spheres were also analysed and compared. 
Sample Preparations 
Two preparations of alginate spheres, with and without microbubbles, were placed in a 
water suspension, in a one-compartment sample holder with 100 ml capacity, at room 
temperature (Figure 5.7). It was easy to keep these two preparations separate in the 
container because, in water, alginate spheres with microbubbles float while the others 
sink. An hour before the experiment, the sample was placed in a warm water bath at 
37 °C, identical to the body temperature. Then, it was immediately wrapped up in foam 
before it was placed in the head coil of the scanner, vertically, with the floating alginate 
spheres residing on the top of the cylindrical sample holder. 
 
 
Figure 5.7 – Homemade sample holder containing alginate spheres with and without 
microbubbles. The natural buoyancy causes the spheres with microbubbles to float 
whilst the others sink; keeping the two preparations fully separated in the container. 
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Experimental Set-up 
The sample was connected to a pressure gauge and a pump. Immediately after the pump 
was switched on, MR images were acquired using the RARE sequence in the transverse 
plane with 3 slices at 5 mm thickness, acquired every 7 seconds. The pressure was cycled 
between 0 and 1 bar, for approximately 5 minutes, with a complete cycle took about 3 
minutes. This experiment was repeated several times with different effective echo times, 
TEeff (400 ms, 500 ms and 600 ms), to explore the effect on the sensitivity. 
Results 
By using the RARE sequence, the MR sensitivity to pressure changes can be maximised 
ďǇǀĂƌǇŝŶŐƚŚĞĞīĞĐƚŝǀĞĞĐŚŽƚŝŵĞdĞī. Image processing was undertaken in Matlab® to 
select specific pixels and analyse the MR signal coming from a single sphere to 
demonstrate the optimum TEeff value that can yield the maximum sensitivity to pressure 
changes (Figure 5.8). The signal changes were found to be most sensitive at TEeff = 500 
ms, approximately 23 % changes per bar, compared to TEeff = 400 ms and TEeff = 600 ms 
(Figure 5.9). In previous theoretical studies (Dharmakumar, Plewes et al. 2002, Bencsik, 
Al-Rwaili et al. 2013), it was found that the sensitivity increased with an increase in the 
field strength. The result obtained from this experiment is surprisingly lower than the 
sensitivity from the 2.35T scanner, where it exhibited up to 40 % signal change per bar. 
However, the stability of the sensitivity on this scanner is better than what we have seen 
on the 2.35T Biospec and there is hardly any signal drift seen throughout the 
measurements with excellent SNR.  
At the same time, we analysed the signal changes coming from a much larger rectangle 
that encompasses both the alginate spheres and the surrounding water. The sensitivities 
exhibited from this method are 15 %, 14% and 12 % signal changes per bar, respective 
to the TEeff values 400 ms, 500 ms and 600 ms (Figure 5.10). The sensitivity yielded from 
this method is approximately 60 % lower compared to the single sphere analysis. 
For the next part of the experiment, we analysed the MR signal from a single pixel 
intensity coming from the centre of a sphere and another single pixel intensity coming 
from the periphery of a sphere (Figure 5.8) and the result is shown in Figure 5.11. The 
signal intensity in the centre of the sphere is constantly higher indicating that the T2* 
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value is higher in this area as compared to the periphery of the spheres (Figure 5.11 a)), 
as seen in the previous experiments. We anticipated that the microbubbles density is 
higher in the periphery. This is consistent with the common feature exhibited by these 
spheres that we observed where the periphery exhibits higher sensitivity to pressure 
changes, which is up to 55 % signal changes per bar whilst the centre exhibits less than 
20 % changes per bar (Figure 5.11 b)). Nevertheless, both these two areas contribute to 
the overall sensitivity of the alginate spheres with microbubbles to the pressure changes 
in the experiment where large volumes of the meal will be used to monitor pressure 
changes. 
 
 
Figure 5.8 – a) One of the RARE images acquired at TEeff = 500 ms using the 3T Philips 
Achieva whole body scanner, when the pressure applied at 0 bar. The MR signal intensity 
differences can be seen at the top and bottom of the specimen, showing alginate 
spheres with and without microbubbles well separated in the container. The two white 
squares represent the pixels selections for the signal intensity analysis coming from a 
single sphere for both preparations. b) Zoomed image of the selected sphere with 
microbubbles and the two circles represent the pixels selection for the signal intensity 
analysis coming from the centre (high intensity) and the periphery (low intensity) of the 
sphere. 
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Figure 5.9 – Graphs showing the sensitivity of the alginate spheres with and without 
microbubbles for different TEeff values of the RARE sequence. The signal intensity change 
is coming from the pixels representing a single sphere for each preparation as shown in 
Figure 5.8. The sensitivity of the alginate spheres with microbubble is highest at TEeff = 
500 ms with 23 % signal changes per bar, whilst the signal intensity coming from the 
alginate sphere without microbubbles remains zero. The MRI relative change is 
calculated by comparing the signal intensity with the start of the image acquisition and 
pressure cycling (measured pressure 0 bar). The red curves show the measured pressure. 
At very low pressures, the MR sensitivity is seen better than that of the pressure gauge.  
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Figure 5.10 – Graphs showing the sensitivity of the alginate spheres with and without 
microbubbles for different TEeff values of the RARE sequence, by selecting a large 
rectangle encompasses the pixels representing the alginate spheres and the surrounding 
water. The sensitivity of the alginate spheres with microbubbles to the pressure change 
is approximately 60 % lower as compared to the single sphere analysis in Figure 5.9. The 
signal intensity coming from the alginate sphere without microbubbles remains zero. 
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Figure 5.11 – Comparing the sensitivity at the centre and at the periphery of one alginate 
sphere with microbubbles. a) The absolute signal changes revealing the signal intensity 
from the centre of the sphere constantly higher than the periphery. b) Relative signal 
change showing the periphery is more sensitive to pressure than the centre of the 
sphere. The red curves show the measured pressure. The MRI relative change is 
calculated by comparing the signal intensity with the start of the image acquisition and 
the pressure cycling (pressure 0 bar). 
 
Assessing the Sensitivity of the Contrast Agent in Simulated Gastric Solution 
Sample Preparations 
The sample preparation was similar to the previous experiment in section 5.3.1.1, with 
the contrast agent only consisting of the alginate spheres with microbubbles. This time, 
after the sample was wrapped up in a foam, it was then placed in a glass beaker to
prevent acid spillage on the MR scanner in case of any leakage from the sample, before 
it was placed in the head coil of the MR scanner. 
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Experimental Set-up 
The sample holder had an inlet and an outlet allowing the liquid medium being flushed 
when required and enabling the sample to be connected to a pressure gauge and a 
pump (Figure 5.12). Immediately after the pump was switched on, MR images were 
acquired using the RARE sequence in a transverse plane with 3 slices at 5 mm thickness, 
every 7 seconds. The pressure was continuously cycled between 0 and 1 bar while 
running the MR scanning, with a cycle applied every 4 minutes. 
 
Figure 5.12 – Illustration showing the equipment set-up for the experiment measuring 
the sensitivity of the contrast agent in a simulated gastric solution. A single-
compartment sample holder containing the alginate spheres with microbubbles was 
connected to a pump and pressure gauge by Swagelok nylon tubing. It also connected 
to a syringe and an outlet valve accommodating the flushing of the simulated gastric 
acid solution into the system. 
 
Results 
Firstly, we analysed the MR signal coming from a large rectangular section of the sample 
in water solvent, highlighted with a white rectangle on MR images in Figure 5.13. The 
signal changes exhibited up to 28 % changes per bar when accounting for all pixels within 
the rectangle. However, by dismissing the pixels that represent the water solvent, the 
sensitivity goes up as high as 35 %, which can be understood as resulting from the 
sensitivity solely coming from the alginate spheres with microbubbles (Figure 5.14). 
About the same sensitivity has been demonstrated in the previous experiments 
presented in this chapter using the 2.35T Biospec MR scanner. 
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In a subsequent MR acquisition, when the acid was introduced into the system replacing 
the water surrounding medium, it is seen that the contrast agent is still functional in the 
new medium, but the sensitivity is decreased to 17 %, a phenomenon we have also seen 
in our previous experiments using the Biospec scanner in section 5.2.2, where it was also 
seen to drop to 17 % signal change per bar.  
The spheres are also seen to be shrinking in the acid solvent because alginate creates a 
tighter gel network in acidic condition. For this, we have estimated the volume shrinkage 
to be approximately 8 % within the 20 minutes of this experiment, using a simple pixel 
intensity threshold to discriminate the volume of solvent from that covered by the gel. 
This effect can also be seen in the RARE images where the space occupied by the spheres 
in acid solution decreased over time (Figure 5.13).  
 
 
Figure 5.13 – RARE images of alginate spheres with microbubbles suspended in two 
different solvents, water (left) and simulated gastric acid (right). In both these images, 
the solvent (water and acid) is dismissed for signal analysis so that the sensitivity is solely 
coming from the spheres. The space occupied by the spheres in acid suspension is 
decreased, demonstrating the shrinking of the spheres. The white squares represent the 
pixels selections for the signal intensity analysis. 
 
In this particular experiment, after an acidic solution was introduced into the system, 
some instabilities can be seen on the pressure cycle (Figure 5.14b) due to the insufficient 
time duration of releasing the pressure at the valve (tap), which was approximately 4 m 
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away from the specimen. The first release of the pressure produced the MR signal 
intensity drop much lower than the second release, indicating that the sample was still 
under pressure although the pressure gauge reading was zero. This is evidenced by the 
second cycle where an instantaneous and unusual increase of the MR signal intensity 
was exhibited, compared to the other two following cycles, upon the introduction of the 
pressure. During the experiment, the second release was done by opening the tap for a 
time duration at least 1 minute longer than the first release, giving enough time for the 
pressure within the sample to drop to zero. Additionally, a similar effect is also observed 
in the fourth and fifth cycle (time of measurement approximately at 18 minutes), 
however, in this case, the pressure gauge reading was immediately increased to 0.6 bar 
after the pressure was introduced, indicating that this part was caused by a blockage 
due to a movement of some of the spheres into the tubing when the pressure was 
released.  
 
Figure 5.14 – Graphs showing two subsequent experiments measuring the sensitivity of 
alginate spheres with microbubbles in a) water and b) acid simulating gastric solution. 
The MRI relative change is calculated by comparing the signal intensity with the start of 
the image acquisition and the pressure cycling (pressure 0 bar). The red curve shows the 
measured pressure. 
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MRI sensitivity in locust bean gum and acid solution simulating gastric 
conditions 
Due to the buoyant characteristic of the alginate spheres with microbubbles, it is a 
challenge to distribute them evenly once they reside in the human stomach because 
they naturally float when placed in a water suspension. Hence, a locust bean gum has 
been used as a suspending medium to prevent them from floating too quickly. In this 
experiment, the sensitivity of the alginate spheres with microbubbles suspended in a 2 % 
w/v locust bean gum is investigated. 
Sample Preparations 
The alginate spheres with microbubbles were prepared and placed in a water 
suspension. Separately, a locust bean gum solution (2 % w/v) was prepared following 
the steps in section 2.4.2 and placed in a beaker. Then, 250 ml of alginate spheres with 
microbubbles were mixed gently with 250 ml of locust bean gum solution, in a plastic 
bottle, 500 ml capacity, at room temperature, simulating the actual volume ratio to be 
ingested by a human volunteer. In order to eliminate as much as possible of trapped air 
bubbles within the mixture, a gentle stirring was used when mixing the alginate spheres 
into the locust bean gum to encourage large bubbles to rise to the surface. Once they 
rose to the surface of the preparation, they were then removed by scooping out with a 
spatula. There were only very few large air-trapped bubbles left after insertion of the 
meal into the bottle. An hour before the experiment, the sample was placed in a warm 
water bath at 37 °C.  
Experimental Set-up 
The sample was connected to Swagelok nylon tubing and immediately wrapped up in 
foam before it was placed in the body coil, which will be used for the study on the human 
volunteer, of the MR scanner. An inlet was created enabling the bottle to be connected 
to a pump and a pressure gauge, allowing the pressure being changed during MRI 
scanning. Immediately after the pump was switched on, MR images were acquired using 
the RARE sequence at TEeff = 500 ms, with 3 slices at 5 mm thickness, every 7 seconds. 
The pressure was continuously cycled between 0 and 1 bar until the MRI scanner 
sequence was finished in 10 min, with a cycle applied every 5 minutes. Due to the large 
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volume of the specimen and the flexibility of the bottle, there was far more water 
volume (about 140 ml) required to be pumped into the system to reach the usual 1 bar 
pressure. 
After the first set of scanning completed, the bottle was taken out from the scanner and 
then 50 ml of the sample was scooped out of the bottle and replaced with acid 
simulating gastric solution at 37 °C. Subsequently, the bottle was immediately 
reconnected to the initial set-up and another set of RARE images were acquired with the 
pressure cycling for 20 min. 
At the end of the first pressure cycle, we found that, even though the pressure gauge 
dropped rapidly to zero, the specimen was still under pressure. This was evidenced by 
the fact that switching the pump back on resulted in an immediate rise of the pressure 
read by the gauge. We concluded that, when releasing the pressure, some locust bean 
gum was brought back into the Swagelok tubing, thereby blocking fluid flow and 
preventing the pressure from being released from the meal.  
 
Results 
 
Figure 5.15 – RARE images of alginate spheres with microbubbles in locust bean gum, 
without (top) and with (bottom) the acid simulating gastric solution. The white 
rectangles representing the ROI selections for the signal intensity analysis. 
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Figure 5.16 – a) The sensitivity of the alginate spheres with microbubbles suspended in 
the locust bean gum, without a solution simulating gastric acid. The MRI relative change 
is calculated by comparing the signal intensity with the start of the image acquisition 
and the pressure cycling (pressure 0 bar). b) The sensitivity of the alginate spheres with 
microbubbles suspended in the locust bean gum, with a solution simulating gastric acid. 
c) The volume of the spheres decreases 3 %, due to the effect of acid on the sample, 
within 20 min observation. This effect can be identified by observing the decrease of the 
peak on the plot every time the pressure is being released from 1 to 0 bar.  
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The locust bean gum with a 2 % w/v concentration successfully kept the spheres from 
physically rising within the sample holder. This is a major improvement from our initial 
locust bean gum preparation with a 1 % w/v concentration, which was not viscous 
enough to immobilise the alginate spheres with microbubbles, which were seen to rise 
within a minute.  
The MR signal was analysed by selecting a large rectangular section of the sample, 
highlighted with white rectangles on the MR images (Figure 5.15). The signal changes 
exhibited up to 35 % changes per bar, prior to adding the acid (Figure 5.16 a)). Then, the 
MR sensitivity of the contrast agent in a locust bean gum with the simulated gastric 
solution drops to 22 % (Figure 5.16 b)). The decrease of the signal intensity is seen, due 
to the effect of the acid, by observing the MR signal taking place at zero pressure. 
However, the sensitivity to the pressure change is seen to increase over time, with the 
maximum MR signal reached the highest pressure, 1 bar, exhibits a remarkable steady 
state, probably due to the signal increase coming from bubble damage somewhat 
compensating the signal decreasing coming from the acid.  
Over time, the spheres are seen to be shrinking after the acid solvent is added to the 
specimen. Again, we estimated the volume change by using Matlab® image processing 
to discriminate the volume of locust bean gum from that covered by the spheres, by 
setting a pixel intensity threshold. The results show that the acid-driven volume 
shrinkage is approximately 3 % within the 20 min of this experiment (Figure 5.16 c)), 
which is much less compared to the previous experiment in section 5.2.2 where the 
alginate spheres were not suspended in a locust bean gum, resulting in a 8 % volume 
shrink. The thick gel of locust bean gum somewhat works as a protection layer, which 
slows down the effect of the acid on the alginate spheres. Overall, the locust bean gum 
with 2 % w/v concentration has been demonstrated to be useful in immobilising the 
spheres, whilst maintaining the robust signal sensitivity of this contrast agent. 
Conclusions 
A pressure sensitive MR contrast agent has been created and tested. It comprised of 
gas-filled microbubbles suspended in soft-solid alginate spheres, which has been 
specifically tailored to investigate the pressure changes in the human stomach.  Dynamic 
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measurements have been used to test its functionality in several conditions including in 
a solvent mimicking the human gastric solution at body temperature. This novel contrast 
agent yielded a high level of sensitivity, up to 40 % MR signal change per bar.  
At the same time, a suitable suspension medium for the spheres, which made of a locust 
bean gum, has found to be useful for immobilisation while keeping its robust sensitivity. 
The primary issue was the rapid motion of the alginate spheres upwards due to their 
buoyancy in an aqueous suspending media. This has been overcome in this work by 
using a 2 % w/v concentration of locust bean gum. In addition, this gel is seen to slow 
down the acidification of the alginate spheres when it is dipped in the simulated gastric 
solution, which can be a great benefit when the contrast agent resides in the human 
stomach for in-vivo investigation. As the acid solution is seen to degrade the pressure 
sensitivity of these spheres, this gel can help in keeping the spheres functional for a 
longer period in the stomach. As a conclusion, with the combination of MR imaging, this 
contrast agent can be used as a novel technique in demonstrating pressure changes in 
the human stomach.   
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6 DEMONSTRATING SPATIAL PRESSURE GRADIENT USING MICROBUBBLE-
BASED MRI CONTRAST AGENTS 
Practical Motivation 
A non-invasive technique for direct MR measurement of the dynamic pressure in the 
stomach is highly desirable as it can be beneficial in helping the clinicians to further 
understand the condition of diseases such as functional dyspepsia, which normally 
associated with chronic disorder of sensation and movement (also known as peristalsis) 
in the upper digestive tract, including stomach. In the past, gas phase MRI has been 
demonstrated as a suitable method to assess a spatial gradient for fluid pressure 
measurements (Bencsik, Ramanathan 2001), but this method is not suitable for medical 
applications. In addition, in the previous chapters, we have successfully demonstrated 
that by using MRI as the imaging tool, gas-filled microbubbles suspended in alginate 
spheres can be used as a method to monitor pressure changes. Although, various studies 
(Alexander, McCreery et al. 1996, Dharmakumar, Plewes et al. 2005, Bencsik, Al-Rwaili 
et al. 2013) have previously investigated the potential of microbubbles as a pressure 
probe in MRI, a spatial pressure gradient has never been demonstrated within a medical 
application. In a publication in 2007, a pressure gradient effect has been demonstrated 
with microbubbles, however, the bubbles preparation was not monodisperse and they 
were suspended in a medium, and were seen to rise within minutes (Morris, Bencsik et 
al. 2007). Besides, the study was conducted in a porous medium consisting of a structure 
similar to sandstones, which was not in a medical application set-up.  
In this chapter, we use gas-filled microbubbles suspended in two different media, a 
viscous liquid gellan gel and the soft-solid alginate gel spheres, to map a pressure 
gradient with the aid of MRI for in-vitro studies, in order to demonstrate their capability 
to be used as a method to measure spatially varying pressure changes in the human 
stomach. The MR image acquisition is performed using the RARE sequence to be able to 
achieve a rapid measurement (less than 1 second) of the MR signal intensity of the 
contrast agent whilst the externally applied pressure changes.  
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Microbubbles in Gellan Gel 
Introduction 
It has been previously demonstrated that gellan gel can be used as a suspending medium 
keeping the gas-filled microbubbles immobilised for more than 40 hours (Morris, 
Bencsik et al. 2008), and exhibiting a sensitivity up to 23 % signal change per bar (Bencsik, 
Al-Rwaili et al. 2013). It suggested that this contrast agent can be used as a non-invasive 
technique for a direct MR measurement of a fluid pressure. In this study, we use this 
similar contrast agent preparation (microbubbles suspended in gellan gel) to 
demonstrate a spatial pressure gradient effect. 
Sample holder design 
 
Figure 6.1 – Diagram showing the design of the sample holder which comprised of two 
compartments separated by a sintered glass disc with pores (5-ϭϱʅŵͿ͘ The finished 
product is shown in Figure 6.2, loaded with the microbubbles contrast agent. 
 
A cell which is comprised of two compartments was manufactured from transparent 
acrylic tubing. The design of this homemade sample holder is shown in Figure 6.1. The 
main parts of the cell, labelled as A1 and A2 in the diagram, were built from two round 
tubes, with 3 mm wall thickness, 15 mm length and 37 mm outer diameter. Next, a piece 
of acrylic was laser cut to form three disks, each with a diameter 37 mm and thickness 
6 mm, labelled as B1, B2 and B3. Then, circular apertures were formed at the centre of 
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each of these disks with diameters 9 mm, 30 mm and 9 mm on B1, B2 and B3 respectively. 
Afterwards, a 3-mm thick sintered glass disc (AM Glassware, Aberdeen, Scotland) with 
30 mm diameter and 5-ϭϱʅŵƉŽƌĞƐǁĂƐĂƚƚĂĐŚĞĚƚŽƚŚĞĐŝƌĐƵůĂr aperture on disk B2. 
Finally, all parts were glued together as shown in Figure 6.1, by using an acrylic adhesive 
(RS components, Northants, UK). Before it was further used for the experiment, the 
integrity of the sample holder was tested by filling it with water and pressurising it up to 
4 bar.  
Sample preparations 
In this particular experiment, the microbubbles were suspended in gellan gel (2 % w/v), 
which works as a bubble immobilisation medium. The mixture of the microbubbles and 
gellan gel was prepared following the protocol fully described in Chapter 2 (section 2.2). 
Then, this mixture was loaded into the two-compartment sample holder (Figure 6.2). 
 
Figure 6.2 – The two-compartment sample 
holder, separated by a sintered glass with micro-
pores, filled with microbubbles suspended in 
gellan gel, ready for MRI pressure gradient 
experiment. 
 
 
Pre-MRI experiment set-up 
Due to the use of an MRI-incompatible pressure gauge, it was difficult to measure the 
actual pressure in both compartments during the MRI measurement. In order to 
demonstrate the time duration of the pressure transient from one compartment to 
another, the timings were measured prior to the MRI scanning. The equipment was set-
up as shown in Figure 6.3, outside the MRI scanner. The assessment shows that there is 
a 60 seconds delay in the time course of the pressure measured in each compartment, 
meaning the pressure is only seen to change in the second compartment one minute 
after the pressure is ramped up in the first one. Following the pump switching off, 
approximately eight minutes are required for both compartment pressures to 
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equilibrate (Figure 6.4). This demonstrates the existence of a pressure gradient in the 
sample holder.
Figure 6.3 – Illustration showing the equipment set up to assess a pressure gradient 
between two compartments of the sample holder. The tubing was filled with gellan gel 
and the pump supplied a flow in order to ramp up the pressure within the system.  
 
 
 
Figure 6.4 – The time course of the measured pressure demonstrating a pressure 
gradient between the two compartments of the sample holder. It demonstrates that 
there is a one-minute delay between the two compartments and it takes approximately 
eight minutes for the pressure to equilibrate within both compartments. 
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Experiment set-up 
 
Figure 6.5 – Illustration showing the equipment set-up for the pressure gradient 
experiment with MRI. The two-compartment sample holder containing microbubbles 
suspended in gellan gel was connected to a pump by Swagelok® tubing. The pressure 
gauges were placed at both sides of the compartments to measure the pressure change, 
however, it was not possible to measure the actual pressure within both compartments 
because of the use of the MRI-incompatible pressure gauges which were placed outside 
the 5 Gauss line of the polarising field (approximately 4 m away from the sample).  
 
The sample was connected to a pump and the full experiment setup is shown in Figure 
6.5. Firstly, without applying any pressure yet, the effective transverse relaxation time, 
T2eff, of the microbubble contrast agent was measured by using the MSME sequence at 
TE = 10 ms and TR = 3000 ms using a Bruker Biospec 2.35T MR scanner. The MSME image 
of the sample showing the T2eff value is displayed in Figure 6.6, and the average T2eff 
value (170ms) from this measurement is used to optimise the next MRI sequence for 
the subsequent image acquisition. 
Then, the pump was set to flow at 50 ml/min rate, to supply an increasing pressure to 
the system, while the outlet was closed. Immediately after the pump was switched on, 
MR images were acquired simultaneously using the RARE sequence (TE=10ms, RARE 
Factor = image size = 64, TEeff = 2T2eff = 340ms). 
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Figure 6.6 – T2eff image of both 
compartments filled with microbubbles 
suspended in gellan gel showing the T2eff 
value before any pressure is being applied 
to the system. The average T2eff value from 
this measurement is then used to optimise 
the RARE sequence in the next MR 
acquisition with the pressure.  
 
 
 
Results 
Figure 6.7 shows two RARE MRI images of both compartments taken at different times 
and demonstrates the spatial pressure gradient. At 6 seconds after switching on the 
pump, the signal intensity in both compartments was almost identical, compared to the 
signal taken at 290 seconds where the signal intensity in compartment 1 was greater by 
a factor of 1.5.  
We analysed the signal intensity and produced plots of its changes over the course of 
time within these two compartments (Figure 6.8). For the signal analysis, the field of 
views (FOV) were selected using ImageJ processing program (NIH, Maryland, USA), in 
order to prevent an image artefact contributing into our analysis. The artefact was 
caused by the gel when it was driven into the sample to ramp up the pressure. On the 
image in Figure 6.7, we identify this as a ‘compression artefact’.  
Figure 6.8 shows the change in MR signal intensity due to the variation of pressure 
across the two compartments. The signal intensity in compartment 1 started to increase 
150 seconds after the pump was turned on. This was followed, 30 seconds later, by a 
signal increase in compartment 2. This 30-second delay is slightly faster compared to the 
time delay we obtained in the pre-experiment in section 6.2.4, where the pressure in 
compartment 2 is seen to increase one minute after the pump switched on in 
compartment 1. This discrepancy shows that, at very low pressures (below than 0.1 bar), 
the MR sensitivity is better than the sensitivity of the pressure gauges we used, in 
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sensing the pressure change. In the future, the use of a higher sensitivity pressure gauge 
should be taken into consideration. 
Following that, the signal intensity in compartment 1 increased more rapidly which 
indicates an increasing spatial pressure gradient between both compartments. As the 
pump was stopped, the signal intensity in compartment 1 decreased whilst in 
compartment 2 it continued to rise, indicating that the pressure was still equilibrating. 
This is in agreement with the result acquired in the pre-experiment in section 6.2.4, 
however, a longer MRI measurement could be performed to observe the signal 
intensities in both compartments reaching the equilibrium as seen in the pre-
experiment, where the pressure in both compartments was seen to equilibrate 
approximately 8 minutes after the pump was switched off.  
Although, the sample was connected to the pressure gauges while acquiring the MR 
images, the actual pressure within both compartments was only indirectly measured 
due to the use of a non-MRI compatible pressure gauge, which was placed outside the 
5 Gauss line of our polarising magnet. Hence, in the future, we propose to use a suitable 
pressure reading method in order to enable a direct measurement of the pressure 
transient between the compartments. 
This particular work has been presented as a poster at the International Conference on 
Magnetic Resonance Microscopy 2015, Munich, Germany (Appendix A). 
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Figure 6.7 – RARE MR images showing both compartments at time 6 seconds and 290 
seconds respectively, showing signal intensity changes and demonstrating a pressure 
gradient effect. 
 
 
Figure 6.8 – MR signal intensity changes to pressure in both compartments, containing 
microbubbles suspended in a Gellan gel. When the pump was switched off (solid red 
line), the signal intensity in compartment 2 (black circle) continue to rise whilst it started 
to decrease in compartment 1 (yellow cross). 
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Microbubbles Entrapped in Alginate Spheres 
Introduction 
With the intent of measuring pressure changes in the human stomach, it is crucial that 
the contrast agent is capable of measuring the dynamic pressure changes in different 
areas within this organ. Although we have demonstrated that the microbubbles 
suspended in a viscous liquid gellan gel is capable of sensing the spatial pressure 
gradient, it would be a challenge to achieve this in the human stomach because this fluid 
solution’s pressure would nearly instantaneously equilibrate throughout the meal 
volume. Hence, we use a large collection of soft-solid alginate spheres with entrapped 
microbubbles as an artificial meal to overcome this issue allowing the measurement of 
pressure changes to local compression. In this way, the microbubbles are immobilised 
in an elastic gel network whilst maintaining its compressibility and flexibility. In this 
experiment, we intend to demonstrate through in-vitro experiment that this contrast 
agent can be used to measure a pressure gradient spatially and temporally. We are 
hoping to be able to sense the local pressure in this meal without the need to have the 
low permeability disc that we previously used in section 6.2.  
Experimental Set-up 
In this experiment, the contrast agent consists of alginate spheres with entrapped 
microbubbles. The spheres were sieved from the water suspension and then placed into 
an empty 50-mL plastic bottle. Additionally, a deflated balloon was connected to an air 
pump, enabling pressure to be applied to the balloon, and then placed into the plastic 
bottle containing the alginate spheres (Figure 6.9). This way, upon inflation, the balloon 
can compress the spheres as it changes size, at varying locations within the vessel, 
hopefully allowing different alginate spheres to experience different pressures in a way 
similar to what we anticipate to see in the case of them residing in the human stomach.  
The sample was imaged using an optimised RARE sequence in a sagittal plane with nine 
contiguous, 4 mm thick slices. We monitored signal intensity changes from within the 
spheres for 23 min as the pressure was cycled between 0 and 1 bar, in order to expand 
the balloon to different sizes. A bicycle pump was used to expand the balloon quickly 
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until the pressure reached 1 bar, and the pressure was slowly released, in steps of 0.1 
Bar. 
 
 
Figure 6.9 – Illustration showing the experimental setup to demonstrate a pressure 
gradient using alginate spheres with microbubbles entrapped. The pump is used to 
inflate the balloon, which then compresses the alginate spheres providing a variation of 
applied pressure in different locations within the sample container. The valve is used to 
release the air allowing the balloon to deflate slowly whilst MRI images of the sample 
are acquired.  
  
6.3.3 Results  
Figure 6.10 shows one of the sets of nine-slice RARE images taken when the pressure 
within the balloon was at 0.7 bar demonstrating that the microbubbles-loaded alginate 
spheres located in different parts of the bottle exhibit differing signal intensity 
suggesting spatial pressure gradients throughout the sample.  
We further analysed the mean signal intensity changes coming from the alginate 
spheres with microbubbles on each slice of the data set as the pressure is ramped up 
and down, thereby changing the balloon size, and then provided a plot for each of the 
image slices (Figure 6.11). The result demonstrates differing signal changes at differing 
slices, as the pressure within the balloon changes. The maximum signal change exhibited 
on the image at slice position 24 mm and the minimum at 4 mm, respectively, with 30 % 
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and 15 % signal changes as the pressure within the balloon gradually changed from 1 
bar to 0 bar.  
 
 
 
Figure 6.10 – One of the sets of the nine-slice MR images taken when the pressure in 
the balloon is 0.7 bar, showing the alginate spheres throughout the sample differing in 
MR signal intensity (SI). The percentage signal change of each of the slice is shown in 
Figure 6.11. 
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Figure 6.11 – Each plot is corresponding to a specific slice of the RARE images, showing 
the MR signal intensity (SI) percentage change exhibited on all nine different image slices, 
throughout the sample, as the pressure is cycled between 0 and 1 bar. The blue and red 
curves represent the MR SI percentage change and measured pressure, respectively. 
The highest SI change is seen on the image at slice 24 mm and the lowest at slice 4 mm. 
This shows that this contrast agent can demonstrate a pressure gradient on the sample. 
 
Conclusions 
In these in-vitro studies, MR imaging using a rapid RARE sequence demonstrates a 
spatial pressure gradient on the specific specimens using our microbubble-based 
contrast agents, which to the best of our knowledge has never been demonstrated 
before. In the first experiment, by using microbubbles suspended in a gellan gel with 2% 
w/v concentration, we show that the MR signal intensity and its time course are 
different in a two-compartment sample holder separated by a sintered glass with pores 
(Figure 6.7 & Figure 6.8). This effect is associated with the size change of the 
microbubbles due to the pressure gradient between the two compartments, which 
affects the overall T2*. It demonstrates that the microbubble contrast agents can be 
used as a fluid pressure measurement tool which shows potential as an agent in clinical
prospects for measuring pressure changes within the human stomach.   
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The second experiment reveals that the alginate spheres with entrapped microbubbles 
exhibit a variation in the MR signal intensity in different locations when the pressure is 
applied, demonstrating their capability in sensing the localised pressure changes (Figure 
6.11). This work shows a great potential for microbubble-based contrast agents to 
measure pressure changes spatially and temporally using MR imaging. It also promises 
that this method can be very useful in medical applications, particularly in measuring a 
rapid and localised pressure change within the human stomach. 
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7 MRI IN-VIVO STUDIES  
Introduction 
In previous chapters, we have demonstrated through in-vitro experiments that the 
alginate spheres with microbubbles exhibited a sensitivity of up to 40 % signal changes 
per bar at the field strength of 2.35T and 3T, showing promising potential as a pressure 
probe for MRI examinations. Following this, we carried out further in-vivo investigations 
on healthy volunteers to demonstrate the capability of this microbubble-based contrast 
agent to sense spatially varying pressure changes in the human stomach. The expected 
pressure exerted in the stomach on its meal, within the antrum region, during the 
digestive period is ranging between 30 and 82 mmHg (40 to 109 mbar) (Bortolotti, 
Annese et al. 2000). It is known that the symptoms of the patients related to functional 
dyspepsia disease, such as nausea, vomiting and belching, are enhanced with the 
stomach distention (Tack, Caenepeel et al. 2001). This related to the alteration of the 
physical responses of the stomach to ingestion of food (Farre, Vanheel et al. 2013). 
For in-vivo studies, the contrast agent is prepared in the form of a meal to be consumed 
by the volunteers before being further scanned with MRI. An initial scanning is 
performed using the RARE sequence which resulted in severe motion artefacts. We 
therefore further explored the BTFE sequence. In this chapter, five in-vivo investigations 
are carried out and for the purpose of the MRI sequence optimisation, several in-vitro 
experiments are also undertaken in between. All of the experiments involving MRI 
scanning in this chapter were carried out using the 3T Philips Achieva whole-body 
scanner at the Sir Peter Mansfield Imaging Centre (SPMIC), at the University of 
Nottingham.  
Study Design 
Selection of Participants 
The ethical approval for the in-vivo studies was acquired from the ethics committee 
of the University of Nottingham. The participation into the study is entirely voluntary 
and all the volunteers gave written informed consent. At the time of writing this 
document, four volunteers (two males, two females, age range 25-55 years) were 
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recruited, for five in-vivo studies. All volunteers had no history of gastrointestinal 
disease and were suitable for MRI scanning. In the process of designing the study, the 
eligibility criteria were written to reduce any possible bias resulting from spurious 
results in subjects with specific underlying conditions, which may alter intra-gastric 
pressure: 
Inclusion criteria: 
x Age between 18 and 55 years x Able to give informed consent 
Exclusion criteria: 
x Pregnancy x History of pre-existing gastrointestinal disorder, including but not limited to: 
• Inflammatory Bowel Disease 
• Coeliac Disease 
• Pancreatitis 
• Active Gallstone disease (biliary colic, cholecystitis) 
• Diverticulitis 
• Cancer of the gastrointestinal tract 
• Irritable Bowel Syndrome x Reported history of the previous resection of any part of the gastrointestinal 
tract other than appendix or gallbladder x Any medical condition making participation in the study potentially 
compromising e.g. diabetes mellitus, respiratory disease limiting ability to lie in 
the scanner  x Contraindications for MRI scanning  x Reported alcohol dependence x Inability to lie flat or exceed scanner limits of weight (120 kg in our case) x Poor understanding of English language x Participation in any medical trials for the past 3 months x History declared by the candidate of food allergy to nuts and shellfish  
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The Contrast Agent Meal 
The production of the alginate spheres was carried out following the protocol described 
in chapter 2 (section 2.3.1) using food grade ingredients in a food safe physiology 
laboratory (ERD145B) at the Nottingham Trent University. Prior to this, the researchers 
involved in the meal preparation obtained a food hygiene certificate. The 500 ml meal 
consisted of a mix of alginate spheres and locust bean gum with a volume ratio of 1:1 is 
prepared for each of the volunteers. 
Study Arrangement 
Participant Preparations 
On the day of the study, the participants arrived at the SPMIC after a minimum of 6 
hours fast. This was to attempt to reduce subject variability and factors that can affect 
gastrointestinal function. Participants were allowed a cup of water on the morning of 
the study if it was consumed at least an hour before coming to the test centre. Then, 
the participant was instructed to change into MRI compatible loose clothing before 
going through the meal ingestion and the MRI protocols. 
Meal Ingestion Protocol 
The 500 ml contrast agent meal, warmed up to 37 °C, was separated into two parts (250 
ml each) and placed into plastic cups. Before consuming it, participants were asked to 
consume a high-fat content meal, 50 ml of Calogen® (Nutricia, UK), to rapidly turn the 
stomach from a fasted into a fed state and to help retain the alginate meal in the 
stomach for a longer time duration (Hoad, Rayment et al. 2009). After 15 minutes, the 
participants were asked to eat, as much as they felt comfortable, of the first part of the 
contrast agent meal (250 ml of the microbubble alginate spheres) within a 10-min period. 
The volunteers were instructed to ingest the spheres without chewing to retain its shape 
and functionality in sensing pressure in the stomach. They then underwent an 
approximately 10-min long MRI scan. Immediately after this scan, the participants were 
asked to eat as much as they felt comfortable of a further 250 ml of the meal within 10 
min. Another approximately 20-min MRI scan was then taken. Throughout the 
investigations, slight changes in the protocol were occasionally carried out based on 
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individual studies, which will be further explained in each of the experiments. Finally, 
the participant is free to go after the MRI scanning is done. 
MRI Protocol 
Initially, the MRI scanning was performed using the RARE sequence. However, after 
undertaking the study on the first volunteer, we found this sequence was greatly 
susceptible to motion artefacts, naturally caused by breathing and the internal organs’ 
involuntary movements. Hence, in the subsequent experiments we moved on to using 
a gradient echo sequence with a faster imaging acquisition, Balanced Turbo Field Echo 
(BTFE) which also known as TrueFISP. In this study, the typical time duration of the 
acquisition of k-space for the RARE is between 300 to 500 ms, and for the BTFE is around 
90 ms. In addition, a spin echo pulse, which also known as a T2 prep time, is applied as a 
preparation pulse before the acquisition of the BTFE sequence (Hoad, Cox et al. 2010) 
to make sure that T2* contrast is left to take place in the contrast agent.  
Flavour Enhancement of the Contrast Agent 
While working on the ingredients of the contrast agent, volunteers found its taste was 
rather plain and not sufficiently appealing to the palate. The taste is important in helping 
the participants to feel comfortable in consuming the meal, however, it is also crucial 
that any additional ingredient will not impede the MR signal and the sensitivity of the 
contrast agent in sensing the pressure. In an attempt to enhance the flavour, we tried 
adding commercially available sweetener (Tesco, UK) and vanilla extract flavouring (Dr. 
Oetker, Germany) in the locust bean gum (LBG) solution.  
Experimental set-up 
The LBG solutions (2 % w/v concentration) were prepared following the procedure 
described in section 2.4.2. For this experiment, three samples of the LBG solutions were 
prepared; (1) with sweetener and vanilla flavouring (2.5 % and 0.8 % w/v concentration 
respectively), (2) with sweetener (0.8 % w/v concentration) and (3) without any additive 
flavour or sweetener (plain). Each of these LBG solutions was filled into separate 50 ml 
plastic test tubes. MRI scanning was then carried out with the RARE sequence (TEeff = 
500 ms) using the 3T Philips scanner. 
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Results  
The RARE image with colour scale signal intensity is shown in Figure 7.1. The result 
demonstrates that the signal intensity of the LBG is decreased with the addition of the 
sweetener and flavouring. As compared to the plain LBG, the decrease is about 13 % in 
the LBG with sweetener, whilst a dramatic drop, approximately 50 %, of the signal 
intensity takes place in the LBG with sweetener and vanilla flavour. In terms of taste, we 
found that it was only slightly improved by adding sweetener into the LBG and further 
enhanced with the vanilla flavour. However, considering the effect on the signal 
intensity, we decided not to add any of these taste enhancers to our contrast agent meal 
for the subsequent experiments. In order to enhance the experience and the process of 
consuming the meal without affecting the signal and sensitivity, the volunteers for the 
in-vivo studies are provided with a variety of strongly scented foods (chocolate and 
lemon) or warm solutions (vanilla and lemon) for them to smell whilst eating the 
contrast agent. The purpose is to help to stimulate their olfactory senses while 
consuming the meal.  
In the future, further exploration on different flavours that could enhance the taste with 
less effect on the MR signal of the meal would be very helpful in providing a better 
experience for the participants (or patient) in consuming the contrast agent meal.  
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Figure 7.1 – The RARE images of three locust bean gum solutions (2 %) in 50 ml plastic 
test tubes, a) with sweetener and vanilla flavour, b) with sweetener and c) without any 
sweetener or flavour (plain). The signal intensity of the LBG solutions in a) and b) 
decreased 50 % and 13 % respectively compared to c) the plain LBG. 
 
In-Vivo Investigation using the RARE Sequence  
Method  
The alginate spheres with microbubbles (250 ml) were prepared the day before the MRI 
procedure and suspended in distilled water in a 500 ml glass bottle before it was stored 
in a fridge. On the day of the MRI study, a 250 ml LBG solution (2 %) was prepared 3 
hours before the investigation. The alginate spheres were sieved out of the glass bottle, 
eliminating the water suspension, and then mixed with the freshly prepared LBG which 
resulted in a total volume of 500 ml of contrast agent. The meal was divided equally into 
two portions and placed into separate plastic cups. After being given a briefing regarding 
the procedure, the volunteer was instructed to ingest the meal following the ingestion 
protocol described in section 7.2.3.2. The volunteer consumed approximately 80 % and 
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40 % of the first and second part of the meal, respectively, which resulted in a total 
volume of an ingested meal of approximately 300 ml. 
The participant was positioned in the scanner with a slightly tilted orientation; left side 
of the body lifted higher than the right side, in order to help to channel the meal within 
the stomach towards the antrum. This enabling the observation of the stomach muscle 
wall contraction on this region on the MR images, while the spheres experience the 
resulting pressure variations. Two sets of dynamic MRI scans were acquired using the 
RARE sequence, mainly to explore the effect of varying the value of TEeff. The first one 
was acquired every 7 seconds with three slices imaged at 5 mm thickness and TEeff = 500 
ms, and the second measurement with one slice imaged at TEeff = 300 ms.
Results 
In the first step of the analysis, the MR images were inspected, slice by slice, and an ROI 
corresponding to the part of the stomach containing the largest part of the meal was 
manually selected by using the ImageJ processing program. In doing so, we noticed large 
deviations from frame to frame, due to motion artefact caused by breathing. This effect 
is further quantitated when the mean of the MR signal intensity in the selected ROI was 
analysed, frame by frame (Figure 7.2). Unfortunately, when motion artefact takes place, 
the pixel intensity loss is severe, and resulting in the exhibited change up to 300 % 
(Figure 7.3).  
The signal variations that we are trying to harvest are expected to be much smaller than 
those presently measured and probably dominated by the motion artefact, and should 
be around 1.6 and 4.3 % when considering the typical 40 % per bar sensitivity of this 
contrast agent. At this point, it is clear that the limitation of the study is presently within 
the artefact most probably caused by breathing. Therefore, in the next experiments we 
worked at improving and somewhat overcoming this effect by exploring different MRI 
sequences, which are less susceptible to the motion artefact, by providing means of 
acquiring k-space in much shorter time durations. 
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Figure 7.2 – Three consecutive sagittal RARE images acquired with TEeff = 500 ms, and 
respectively taken at 21, 28 and 35 seconds of the measurement. This demonstrates 
large deviations, from frame to frame, of the area of the meal in the stomach captured 
by the selected slice, mainly caused by breathing motion as well as large deviations in 
MR signal intensity. The letters h, f, a and p indicate the directions relative to the position 
of the volunteer in the scanner, and respectively stand for head, feet, anterior and 
posterior. 
 
 
Figure 7.3 – Graph showing the percentage of the mean signal intensity variation over 
the meal is really high (between 100 to 300 % changes) probably due to movement 
artefact caused by breathing during the time duration of the k-space acquisition 500 ms. 
 
Exploring HASTE and BTFE Sequences to Minimise the Effect of Movement 
Artefacts  
We need to be able to assess the signal intensity changes related to motion (or other 
sources) and not due to pressure changes, in order to explore and quantitate different 
MRI sequences aimed at reducing the unwanted artefacts. This was achieved by running 
more in-vivo studies with an artificial meal identical to the one already used, but not 
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comprising of any microbubbles. In such a meal, any MR signal changes will not be due 
to pressure changes. 
Method 
A 500 ml contrast agent meal, consisting of the alginate spheres without microbubbles 
suspended in LBG solution, was prepared and then ingested by the volunteer following 
the standard experimental protocol (section 7.2.3.2). The total amount of the contrast 
agent consumed by the volunteer on this occasion was approximately 54 % (270 ml). 
The dynamic MRI images were acquired using two different sequences, Half-Fourier 
Acquisition Single-shot Turbo Spin Echo Imaging (HASTE), and Balanced Turbo Field Echo 
(BTFE). HASTE is another Turbo Spin Echo sequence, which is very similar to RARE. It uses 
a half Fourier transform acquisition, which is used to reduce the data acquisition time 
by acquiring only a part of k-space. Whilst, the BTFE is a gradient echo sequence. One 
data set with three-slice images was acquired using HASTE (TR = 991 ms) at TEeff = 400 
ms and another set with single-slice images using the BTFE sequence (TE = 1.71 ms, TR 
= 3.4 ms) with T2 prep time = 50 ms.  
Results  
For the image analysis, we first compared the signal intensity change coming from two 
different methods of ROI selection, one using manual selection by hand drawing the 
edge of the meal and another one by selecting a smaller elliptical area within the 
stomach (Figure 7.4), which is similar to the technique previously used in 7.4.2. By using 
the ImageJ software, both of the selection methods were performed on the data set 
acquired with the BTFE sequence. Then, the ROI selection was further uploaded into 
Matlab® and processed to analyse the signal intensity changes.  
The percentage of signal intensity change for this study performed by comparing the 
intensity relative to the mean signal intensity of the second and the third images, where 
the magnetisation had reached its steady state. The elliptical ROI exhibits less variation 
in the meal mean signal intensity, as shown in Figure 7.5. For the BTFE images, the full 
stomach selection shows an overall variation of 7 %, while the elliptical area selection 
only shows a change of 5 %. By further neglecting the odd outlier seen at 0.9 minute of 
the measurement, the percentage change drops to less than 2 %, which clearly 
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demonstrates that the elliptical selection is a better route in gaining a stable ROI for the 
analysis from one frame to another.  
The main reason for this is likely to reside in that the elliptical area selection can be taken 
near the centre of the stomach where the meal is more homogeneous, decreasing the 
effects of the edge-artefacts, which is more susceptible to the movement normal to the 
stomach wall. At the same time, this selection method also allows two separate ROIs to 
be targeted simultaneously for comparison, and in particular, within the body of the 
stomach and the antrum. Although the elliptical ROI method has the drawback that 
there are fewer pixels accounted for signal analysis compared to the hand-drawn ROI, 
we moved on to performing the subsequent analysis in this particular study with the 
elliptical area selection due to the lower signal variation exhibited.  
 
 
Figure 7.4 – a) BTFE coronal MRI image showing the meal (alginate spheres without 
microbubbles) in the stomach, and the surrounding organs. Two ROI selection methods 
are used to analyse the signal intensity change, b) elliptical and c) hand-drawn ROI 
selections. The corresponding signal intensity changes are plotted on the graph in Figure 
7.5. 
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Figure 7.5 – Plot showing the comparison between two ROI selection methods, in terms 
of signal intensity changes. The elliptical selection (S1 – red curve) demonstrates less 
signal variation compared to the hand-drawn selection around the edge of the stomach 
(S2 – blue curve), demonstrating that the first method is less susceptible to the 
movement artefact. 
 
 
Figure 7.6 – The mean signal intensity comparison between the BTFE (single slice) and 
the HASTE (three slices) sequences. The signal variation coming from the BTFE sequence 
is dramatically reduced to 2 %, compared to the HASTE which exhibits signal changes 
between 20 to 50 %. 
 
The mean signal intensities of the meal within an elliptical ROI for both BTFE and HASTE 
were calculated and displayed for comparison (Figure 7.6). This was done for the single-
slice BTFE images and for all of the three slices HASTE images. In addition, since the 
dynamic acquisition for HASTE data set was taken for only 2 consecutive minutes, the 
comparison can only be observed within this time frame. As a result, the motion artefact 
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is more prominent in HASTE, where the signal intensity change fluctuates between 20 % 
to 50 %. In contrast, it is only 2 % on the BTFE images. We can therefore conclude that, 
the BTFE is the most appropriate MR sequence to be used for our investigation with 
regards to its effectiveness in reducing the motion artefact. However, due to its ultrafast 
scanning of k-space, a preparation pulse is required, for us, with the BTFE, to make sure 
that some T2* contrast is left to take place in the contrast agent. This preparation pulse 
is known as the T2-prep time, and the investigation on varying the length of this time is 
further discussed in section 7.6.3.  
In the next in-vivo experiment, with the microbubbles present in the meal, a percentage 
change is expected to be higher than the value that currently measured (without 
microbubbles), due to the effect of the pressure in the stomach being sensed by the 
meal. Although the BTFE sequence is showing promise in reducing the motion artefact, 
unfortunately, another issue has arisen when the study undertaken with the meal 
comprises of microbubbles. Due to the meal high heterogeneity with the presence of 
microbubbles, a different part or portion of the meal that is being interrogated provides 
different mean signal intensity. This issue will be fully discussed in section 7.7, where 
the improvements obtained with the use of the respiratory triggering. 
We also further analysed the images, by normalising the signal intensity relative to the 
mean of the highest signal intensities found in the meal, assuming it is a representative 
of the LBG. It may therefore be possible to somewhat compensate the motion artefact 
by ensuring that the MR signal strength coming from the LBG alone is scaled to a 
constant value. The normalisation method allows us to effectively enhance the signal 
change due to the pressure change, provided that the percentage of pixels that we are 
using is representative of the LBG only. However, a problem will occur when this 
percentage is increased to the point that it is no longer representative of the intensity 
of LBG and starts to include important data such as the periphery of the spheres. At this 
point, the normalisation will then deteriorate the sensitivity of the contrast agent to 
pressure changes, hence, an optimum value should be further calculated. 
In this endeavour, firstly, we investigated the effect of the normalisation in the BTFE 
images by comparing the signal change in the meal, by taking off the top 5, 10, 15 and 
20 % of the signal intensity. The MR signal coming from the LBG alone is not expected 
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to exhibit much deviation, except the drift due to the effect of the acid. Surprisingly, as 
the percentage of the signal intensity taken to represent the average intensity of the 
LBG increases the percentage of the intensity change within the meal is shown to reduce 
(Figure 7.7). This further evidenced the meal heterogeneity contributes to the signal 
intensity change, when the analysis performed from one image to another. 
The figures showing the effect of changing the pixels accounted for as the LBG with 
differing percentages is shown in Figure 7.8. By taking the 10 % normalisation as an 
example, the signal intensity percentage change in the alginate spheres without 
microbubbles was found to be around 1 %, compared to the one without normalisation 
which is around 2 %. In this particular study, the 20 % normalisation appears to be most 
effective in reducing the signal variations coming from the meal without microbubbles. 
For the meal with microbubbles where the meal heterogeneity is expected to be much 
higher, perhaps the normalisation could be used to further reduce this effect. 
 
 
Figure 7.7 – Plot showing the effect of normalising the signal intensity to the highest 
intensity found on the image of alginate spheres without microbubbles meal, in an 
attempt to scale the signal intensity coming from LBG to a constant value. The signal 
intensity change observed by removing the top 5, 10, 15 and 20 % of the signal intensity, 
respectively represented by the blue, red, black and green curves.  
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Figure 7.8 – a) MR image of the meal within the stomach. b) The ROI selection (mask) 
used for analysis. The images c) to f) showing the pixels accounted for LBG, when 
different percentages (5, 10, 15, 20 %) are explored for the normalisation. 
 
Optimisation of the BTFE Sequence in Sensing Pressure Changes in the Human 
Stomach 
In-Vivo Study: Varying the Image Resolution  
In the previous section, we have demonstrated the BTFE sequence effectively reduced 
the motion artefact as compared to the HASTE and the RARE sequences, hence we 
moved on to use this sequence as our imaging method in the consequent studies. In 
order to optimise the sequence, we explore a variation of spatial resolutions in an 
attempt to further minimise the motion artefact. In this experiment, we gradually 
decreased the spatial resolution, hoping to reduce the motion artefact. It is known that 
high image resolution has high sensitivity to motion artefacts and often requires longer 
acquisition time that again worsens the movement artefact.  
Method  
As usual for our in-vivo investigations, 500 ml of the contrast agent meal (250 ml alginate 
spheres with microbubbles mixed with 250 ml locust bean gum) was prepared. Then, in 
this particular experiment, the volunteer was instructed to ingest the whole meal at 
once, instead of taking half-and-half as for the previous two volunteers. This was to try 
to avoid a scanner problem taking place when taking the bed out and in, in the middle 
of the experiment, which caused an issue with the previous volunteer, not allowing 
further scanning until ‘new patient’ registration was logged in. Exceptionally, this 
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particular volunteer managed to consume the whole volume of the meal, before 
entering the MR scanner in a supine position.  
In this study, six sets of dynamic MR images were obtained using the BTFE sequence 
with a single-slice image taken every 3 seconds for 5 minutes, mainly differing in the 
resolution of the image from experiment to experiment. The acquisition was started 
with the highest resolution (0.826) and it was then decreased gradually, in each 
subsequent experiment. The followings are the sequence details: 
 
 
Table 7.1 – Details of parameters used for the BTFE sequence, mainly exploring different 
image resolutions and the effect on the sensitivity of the contrast agent meal. 
 
Results  
The signal intensity analysis was carried out by selecting two ROIs of the meal, within 
two different regions in the stomach (antrum and body of the stomach, see Figure 7.9). 
In all of the data sets, the MR signal intensity changes in the antrum are systematically 
higher compared to those seen in the main body of the stomach, respectively around 7 
to 10 % and 4 to 5 % (Figure 7.10). The data also shows that the MR signal changes 
exhibited are higher than previously seen in the study on the meal without microbubbles, 
regardless of the spatial resolution value explored, which is anticipated as this sensitivity 
difference could be due to the effect of the pressure exerted by the stomach. 
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Unfortunately, due to the presence of the microbubbles, spatial heterogeneity in the 
meal is further enhanced and this also contributed to the signal change.  
Following that, we performed a normalisation, as previously explained in section 7.5.2, 
by removing 10 % of the highest signal intensity as a representative of LBG signal 
intensity. Initially, a sensitivity increase was expected, however the signal changes are 
instead decreased to approximately between 4 to 6 % in the antrum and between 2 to 
3 % in the body of the stomach (Figure 7.10). In an attempt to explain this, it is possible 
that the variation in the appearance of LBG on the acquired images contributes to the 
alteration of the signal intensity from slice to slice of the image.  
 
 
Figure 7.9 – ROI selections within the meal (alginate spheres with microbubbles) in 
different regions in the stomach for signal intensity analysis.  
 
By having a closer look at the data, in the instances where the volunteer held their 
breath, at the beginning and within the experiment (specifically on Figure 7.10f at 2.5 
minutes of the measurement), the signal in the antrum is seen to exhibit signal changes 
substantially larger than that seen in the main body of the stomach, within the expected 
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range of sensitivity to pressure changes (4 %). This is perhaps evidence of stronger 
pressure changes in the antrum compared to the main body of the stomach.  
The outcome of varying the image resolution demonstrates that the signal fluctuation is 
seen to remain the same in all of the resolution values explored in this experiment 
(Figure 7.10), except in Figure 7.10d where the signal change exhibited up to 20 % which 
mainly due to the large variation of the meal volume captured by the selected image 
slice. Even with the lowest resolution that we have explored (0.185 mm/pixel), the 
images are still clear enough to allow a clear selection of the meal within the two main 
regions of the stomach.  
Unfortunately, none of these experiments, however, was taken in exactly identical MR 
conditions to those in the previous volunteer with the meal without microbubbles 
(section 7.5), in terms of the MR sequence parameters. Hence, we cannot make a direct 
comparison or conclude that the signal intensity changes in this study are solely due to 
the pressure changes in the stomach. In fact, the high signal stability in instances where 
the volunteer is known to hold their breath clearly demonstrates that we are still 
severely suffering from either motion artefact, or from the slice collecting a signal from 
differing areas of the meal.
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In-Vitro Experiment: Varying the Slice Thickness of the BTFE Sequence 
In this in-vitro study, we acquire the MRI images and observe the signal intensity change 
to pressure changes by varying the slice thickness. Furthermore, without any pressure 
being applied, we also perform another experiment to quantitate the signal intensity 
change as the slice selection being moved throughout the sample. We anticipate that it 
is possible the variation in the appearance of the meal on different image slice (meal 
heterogeneity) contributes to the alteration of the signal intensity from slice to slice of 
the dynamic images in the previous studies.  
Experimental set-up 
Alginate spheres with microbubbles were prepared and suspended in distilled water, 
then loaded into a 100-ml Perspex container before being placed in a water bath at 37 °C. 
The sample was further connected to a pump and placed in the 3T MRI scanner in a 
vertical orientation. For the first part of the experiment, the MR images were obtained 
using the BTFE sequence (T2-prep = 100 ms) varying the slice thickness (5 mm, 7 mm, 8 
mm, 10 mm, 12 mm and 15 mm) while externally applying pressure changes. In the 
second part, we acquired the BTFE images by changing the slice location in a vertical 
direction towards the bottom of the sample, without applying any pressure. For this part 
of the experiment, two data sets were obtained with different slice thicknesses (5 mm 
and 15 mm) and the slice selection was moved in 5 mm increments across the sample, 
resulting in eight slices in each set. 
Results 
Square ROIs were selected for the analysis, as shown on one of the images in  
Figure 7.11a. In the first part of the experiment, in order to quantitate the sensitivity of 
the contrast agent when increasing the slice thickness, the mean MR signal intensity 
from the ROIs were analysed and relative MR signal changes to the signal found in the 
first image that had reached the longitudinal magnetisation steady state is shown, as a 
function of the applied pressure. In order to perform a processing realistic of the 
situation where the meal resides in the stomach, there was no signal thresholding 
undertaken, used as an attempt to dismiss the LBG from the analysis in in-vitro studies 
in the previous chapters. This is because all pixels will have some contribution from the 
154 
 
 
alginate and some from the locust bean gum when the slice is thick enough. Since the 
thresholding is meaningless for the thickest slice, it was not used in any of the other slice 
thickness values for the consistency of the processing strategy. 
The results show small sensitivity changes to the slice thickness, as it remains more or 
less around 40 % (standard deviation 2.08 %) signal change per bar in all experiments 
(Figure 7.12). This suggests that in order to minimise the effect of movement in causing 
artefact on the MR images and the meal spatial heterogeneity, which are the main 
limiting factor in the in-vivo study, it is safe to increase the slice thickness, which does 
not result in substantial sensitivity loss.  
In the experiment where the selected slice was moved throughout the sample, without 
applying any pressure, we show the relative signal change from one slice to another, 
using the first slice as the reference in Figure 7.11b. As a result, the signal intensity varies 
substantially, up to 25 % over a 30 cm displacement (Figure 7.13). This could be due to 
the alginate spheres with microbubbles tend to float when residing in water causing 
more fluid to accumulate towards the bottom of the sample. These particular results 
suggest that breathing-induced displacements of the selected slice are most probably 
the origin of some of the large signal changes that we have seen in our in-vivo studies, 
so far, and certainly substantiates the need to do respiratory-gated MRI. 
 
  
Figure 7.11 – MRI images taken with the BTFE sequence at 5 mm slice thickness a) 
measuring the signal intensity change to the pressure change, with a measured pressure 
at 0 bar for this particular image, and b) the first slice used as a reference to demonstrate 
the signal intensity change as the selected slice moved throughout the sample, when 
there is no pressure being applied. White rectangle and circle show the selected ROI for 
the analysis of the signal intensity. 
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Figure 7.12 – Plot showing the relationship between the sensitivity of alginate spheres 
with microbubbles to pressure change, as a function of the MR image slice thickness. 
The sensitivity exhibited around 40 % (standard deviation 2.08 %) signal change per bar 
in all experiments. 
 
 
Figure 7.13 – Plots showing the signal intensity change by shifting the position of the 
selected slice within the sample, when there is no applied pressure. 
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In-Vitro Experiment: Varying the T2 prep Time of the BTFE Sequence 
In our study, the T2 prep time is a time delay which is applied as a preparation pulse 
before the acquisition of the BTFE sequence (Hoad, Cox et al. 2010) to make sure that 
T2* contrast is left to take place in the contrast agent. Here, we explore the effect of 
varying the T2 prep time on the sensitivity of the contrast agent in sensing the pressure 
changes. 
Experimental set-up 
The sample was prepared and the experiment was set up identically to the earlier study 
described in section 7.6.2. In this experiment, the images were acquired using the BTFE 
sequence with two alternating T2 prep time values within one acquisition, resulting in 
fifty MR images taken within a 5-minute long measurement. This was repeated several 
times by varying the values of the pair of the T2 prep times, which were 20, 50, 75, 100, 
125 and 150 ms. All the T2-prep times were repeated three times with the exception of 
75 ms and 125 ms, where time constraints only allowed to acquire a single experiment. 
Although a difficulty occurred during the experiment, a blockage caused by spheres 
entering the tubing, this was solved by taking out the sample from the scanner, 
removing and reconnecting the tubing, after the blockage was flushed out. Then, the 
sample was replaced into the scanner upside down, so that the water was driven into it 
from the bottom, avoiding any possible floating alginate being driven back into the 
tubing when releasing the pressure.  
Results 
The MR images were analysed and the change in our contrast agent’s MR sensitivity to 
the change in the T2-prep time is demonstrated. The results showed that the overall 
mean signal intensity in the sample is increased with decreasing in T2-prep times (Figure 
7.14), as expected, as the T2* attenuation effect is stronger with increasing values of 
time delay.  
Furthermore, the sensitivity to the pressure change as a function of the T2-prep time 
values is shown in Figure 7.15, which demonstrates a trend of increasing sensitivity with 
increasing T2-prep time, as expected. However, the T2 prep time values of 75 and 125 
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ms, which were acquired in the same data set, show unusually high sensitivity to 
pressure even though the signal intensity they exhibit is well within the trend of the 
exponential decay curve with T2-prep time in Figure 7.14. We are not certain about the 
reason for this but we anticipate it could be due to our bubble size having an optimum 
T2eff value producing the best sensitivity to pressure. We further investigated this in the 
following in-vivo study (section 7.7.1) to try to clarify if this effect was genuine, but there 
was no sensitivity enhancement demonstrated. 
From the overall results of this experiment, we have shown that 50 ms is the best viable 
T2-prep time value as it exhibits very similar sensitivity to that obtained at 100 ms. This 
lower T2-prep time, 50 ms, is further advantageous as it is expected to decrease the 
susceptibility to movement when compared to 100 ms.  
 
 
Figure 7.14 – The plot showing the overall mean signal intensity decrease in the sample 
containing alginate spheres with microbubbles with increasing T2 prep time. Each of the 
measurements repeated three times (solid circles), except for 75 ms and 125 ms with 
only one experiment each. The mean value of the three repeats (hollow circles) and their 
exponential fit (solid line) are also provided, with estimated T2* value 166 ms. 
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Figure 7.15 – The plot showing the sensitivity of this contrast agent to pressure changes 
as the T2 prep time is changed. Each of the measurements repeated three times, except 
for 75 ms and 125 ms with only one experiment each. 
 
In-vivo Investigations of the Alginate Spheres Using the BTFE Sequence with 
Respiratory Triggering  
During normal breathing, the stomach moves and causing a selected slice captures a 
slightly different location of the tissue in each of the MR images, which in our case, also 
contributes to the signal variations in the meal, hindering the accurate quantitation of 
the signal that solely coming from the pressure change in the stomach. Our strategy to 
overcome this issue is by incorporating the MR image acquisition with the respiratory 
triggering. This involves in tracking the respiratory cycle motion and acquiring images 
within a selected interval of the cycle. This way, the acquired dynamic images are 
expected to be more constant, from one image to another. The experiment, firstly, 
performed on the alginate spheres without microbubbles to establish any MR signal 
changes will not be due to pressure changes. Then, a further investigation carried out 
on the meal with the presence of the microbubbles. 
In-Vivo Study on Alginate Spheres without Microbubbles  
Method  
The meal consisted of the alginate spheres without microbubbles in locust bean gum. 
The total amount ingested by the volunteer was about 250 ml. For this study, the 
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volunteer was in a supine position and the images were obtained in the coronal plane 
using the BTFE sequence with and without the respiratory triggering. In addition, the 
images were also acquired with two different slice thicknesses, 10 mm and 15 mm, and 
two different T2-prep times, 50 and 75 ms, exploring their effect in optimising the 
sequence to better reduce the movement artefact.  
Results  
For the image analysis, the software was written to allow ROI tracking from frame to 
frame performed on interpolated images, with eight additional pixels in both 
dimensions, by using a cross-correlation analysis with the interpolated image of the first 
frame on the selected ROIs. A square-shaped ROI (Figure 7.16) from the meal was 
selected, and another one from a small section of the liver, served as a reference 
because signal intensity within this region is expected to have less deviation. The ROI 
tracking was undertaken to try to have the selected ROIs within the exact same tissue 
area in each of the acquired dynamic images, in spite of small horizontal and vertical 
shifts taking place in the raw images.  
 
 
Figure 7.16 – a) MR image acquired showing the meal (alginate spheres without 
microbubbles) in the stomach with the surrounding organs. The white squares indicate 
the selected ROIs for signal intensity analysis, in the liver and in the meal (stomach). 
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When comparing the experiments with and without the use respiratory triggering, the 
MR images clearly appear more stable and less affected by the movement artefact with 
the use of the respiratory gating. The percentage of signal intensity change without the 
respiratory triggering is about 6 to 8 %, decreasing to about 2 to 3 % with the respiratory-
gating (Figure 7.17). However, there are also a few images exhibiting very large artefacts, 
coming from rare instances where the scanner failed at tracking the volunteer's 
respiration. In addition, large susceptibility artefacts appeared on all the images caused 
by blood flow and lung displacement which affect the signal substantially. The affected 
regions were avoided from the signal analysis and not included in the signal deviations 
exhibited by the data shown on the graphs. 
In this particular study, the pressure change within the stomach should not bring any 
effect because the meal consisted of the spheres without microbubbles. However, the 
signal variations still measured in this meal with the use of respiratory triggering could 
be originating from T1 partial recovery (Figure 7.18), since the value of the repetition 
time, TR, was not set constant with the use of this technique. This could be affected by 
the change in respiration rate and depth of the participant over time. The signal intensity 
change in the meal follows the TR quite closely, probably due to its long T1, whilst the 
liver does not, probably due to its short T1. Additionally, a signal drift can be seen in the 
meal which most possibly caused by the effect of the stomach acid. However, this also 
appeared in the liver, which was not expected, could be caused by the scanner electronic 
drift. For the next in-vivo study, when using the meal with the presence of microbubbles, 
the signal intensity change is expected to be higher than this, due to the effect of the 
pressure in the stomach.  
In the experiment investigating the effect of changing the slice thickness between 5 mm 
to 10 mm, we only found a very minimal effect with a reduction in the signal variation 
about 1 % (Figure 7.19). This result is in agreement with the in-vitro experiment result 
in section 7.6.2.2, where the variation in the slice thickness did not bring any strong 
effect on the sensitivity of the contrast agent to pressure. When increasing the T2-prep 
time from 50 to 75 ms, there is no deterioration of the signal changes, probably because 
the T2* sensitivity is developing in the tissue without the application of the field 
gradients. 
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Figure 7.17 – The signal intensity change in the meal (alginate spheres without 
microbubbles) and in the liver (a) without and (b) with the respiratory triggering. The 
signal fluctuation is more prominent in the images acquired without the respiratory 
triggering, approximately 6 to 8 %, compared to its counterpart with the respiratory 
triggering, only around 2 to 3 % signal changes. The imaging parameters for both data 
sets are as follow; T2-prep time = 50 ms and slice thickness = 10 mm. 
 
Figure 7.18 – Plots showing the signal intensity of the meal (alginate spheres without 
microbubbles) and the liver within the selected ROIs in each of the image frames, with 
their corresponding repetition time. The signal intensity changes with the change in the 
repetition time on each of the frames, especially in the meal.  
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Figure 7.19 – Plots demonstrating the signal intensity change in the meal (alginate 
spheres without microbubbles) and the liver, when exploring the effect of changing MRI 
parameters. The parameters are changed in reference to the experiment in Figure 7.17; 
(a) slice thickness 15 mm, T2 prep time 50 ms and (b) slice thickness 10 mm, T2 prep time 
75 ms. The imaging was performed with the use of the respiratory triggering. By 
comparing to the plot in Figure 7.17(b), there is no obvious sensitivity change observed 
with the change of these parameters.  
 
In-Vivo Study on Alginate Spheres with Microbubbles  
Method  
The meal with a volume of 500 ml consisted of the alginate spheres with microbubbles 
in locust bean gum. In previous in-vivo studies, the microbubbles were prepared 
approximately 24 hours before the MRI acquisition, but this time, they were prepared 
in the morning of the day of the experiment, as we anticipated that the sensitivity of the 
contrast agent could be further enhanced if the microbubbles were prepared 
immediately before the examination. The total amount ingested by the volunteer was 
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about 250 ml, in two separate smaller meals. The same volunteer had participated in 
the previous study (section 7.7.1) with the same meal without microbubbles. 
For this experiment, the volunteer was in a prone position in the MR scanner, with the 
hope that in this position the body or the stomach movement caused by the breathing 
would be minimised. The scanning was undertaken using the BTFE sequence (T2-prep 
time = 50 ms, slice thickness = 5 mm) with the respiratory triggering.
 
Results  
 
Figure 7.20 – a) MRI image showing the meal (alginate spheres with microbubbles) in 
the stomach, with the surrounding organs, acquired with the BTFE sequence with the 
respiratory gating. The white squares represent the ROI selections for signal intensity 
analysis in the meal and the liver. 
 
The images were analysed by selecting two square-shaped ROIs (Figure 7.20), one from 
the meal, where pixel intensity changes due to the pressure are expected, and another 
one from a small section of the liver, where pixel intensity deviations are expected to be 
much lower. The main challenge of the signal intensity analysis is to find a suitable area 
where the meal spatial structure holds fairly constant, as there is a lot of movements 
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within the meal due to the natural peristaltic effect coming from the wall of the stomach. 
Hence, similar to the analysis undertook in the previous study (7.7.1.2), an ROI tracking 
from frame to frame was performed on the interpolated images, with eight additional 
pixels in both dimensions, by using a cross-correlation analysis with the interpolated 
image of the first frame on both ROIs. The purpose is to try to have the selected ROIs to 
track the same tissue area in each of the acquired dynamic images. The meal tracking 
here is easier due to its severe heterogeneity. The tracking does not work very well in a 
homogeneous area, hence the successful tracking of the ROI in the liver required the 
selection of a second ROI with heterogeneous structure, taken from the blood vessels 
within the liver. Then, after tracking of the corresponding tissue was successful, the plots 
of the signal intensity coming from both of these areas are produced.  
Initially, the signal intensity coming from the meal is seen to exhibit changes within 10 %. 
However, the signal coming from the liver, which should be constant, is also seen to 
fluctuate within 5 % (Figure 7.21). The similar effect has been previously exhibited 
(section 7.7.1), and we suggest that this could be due to the effect of the T1. This is 
further evidenced when we observed the fluctuation of the signal intensity where it is 
seen to follow closely the changes in the acquisition time length of each of the image 
frames (Figure 7.22). Although there was certain instance in the measurement shown in 
Figure 7.21 (from 1.1 to 2 min), where the signal intensity in the liver is fairly constant 
while in the stomach exhibited 5 %, the length of this occasion was too short to enable 
us to conclude that this was genuinely coming from pressure exerted by the stomach. 
By assuming the signal coming from the liver as the baseline, a plot then produced by 
dividing the mean signal intensity of the meal over the liver (Figure 7.23). We were 
hoping that this plot is closer to disclosing the effect of the pressure changes within the 
antrum of the stomach, although unfortunately these signal changes are also resulting 
from the meal motion combined with the meal heterogeneity, the meal elasticity, the 
SNR and the T1 differences of the meal and the liver. In comparison with the previous 
experiment where a meal without microbubbles was explored in section 7.7.1, the signal 
intensity changes here are definitely larger, but the meal heterogeneity is also much 
enhanced, and we cannot unfortunately conclude that the larger signal intensity 
changes here are solely due to the pressure changes. 
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Figure 7.21 – MRI Signal intensity changes within the ROIs (shown in Figure 7.20) in the 
meal of alginate spheres with microbubbles (antrum area) and the liver, acquired with 
the BTFE sequence with the respiratory triggering. The signal intensity change in the 
meal is between 5 to 10 %, while it is less than 5 % in the liver. 
 
Figure 7.22 – Plots showing the signal intensity of the meal (alginate spheres with 
microbubbles) and the liver within the selected ROIs in each of the image frames, with 
their corresponding repetition time. The signal intensity changes with the change in the 
time acquisition in each the frames.  
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Figure 7.23 – Plot showing the division of the mean signal intensity in the meal over the 
liver. The fluctuation seen here could be due to the pressure changes, however, this 
could also be influenced by the T1 differences between the liver and that of the meal. 
 
In spite of the respiratory triggering, some relative tissue displacements taking place 
from frame to frame can be seen, the meal is being pro-actively moved by the stomach, 
and the meal itself exhibits elasticity which makes the tracking of a portion of the meal 
very difficult. The meal pixel intensity is very heterogeneous locally within the length 
scale of the alginate spheres, due to the T2* effect of microbubbles, and non-locally on 
the length scale of the stomach, which is the brightest towards the antrum, as would be 
expected as the pressure there is the highest. The meal exhibits little relative motion far 
away from the antrum, and large deviations from frame to frame in the antrum. 
In addition, similarly to what can be seen in 7.7.1, it appears that the overall signal 
intensities coming from both the meal and the liver are decreasing over time, with a 
signal drift about 20 % and 8 %, respectively in the meal and in the liver, within this 5.5 
minutes observation. The enhanced drift seen in the meal could be due to the effect of 
the acid on the meal.  
Participants’ Feedback 
Every time after finishing each of the in-vivo experiments, the volunteers were asked for 
any feedback regarding their whole experience throughout the study, from ingesting the 
meal to the MRI measurements. In addition, a verbal follow-up regarding the volunteer 
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general conditions, especially related to any digestive issue, was also carried out a day 
after the investigation and none of them had any difficulties to report.  
The main feedback we received from all of the participants was that the taste of the 
meal was too plain and could be further improved. This led to a difficulty in finishing 
ingesting the whole volume of the meal, and only one participant had managed to 
consume the whole meal. We did an initial investigation to try to add sweetener and 
flavouring (section 7.3), unfortunately this affected adversely the signal intensity of the 
meal, hence no taste enhancer was added. This should be further explored in the future 
to be able to provide a better experience for the volunteer (or patient). It was also 
mentioned that one of the challenges was not being allowed to chew the meal, instead 
we requested that the meal was swallowed whole, to keep the microbubbles functional 
by keeping the shape of the spheres. This perhaps could be tackled with the use of a 
liquid meal or reducing the size of the alginate sphere. 
Conclusions 
In this chapter, five MRI in-vivo studies involving human volunteers and three in-vitro 
experiments were undertaken to test the functionality of the lipid-based microbubbles 
suspended in alginate gel in the form of small spheres, to measure the dynamic pressure 
changes within the human stomach. Following the in-vitro experiments set-up, this 
contrast agent has been proven to be capable of sensing pressure changes with a typical 
sensitivity exhibited around 40 % signal changes per bar. In the initial in-vivo studies 
using the RARE sequence, the measurement was mainly flawed by the movement 
caused by breathing. Then, this effect was reduced by using a fast imaging sequence 
called the BTFE, incorporated with a spin echo pulse sequence. Then, we encountered a 
further issue where the signal variations due to the fact that each MRI image captures a 
slightly different area, but this was minimised by the use of the respiratory triggering. 
Although the peristaltic movement within the stomach is seen to alter the overall signal 
intensity of the contrast agent meal, at this point of the study we could not conclude 
that these signal intensity changes are solely due to the pressure changes. The signal 
changes may result from (i) the T1 effect because the MRI acquisition was triggered by 
respiratory gating, (ii) tissue elasticity (slight ingress of varying tissues in different frames 
168 
 
 
are seen in the analysed ROIs) (iii) the SNR. One alternative way perhaps can improve 
the condition caused by these factors is by replacing the meal with much smaller 
alginate spheres. Another option, using a homogeneous liquid meal would probably be 
one of the solutions, however, there is a high risk of the meal exhibiting an 
instantaneous pressure equilibration and possible faster effect of the stomach acid on 
the liquid meal.  
For further application of this technique, instead of measuring the dynamic pressure 
change in the antrum, it could also be used to measure the tonic pressure change on 
feeding by the stretching and relaxation of the stomach wall muscles, which currently 
can only be measured invasively by a barostat. 
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8 DISCUSSION 
This work is focusing on the development of microbubble-based contrast agents for 
ingestion, for humans, with applications in diagnostic Magnetic Resonance Imaging of 
the gastrointestinal system, by means of non-invasive meal pressure measurement. A 
pressure sensitive MR contrast agent has been manufactured and tested, through in-
vitro and in-vivo investigations. The contrast agent comprised of gas-filled microbubbles 
suspended in soft-solid alginate spheres, which has been specifically tailored to sense 
the pressure changes in the human stomach. To our best knowledge, this method has 
never been explored before. The principle underlying the method is that of the 
compressibility of the microbubbles enabling size changes when the pressure is applied, 
causing a change of magnetic field perturbation on its surrounding, hence the change of 
the MR signal coming from water molecules diffusing in this environment. 
The T2eff relaxation time of the alginate spheres has been assessed, in both the 2.35T 
small animal Bruker and the 3T whole body Philips MRI scanners, by comparing the 
preparations with and without the presence of microbubbles. A substantial decrease of 
the T2eff was observed in the presence of gas-filled microbubbles in the alginate spheres, 
by a factor of 2. Dynamic measurements have been further used to test the functionality 
of these contrast agents, through in-vitro investigations, in several conditions including 
in a solvent mimicking the human gastric solution at body temperature. The alginate 
spheres with microbubbles yielded a high level of sensitivity, up to 40 % MR signal 
change per bar, whilst the signal intensity remains constant in the alginate spheres 
without microbubbles. This further supports the fact that the signal intensity change 
coming from the contrast agent is solely due to the presence of microbubbles. 
An interesting additional outcome of this study is the demonstration of a spatial gradient 
of T2eff value seen between the centre and the periphery of alginate spheres with 
microbubbles. We anticipated the microbubbles density and the curing process may 
both contribute to the mechanisms causing this radial spatial gradient. This effect was 
further explored by measuring the sensitivity of the two areas to pressure changes, 
where it was seen that the T2eff value in the centre of the alginate sphere was constantly 
higher compared to the periphery, suggesting microbubbles density is higher in the 
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periphery. Both of these regions contribute to the increase in the T2eff value of the whole 
alginate spheres when the pressure is increased, with the periphery exhibits a higher 
sensitivity, which is up to 58 % T2eff change per bar whilst the centre exhibits 24 % change 
per bar.  
A gel solution made of the locust bean gum (2 % w/v) was used as a suspending medium 
and as an immobilisation tool, by restricting the alginate spheres from moving upwards 
due to the natural buoyancy of the entrapped microbubbles. At the same time, this gel 
was also found to be useful in slowing down the acidification effect, where it was seen 
to cause a decrease in the T2eff value of the spheres. With these in hand, the contrast 
agent was further tested in-vivo to demonstrate its capability to be used, in conjunction 
with an MRI scanner, as a novel technique in measuring the dynamic pressure change in 
the human stomach. 
Five in-vivo studies were carried out on healthy human volunteers, and a 500-ml of the 
contrast agent was prepared as a meal for each volunteer. The initial result, when the 
RARE sequence was used, showed that the acquired signal change (up to 300 % change) 
was dominated by the motion artefact caused by breathing. This effect was successfully 
reduced by using an ultrafast BTFE (or TrueFIST) MRI sequence, with echo pulse 
preparation.  
Later, a further issue was encountered where the signal variation being measured found 
to be largely due to the inhomogeneity of the meal with differing parts of the meal being 
captured on each separate consecutive MRI images. We attempted to minimise this by 
the use of the respiratory triggering and more advance post processing for image 
analysis, where the software was written on MATLAB to allow ROI tracking from frame 
to frame performed on interpolated images, by using a cross-correlation analysis with 
the interpolated image of the first frame on the selected ROIs. This was undertaken to 
try to have the selected ROIs within the exact same tissue area in each of the acquired 
dynamic images, in spite of small horizontal and vertical shifts taking place in the raw 
images. 
However, the natural peristalsis of the stomach wall, especially in the antrum region, 
causing a partial volume effect which made it additionally challenging to capture the 
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same area of the meal in each of the dynamic images being acquired. By using the cross-
correlation analysis, the signal intensity change exhibited in the meal is between 5 to 
10 %. It has been shown previously by Bortolotti et al. (2000) that the pressure exerted 
in the stomach on its meal, within the antrum region, during the digestive period is 
ranging between 30 and 82 mmHg (40 to 109 mbar). This means, our result is slightly 
higher than expected, which is between 1.6 to 4.4 % signal change, when considering 
the sensitivity of the contrast agents at 40 % change per bar. Hence, at this point of the 
in-vivo study we could not conclude that these signal intensity changes are solely due to 
the pressure changes. The signal changes may result from (i) the T1 effect because the 
MRI acquisition was triggered by respiratory gating, (ii) tissue elasticity (slight ingress of 
varying tissues in different frames are seen in the analysed ROIs) (iii) the SNR. 
For further work, possible solutions exist in the production of alginate spheres in a 
smaller form or in a liquid meal, however, there is a high risk of the meal exhibiting an 
instantaneous pressure equilibration and possible faster effect of the stomach acid on 
the liquid meal. This also means it is worth exploring different suspending medium which 
can slow down the deterioration of the sensitivity due to the acid. Another possible 
application is that the contrast agent can be used to measure the tonic pressure in the 
region of the body of the stomach, where less wall movement is seen, as compared to 
the dynamic changes in the antrum. In the future success of this technique, we may also 
be able to use this contrast agent to track down further to the intestines, not just for 
measuring the pressure but also for other investigations such observing the effect of 
acidic and alkaline environment in digestive system. 
Besides, there has still many scopes can be further explored; the preparations and the 
sensitivity of the contrast agent meal, as well as the combination of the MRI technique 
such as the use of a different MRI sequence and differing in the external magnetic field 
strength. 
When we increased the bubble to twice of the density, the sensitivity only increased 
approximately 29 %, which is much less than we expected, a 200 % increase as 
demonstrated by Bencsik et al. (2013). We suspect that at higher bubbles density, the 
gradient fields originating from individual bubbles start to overlap causing the sensitivity 
of the contrast agent with bubble density to leave linearity. Nonetheless, the sensitivity 
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of the microbubble still can be changed by exploiting the magnetic susceptibility of the 
microbubble shell by incorporating magnetic materials on the shell of the bubble, e.g. 
iron nanoparticles. Additionally, the sensitivity of the contrast agent can be further 
increased by exploring different size of microbubbles. 
In terms of the contrast agent preparation, the curing effect can be further investigated 
in forming a stable alginate sphere by manipulating the concentration of the calcium 
lactate solution. Also, it is worth exploring a different method of manufacturing the 
alginate spheres that could result in the creation of homogeneous spheres, in particular, 
internal gelation mechanism which has been previously demonstrated as an alternative 
method with such a potential. Furthermore, we should be able to explore the physical 
condition of the meal, in terms of structure and nutrient content, which can be used to 
observe different behaviour of the stomach for example, the high fat containing 
materials could bring different effect on the stomach function compared to the low fat 
materials. 
In conclusion, these microbubble-loaded alginate spheres have shown great potential 
as biocompatible MR contrast agents measuring localised pressure changes in the 
human stomach. With further improvement, this exciting work will open up an 
alternative and less invasive route for the clinicians to achieve a better understanding 
of the clinical condition related to functional dyspepsia. In comparison to the current 
existing techniques, manometry and bariatric, this method also provides a shorter 
examination time.  
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